Disease_category,Disease,Protein,Protein_definition,NB_individual,NB_case,HR[95%CI],P_value
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,A1BG,Alpha-1B-glycoprotein,2171,104,11.03 [3.46-35.20],5.00462862523612e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AAMDC,Mth938 domain-containing protein,2110,105,0.92 [0.64-1.34],0.6746178419573496
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AARSD1,Alanyl-tRNA editing protein Aarsd1,2479,123,0.98 [0.73-1.30],0.8722114446253639
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ABCA2,ATP-binding cassette sub-family A member 2,2105,101,2.29 [1.56-3.37],2.382790968553888e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ABHD14B,Protein ABHD14B,2469,121,1.03 [0.77-1.39],0.843162954051948
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ABL1,Tyrosine-protein kinase ABL1,2479,123,1.24 [0.99-1.55],0.064860389766831
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ABO,Histo-blood group ABO system transferase,2174,105,0.94 [0.82-1.06],0.2982234978997461
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ABRAXAS2,BRISC complex subunit Abraxas 2,2105,101,1.12 [0.83-1.51],0.4644766119950888
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",2421,119,1.17 [0.98-1.40],0.0896670374871366
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",2135,102,0.97 [0.72-1.31],0.8645642965238953
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",2168,106,0.85 [0.68-1.06],0.1566658930913302
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ACAN,Aggrecan core protein,2471,122,1.19 [0.69-2.07],0.5314259660386611
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ACE,Angiotensin-converting enzyme,2174,105,2.37 [1.25-4.50],0.0080308815535643
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ACE2,Angiotensin-converting enzyme 2,2451,119,1.11 [0.88-1.40],0.3826294681020442
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ACHE,Acetylcholinesterase,2132,103,1.31 [0.80-2.15],0.2899449947139075
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ACOT13,Acyl-coenzyme A thioesterase 13,2165,101,0.99 [0.84-1.17],0.93074730002428
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,2498,123,0.95 [0.70-1.31],0.7659062337486927
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ACP1,Low molecular weight phosphotyrosine protein phosphatase,2106,103,0.69 [0.44-1.09],0.1139812220132659
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ACP5,Tartrate-resistant acid phosphatase type 5,2513,124,2.10 [1.37-3.23],0.0006959902460874
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ACP6,Lysophosphatidic acid phosphatase type 6,2513,125,1.14 [0.88-1.47],0.3186954551613332
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ACRBP,Acrosin-binding protein,2161,104,1.09 [0.67-1.76],0.734653983604471
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ACRV1,Acrosomal protein SP-10,2106,103,1.26 [1.08-1.48],0.0035872584967787
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ACSL1,Long-chain-fatty-acid--CoA ligase 1,2105,101,0.88 [0.48-1.61],0.6710316971286516
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ACTA2,"Actin, aortic smooth muscle",2451,119,2.11 [1.70-2.62],1.4917268770559788e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ACTN2,Alpha-actinin-2,2105,101,1.29 [0.99-1.69],0.0607940987476443
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ACTN4,Alpha-actinin-4,2444,122,1.23 [0.78-1.92],0.3752151376248771
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ACVRL1,Serine/threonine-protein kinase receptor R3,2472,122,6.37 [4.35-9.33],1.5902091040361839e-21
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ACY1,Aminoacylase-1,2498,123,0.91 [0.72-1.13],0.3845027095825434
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,2105,101,1.24 [0.91-1.69],0.1818537492862678
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ACYP1,Acylphosphatase-1,2128,102,0.87 [0.65-1.17],0.349940252574241
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ADA,Adenosine deaminase,2530,124,1.41 [0.93-2.12],0.1050263116894339
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ADA2,Adenosine deaminase 2,2482,122,3.06 [2.37-3.94],6.106813466173948e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,2106,103,2.60 [1.76-3.83],1.4705593102941751e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,2451,119,1.74 [1.05-2.87],0.0306528769179319
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,2476,122,2.66 [1.76-4.04],3.983047434181535e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,2530,124,2.57 [1.55-4.27],0.0002585196876709
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,2513,124,2.19 [1.39-3.45],0.0006739035780714
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,2165,101,3.69 [2.43-5.62],1.002552937376713e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,2106,103,1.86 [1.02-3.39],0.0438507655399911
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,2530,124,1.53 [0.81-2.90],0.1880273414889469
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,2479,123,1.68 [1.19-2.37],0.0029197236913065
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,2451,119,1.69 [1.21-2.37],0.0022622416010443
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,2106,103,1.77 [1.13-2.77],0.0121328940121048
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,2497,124,0.79 [0.57-1.11],0.1740908441931932
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ADAMTSL2,ADAMTS-like protein 2,2175,103,2.62 [1.77-3.86],1.2383469404068827e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ADAMTSL4,ADAMTS-like protein 4,2110,105,1.78 [0.82-3.85],0.1439377005294966
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ADAMTSL5,ADAMTS-like protein 5,2168,106,1.24 [0.79-1.94],0.3422134601872583
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,2421,119,1.05 [0.64-1.71],0.8586290888203619
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ADD1,Alpha-adducin,2132,103,0.91 [0.69-1.20],0.5041942914281701
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ADGRB3,Adhesion G protein-coupled receptor B3,2472,122,3.74 [2.44-5.72],1.370014519930501e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ADGRD1,Adhesion G-protein coupled receptor D1,2132,103,2.19 [1.48-3.23],7.723944897534109e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ADGRE1,Adhesion G protein-coupled receptor E1,2165,101,1.49 [1.10-2.04],0.011109290938709
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ADGRE2,Adhesion G protein-coupled receptor E2,2510,121,4.64 [2.89-7.45],1.9363819000234668e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ADGRE5,Adhesion G protein-coupled receptor E5,2520,124,3.44 [2.37-5.00],9.679926657123023e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ADGRF5,Adhesion G protein-coupled receptor F5,2168,106,1.66 [0.81-3.40],0.1654177564359376
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ADGRG1,Adhesion G-protein coupled receptor G1,2479,123,1.48 [1.31-1.68],6.22215833470298e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ADGRG2,Adhesion G-protein coupled receptor G2,2498,123,0.32 [0.18-0.55],4.09285593286534e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ADGRV1,Adhesion G-protein coupled receptor V1,2108,103,0.85 [0.61-1.17],0.3164783690900243
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ADH1B,All-trans-retinol dehydrogenase,2132,103,0.85 [0.68-1.06],0.1574990063090906
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,2451,119,0.72 [0.60-0.87],0.0007589954069221
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ADIPOQ,Adiponectin,2171,104,0.94 [0.72-1.22],0.6514357828781372
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ADM,Pro-adrenomedullin,2516,125,6.88 [3.93-12.03],1.4409036200693072e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ADRA2A,Alpha-2A adrenergic receptor,2105,101,0.82 [0.58-1.16],0.2551714121740424
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AFAP1,Actin filament-associated protein 1,2132,103,0.85 [0.67-1.09],0.198895425877037
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AFM,Afamin,2171,104,0.37 [0.16-0.81],0.0137882447930139
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AFP,Alpha-fetoprotein,2469,122,0.59 [0.45-0.77],7.168213506245347e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AGBL2,Cytosolic carboxypeptidase 2,2108,103,1.17 [0.96-1.42],0.1149958434340169
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AGER,Advanced glycosylation end product-specific receptor,2497,121,1.71 [1.19-2.46],0.0039933336574327
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AGR2,Anterior gradient protein 2 homolog,2414,118,1.41 [1.21-1.63],8.470520787521967e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AGR3,Anterior gradient protein 3,2416,119,1.20 [0.91-1.57],0.1950274020171456
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AGRN,Agrin,2510,121,3.23 [2.46-4.23],2.1894918310017402e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AGRP,Agouti-related protein,2530,124,2.17 [1.58-2.99],1.6253234326504705e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AGT,Angiotensinogen,2174,105,1.09 [0.50-2.38],0.8317087212239567
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AGXT,Serine--pyruvate aminotransferase,2498,123,1.05 [0.86-1.27],0.6496014436141462
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AHCY,Adenosylhomocysteinase,2498,123,0.95 [0.75-1.20],0.6602011729861444
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AHNAK,Neuroblast differentiation-associated protein AHNAK,2110,105,1.07 [0.60-1.90],0.8270137884762293
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AHNAK2,Protein AHNAK2,2110,105,1.75 [1.07-2.85],0.0246594081683303
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,2161,104,0.92 [0.67-1.27],0.62800128482768
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AHSG,Alpha-2-HS-glycoprotein,2174,105,1.77 [0.88-3.56],0.109268568981763
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AHSP,Alpha-hemoglobin-stabilizing protein,2498,122,0.86 [0.71-1.05],0.1348001784718979
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AIDA,"Axin interactor, dorsalization-associated protein",2119,101,1.00 [0.80-1.26],0.9991719723700744
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AIF1,Allograft inflammatory factor 1,2421,119,0.97 [0.70-1.34],0.8601509261547902
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AIF1L,Allograft inflammatory factor 1-like,2110,105,1.37 [1.04-1.79],0.0225824150836356
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AIFM1,"Apoptosis-inducing factor 1, mitochondrial",2476,123,1.07 [0.92-1.24],0.3782093468127473
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AK1,Adenylate kinase isoenzyme 1,2498,123,0.74 [0.57-0.96],0.0210252832048821
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AK2,"Adenylate kinase 2, mitochondrial",2160,104,0.92 [0.77-1.10],0.3524521112971572
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AKAP12,A-kinase anchor protein 12,2132,103,0.87 [0.32-2.34],0.7765054126289964
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AKR1B1,Aldo-keto reductase family 1 member B1,2421,119,1.09 [0.88-1.35],0.4089932458487098
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AKR1B10,Aldo-keto reductase family 1 member B10,2119,101,1.08 [0.86-1.35],0.5062205182512121
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AKR1C4,Aldo-keto reductase family 1 member C4,2451,119,1.07 [0.76-1.50],0.7089235798235392
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AKR7L,Aflatoxin B1 aldehyde reductase member 4,2106,103,1.00 [0.78-1.29],0.9754909661204562
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AKT1S1,Proline-rich AKT1 substrate 1,2431,119,1.14 [0.89-1.46],0.302575574502909
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AKT2,RAC-beta serine/threonine-protein kinase,2162,104,0.95 [0.82-1.10],0.5051344068233443
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AKT3,RAC-gamma serine/threonine-protein kinase,2405,118,1.15 [0.87-1.53],0.3257652454252573
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ALCAM,CD166 antigen,2530,124,4.86 [2.49-9.49],3.549360236892631e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ALDH1A1,Retinal dehydrogenase 1,2505,122,0.80 [0.61-1.04],0.0988075012430515
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ALDH2,"Aldehyde dehydrogenase, mitochondrial",2161,104,1.38 [1.14-1.66],0.0007768588092914
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",2497,123,0.94 [0.77-1.14],0.5337666456411658
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",2162,104,1.07 [0.72-1.61],0.7282918605579343
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ALMS1,Alstrom syndrome protein 1,2135,102,1.63 [1.20-2.21],0.0018197350651991
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ALPI,Intestinal-type alkaline phosphatase,2106,103,1.13 [0.98-1.30],0.0951501705985404
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ALPP,"Alkaline phosphatase, placental type",2479,123,1.11 [0.96-1.29],0.1719434427382133
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AMBN,Ameloblastin,2444,122,0.76 [0.39-1.49],0.4247399532854286
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AMBP,Protein AMBP,2514,125,15.59 [8.24-29.51],3.240293677797936e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,2175,103,1.34 [0.61-2.93],0.4690056345989355
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AMFR,E3 ubiquitin-protein ligase AMFR,2431,119,1.01 [0.77-1.33],0.9463513494513864
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AMIGO1,Amphoterin-induced protein 1,2119,101,0.93 [0.62-1.40],0.7382442258453769
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AMIGO2,Amphoterin-induced protein 2,2479,123,2.71 [1.45-5.09],0.0018649849294339
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AMN,Protein amnionless,2444,122,1.31 [0.95-1.82],0.1033122861068887
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AMOT,Angiomotin,2132,103,0.92 [0.58-1.48],0.7375381899317787
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AMOTL2,Angiomotin-like protein 2,2153,103,1.11 [0.77-1.62],0.567649157057533
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AMPD3,AMP deaminase 3,2160,104,1.06 [0.82-1.37],0.6670000960547807
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,2041,94,0.87 [0.59-1.26],0.4537400208475922
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AMY2A,Pancreatic alpha-amylase,2412,113,1.06 [0.77-1.44],0.7299657323346019
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AMY2B,Alpha-amylase 2B,2338,109,1.06 [0.78-1.45],0.7155569025621555
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ANG,Angiogenin,2494,122,2.55 [1.70-3.84],6.345829745787009e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ANGPT1,Angiopoietin-1,2489,121,1.03 [0.85-1.24],0.767616769323696
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ANGPT2,Angiopoietin-2,2516,125,3.25 [2.34-4.51],1.869020698033709e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ANGPTL1,Angiopoietin-related protein 1,2456,121,1.72 [1.01-2.92],0.0466685184727949
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ANGPTL2,Angiopoietin-related protein 2,2499,121,1.74 [1.19-2.54],0.0040474585645686
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ANGPTL3,Angiopoietin-related protein 3,2499,122,1.01 [0.66-1.55],0.9489617841155562
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ANGPTL4,Angiopoietin-related protein 4,2509,121,3.47 [2.50-4.84],1.6536074182872496e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ANGPTL7,Angiopoietin-related protein 7,2516,125,2.33 [1.64-3.32],2.7356247307025023e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ANK2,Ankyrin-2,2105,101,1.02 [0.77-1.35],0.9032663857870888
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,2106,103,1.00 [0.79-1.26],0.9871762134992028
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ANKRA2,Ankyrin repeat family A protein 2,2087,102,0.80 [0.56-1.14],0.2249513962981953
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ANKRD54,Ankyrin repeat domain-containing protein 54,2421,119,0.86 [0.64-1.16],0.3305346893830978
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,2110,105,0.85 [0.49-1.46],0.5491681427299602
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ANPEP,Aminopeptidase N,2498,122,1.82 [1.09-3.04],0.0211679680334251
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ANXA1,Annexin A1,2120,103,0.90 [0.58-1.39],0.6260710862604231
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ANXA10,Annexin A10,2431,119,1.15 [0.96-1.37],0.1222087717831266
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ANXA11,Annexin A11,2496,123,0.85 [0.67-1.06],0.1518231920502562
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ANXA2,Annexin A2,2078,105,0.97 [0.74-1.25],0.7930740008291177
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ANXA3,Annexin A3,2513,124,0.98 [0.78-1.23],0.8600005618684539
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ANXA4,Annexin A4,2484,121,0.87 [0.69-1.10],0.2458328170531435
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ANXA5,Annexin A5,2424,119,2.49 [1.83-3.37],4.363522443466645e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AOC1,Amiloride-sensitive amine oxidase [copper-containing],2444,122,0.84 [0.59-1.18],0.3035066592667294
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AOC3,Membrane primary amine oxidase,2503,122,7.05 [4.43-11.22],1.8034752597667127e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AP1G2,AP-1 complex subunit gamma-like 2,2161,104,0.97 [0.77-1.23],0.7962240028079204
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AP2B1,AP-2 complex subunit beta,2119,101,0.93 [0.62-1.40],0.7334908142679466
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AP3B1,AP-3 complex subunit beta-1,2165,101,1.13 [0.88-1.45],0.3558440767395324
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AP3S2,AP-3 complex subunit sigma-2,2160,104,1.05 [0.71-1.55],0.800647717584648
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,2479,123,1.21 [0.88-1.67],0.2370420383705023
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,APCS,Serum amyloid P-component,2146,104,0.56 [0.32-0.98],0.0415465055704013
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,2510,125,0.93 [0.71-1.23],0.6285748582894661
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,APLP1,Amyloid-like protein 1,2498,123,0.72 [0.53-0.97],0.0331149806206123
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,APOA1,Apolipoprotein A-I,2171,104,0.34 [0.15-0.77],0.0099507340972347
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,APOA2,Apolipoprotein A-II,2174,105,1.50 [1.07-2.12],0.0198743757796052
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,APOA4,Apolipoprotein A-IV,2171,104,3.33 [2.22-5.01],6.133180400758341e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,APOB,Apolipoprotein B-100,2174,105,0.91 [0.40-2.07],0.8162882951143492
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,APOBR,Apolipoprotein B receptor,2110,105,0.86 [0.56-1.33],0.5078472552024897
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,APOC1,Apolipoprotein C-I,2166,104,0.47 [0.29-0.77],0.0028416799378892
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,APOD,Apolipoprotein D,2085,101,0.47 [0.26-0.84],0.0112793530815259
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,APOE,Apolipoprotein E,2171,104,0.71 [0.49-1.03],0.0712777973022706
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,APOF,Apolipoprotein F,2174,105,1.12 [0.65-1.95],0.6833391829398925
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,APOH,Beta-2-glycoprotein 1,2505,122,1.47 [1.00-2.17],0.0504948216395856
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,APOL1,Apolipoprotein L1,2174,105,0.70 [0.48-1.03],0.0731505671708651
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,APOM,Apolipoprotein M,2503,122,0.42 [0.25-0.71],0.0011700382780225
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,APP,Amyloid-beta precursor protein,2503,121,1.18 [0.93-1.50],0.1657427312273896
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,APPL2,DCC-interacting protein 13-beta,2132,103,0.96 [0.81-1.14],0.6327420818271923
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,APRT,Adenine phosphoribosyltransferase,2474,122,1.16 [0.82-1.66],0.4025440247840621
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ARAF,Serine/threonine-protein kinase A-Raf,2135,102,1.06 [0.80-1.40],0.6761175843249321
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AREG,Amphiregulin,2479,123,2.97 [2.31-3.82],1.8580072180201506e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ARF6,ADP-ribosylation factor 6,2165,101,0.99 [0.82-1.18],0.8755177717888672
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ARFIP1,Arfaptin-1,2162,104,1.06 [0.81-1.41],0.6617610383774555
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ARG1,Arginase-1,2463,123,0.59 [0.44-0.79],0.0005389158734873
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ARG2,"Arginase-2, mitochondrial",2161,104,1.34 [0.93-1.93],0.1160770836879563
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ARHGAP1,Rho GTPase-activating protein 1,2421,119,0.73 [0.51-1.04],0.0846359863834831
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ARHGAP25,Rho GTPase-activating protein 25,2421,119,1.07 [0.81-1.40],0.6437475362393984
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ARHGAP30,Rho GTPase-activating protein 30,2135,102,0.99 [0.59-1.65],0.9644180959202004
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ARHGAP45,Rho GTPase-activating protein 45,2132,103,1.02 [0.81-1.29],0.8580428545926675
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ARHGAP5,Rho GTPase-activating protein 5,2087,102,0.96 [0.74-1.24],0.754082174707762
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ARHGEF1,Rho guanine nucleotide exchange factor 1,2160,104,1.03 [0.82-1.27],0.8212429782778082
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ARHGEF10,Rho guanine nucleotide exchange factor 10,2162,104,1.05 [0.87-1.27],0.6209746681930732
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ARHGEF12,Rho guanine nucleotide exchange factor 12,2500,123,1.04 [0.89-1.22],0.6000687160859803
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ARHGEF5,Rho guanine nucleotide exchange factor 5,2108,103,1.21 [0.96-1.53],0.1148443083345591
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ARID3A,AT-rich interactive domain-containing protein 3A,2108,103,0.87 [0.51-1.47],0.5969343469992977
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ARID4B,AT-rich interactive domain-containing protein 4B,2431,119,0.96 [0.65-1.42],0.8368243676320739
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ARL13B,ADP-ribosylation factor-like protein 13B,2105,101,0.98 [0.75-1.30],0.9047872789971344
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,2105,101,1.01 [0.62-1.65],0.9730241714801142
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ARMCX2,Armadillo repeat-containing X-linked protein 2,2108,103,1.09 [0.79-1.51],0.6097738711675675
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ARNT,Aryl hydrocarbon receptor nuclear translocator,2444,122,1.45 [1.14-1.86],0.0030522046810988
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,2105,101,0.97 [0.65-1.43],0.8620170912109241
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ARSA,Arylsulfatase A,2505,122,0.99 [0.70-1.39],0.9412857653887527
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ARSB,Arylsulfatase B,2479,123,1.02 [0.77-1.36],0.864368772293759
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ART3,Ecto-ADP-ribosyltransferase 3,2503,122,2.14 [1.47-3.11],6.65982907947353e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ART5,Ecto-ADP-ribosyltransferase 5,2108,103,1.16 [0.90-1.50],0.2631728180262359
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ARTN,Artemin,2444,122,1.23 [0.90-1.69],0.1959956665355432
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ASAH1,Acid ceramidase,2162,103,1.04 [0.69-1.56],0.86370095150979
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ASAH2,Neutral ceramidase,2476,122,0.92 [0.70-1.22],0.5750145388935395
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ASGR1,Asialoglycoprotein receptor 1,2476,122,3.98 [2.74-5.78],4.322408639419849e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ASGR2,Asialoglycoprotein receptor 2,2174,105,4.86 [2.74-8.63],6.564649131875779e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ASPN,Asporin,2168,106,2.08 [1.16-3.71],0.0133955034742512
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ASPSCR1,Tether containing UBX domain for GLUT4,2162,104,0.98 [0.73-1.32],0.9152824471705194
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ASRGL1,Isoaspartyl peptidase/L-asparaginase,2110,105,0.94 [0.78-1.14],0.5561900842830237
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ASS1,Argininosuccinate synthase,2105,101,0.96 [0.76-1.21],0.72127582999997
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ATF2,Cyclic AMP-dependent transcription factor ATF-2,2431,119,1.19 [0.99-1.44],0.0671545136225765
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ATF4,Cyclic AMP-dependent transcription factor ATF-4,2087,102,0.85 [0.48-1.49],0.5619763933447983
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ATG16L1,Autophagy-related protein 16-1,2165,101,1.12 [0.90-1.40],0.3260303201590164
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ATG4A,Cysteine protease ATG4A,2421,119,0.92 [0.70-1.22],0.5692467425963051
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ATOX1,Copper transport protein ATOX1,2497,124,1.30 [1.03-1.65],0.0271524167860686
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,2105,101,1.12 [0.75-1.65],0.5876923311864448
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,2105,101,1.35 [0.79-2.29],0.2681365003471968
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,2105,101,1.40 [0.92-2.14],0.1203585695977696
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ATP1B4,Protein ATP1B4,2087,102,0.95 [0.59-1.53],0.8418661394460966
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ATP2B4,Plasma membrane calcium-transporting ATPase 4,2105,101,0.68 [0.44-1.04],0.0767258025318857
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ATP5F1D,"ATP synthase subunit delta, mitochondrial",2105,101,0.97 [0.64-1.45],0.863140786955668
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ATP5IF1,"ATPase inhibitor, mitochondrial",2510,121,1.01 [0.87-1.17],0.8814114601755885
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ATP5PO,"ATP synthase subunit O, mitochondrial",2431,119,1.25 [0.97-1.63],0.0903706819267134
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ATP6AP2,Renin receptor,2421,119,1.61 [1.17-2.22],0.0034532991612255
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ATP6V1D,V-type proton ATPase subunit D,2479,123,1.21 [0.70-2.10],0.5001480292504302
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ATP6V1F,V-type proton ATPase subunit F,2426,118,1.04 [0.82-1.31],0.7657035685124326
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ATP6V1G1,V-type proton ATPase subunit G 1,2110,105,1.08 [0.83-1.40],0.5660480533939389
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ATP6V1G2,V-type proton ATPase subunit G 2,2105,101,0.98 [0.79-1.21],0.8358896949548351
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ATRAID,All-trans retinoic acid-induced differentiation factor,2165,101,3.73 [2.50-5.54],8.595027398790905e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ATRN,"Attractin, Isoform 2",2171,104,2.80 [0.96-8.22],0.0600600036093878
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ATXN10,Ataxin-10,2431,119,1.07 [0.86-1.33],0.5590742819480232
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ATXN2,Ataxin-2,2108,103,0.99 [0.84-1.16],0.8754731165816164
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ATXN2L,Ataxin-2-like protein,2162,104,0.98 [0.67-1.43],0.923173462518391
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ATXN3,Ataxin-3,2160,104,1.00 [0.74-1.36],0.998496947698509
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AXIN1,Axin-1,2500,123,1.02 [0.86-1.20],0.856407801536813
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AXL,Tyrosine-protein kinase receptor UFO,2503,122,2.04 [1.21-3.44],0.007477095553549
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AZI2,5-azacytidine-induced protein 2,2162,104,1.15 [0.83-1.59],0.4115851509399061
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AZU1,Azurocidin,2435,121,0.96 [0.78-1.19],0.7276795088077457
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,B2M,Beta-2-microglobulin,2171,104,3.77 [2.51-5.65],1.5027077330967278e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,2105,101,1.47 [0.58-3.72],0.4176564195713413
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",2110,105,3.96 [2.42-6.47],4.080175693812852e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,B4GALT1,"Beta-1,4-galactosyltransferase 1",2510,121,5.73 [3.54-9.25],9.91776803395743e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,B4GAT1,"Beta-1,4-glucuronyltransferase 1",2505,122,2.08 [1.07-4.04],0.0300656534983401
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BABAM1,BRISC and BRCA1-A complex member 1,2106,103,0.78 [0.36-1.68],0.5245050574603893
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BACH1,Transcription regulator protein BACH1,2500,123,1.02 [0.82-1.27],0.8493345926554177
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BAG3,BAG family molecular chaperone regulator 3,2472,122,0.96 [0.66-1.40],0.8306968500191876
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BAG4,BAG family molecular chaperone regulator 4,2106,103,1.03 [0.71-1.51],0.8607269826232008
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BAG6,Large proline-rich protein BAG6,2451,119,1.36 [0.89-2.07],0.1531187121730697
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,2421,119,1.29 [1.04-1.59],0.0194112211889246
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BAMBI,BMP and activin membrane-bound inhibitor homolog,2421,119,2.70 [2.04-3.57],4.905176298255889e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BANK1,B-cell scaffold protein with ankyrin repeats,2500,123,0.99 [0.85-1.15],0.8937204682781719
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BAP18,Chromatin complexes subunit BAP18,2160,104,1.00 [0.76-1.31],0.9820274888090944
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BATF,Basic leucine zipper transcriptional factor ATF-like,2119,101,1.00 [0.78-1.28],0.9905927599833716
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BAX,Apoptosis regulator BAX,2426,119,1.16 [0.98-1.39],0.0882372660531297
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BCAM,Basal cell adhesion molecule,2505,122,4.03 [2.20-7.38],6.201677956385097e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BCAN,Brevican core protein,2476,122,0.54 [0.35-0.83],0.0053467501831434
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",2168,106,0.99 [0.56-1.74],0.9588876323305482
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",2108,103,0.73 [0.46-1.17],0.1927390606202869
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BCHE,Cholinesterase,2132,103,0.73 [0.41-1.31],0.2865036955219229
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BCL2,Apoptosis regulator Bcl-2,2165,101,1.29 [0.93-1.78],0.1230278439454724
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BCL2L1,Bcl-2-like protein 1,2160,104,0.94 [0.77-1.14],0.5065470436760597
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",2500,123,2.46 [1.58-3.84],7.319839602849834e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BCL2L15,Bcl-2-like protein 15,2106,103,1.16 [0.88-1.54],0.2878624965075522
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BCL7A,B-cell CLL/lymphoma 7 protein family member A,2087,102,0.84 [0.60-1.17],0.2955084614790921
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BCL7B,B-cell CLL/lymphoma 7 protein family member B,2161,104,0.75 [0.45-1.23],0.2533660838756439
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BCR,Breakpoint cluster region protein,2500,123,1.05 [0.89-1.25],0.5582666409162031
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BDNF,Brain-derived neurotrophic factor,2175,103,1.02 [0.81-1.28],0.8605225893021444
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BECN1,Beclin-1,2110,105,1.11 [0.80-1.52],0.5365947399677211
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BEX3,Protein BEX3,2087,102,1.04 [0.71-1.55],0.8287856471539562
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BGLAP,Osteocalcin,2175,103,0.99 [0.82-1.21],0.9516033026798936
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BGN,Biglycan,2419,119,0.95 [0.83-1.09],0.4548181959370947
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BHLHE40,Class E basic helix-loop-helix protein 40,2108,103,0.96 [0.72-1.28],0.7868748393666616
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,2105,101,1.21 [0.55-2.68],0.637006887450423
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BID,BH3-interacting domain death agonist,2500,123,0.89 [0.70-1.14],0.3689578855667269
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BIN2,Bridging integrator 2,2505,122,0.98 [0.82-1.17],0.8454651365584152
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BIRC2,Baculoviral IAP repeat-containing protein 2,2421,119,1.11 [0.86-1.45],0.4241549705369377
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BLMH,Bleomycin hydrolase,2530,124,1.14 [0.70-1.86],0.6073047545915358
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BLNK,B-cell linker protein,2106,103,0.66 [0.38-1.13],0.1271187485420339
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,2108,103,0.73 [0.54-0.98],0.0384411352154583
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,2160,104,0.99 [0.62-1.57],0.9671628430670052
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BLVRB,Flavin reductase,2505,122,0.86 [0.67-1.10],0.2218263681564288
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BMP10,Bone morphogenetic protein 10,2132,103,1.89 [1.08-3.33],0.0261094522400127
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BMP4,Bone morphogenetic protein 4,2472,122,1.00 [0.72-1.37],0.9784838188955164
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BMP6,Bone morphogenetic protein 6,2450,119,1.45 [0.97-2.16],0.0717510847768905
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BMPER,BMP-binding endothelial regulator protein,2132,103,3.09 [1.84-5.19],1.9978266793150293e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,2168,106,0.74 [0.41-1.35],0.3295880385447276
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,2106,103,1.54 [1.07-2.23],0.0211918651116537
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BOC,Brother of CDO,2451,119,3.56 [1.88-6.75],0.0001007116359425
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BOLA1,BolA-like protein 1,2108,103,1.19 [0.89-1.58],0.2467746836177283
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BOLA2_BOLA2B,BolA-like protein 2,2110,105,0.93 [0.65-1.33],0.6974866935018916
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BPIFA2,BPI fold-containing family A member 2,2043,100,0.80 [0.67-0.96],0.0133573078818094
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BPIFB1,BPI fold-containing family B member 1,2497,122,0.87 [0.69-1.11],0.2794126564925242
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BPIFB2,BPI fold-containing family B member 2,2165,106,0.93 [0.72-1.22],0.6093294964049394
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BRAP,BRCA1-associated protein,2143,100,1.07 [0.90-1.29],0.4320670161790426
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BRD1,Bromodomain-containing protein 1,2135,102,0.59 [0.29-1.22],0.1538259252681582
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BRD2,Bromodomain-containing protein 2,2108,103,0.63 [0.32-1.22],0.1679399862513493
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BRD3,Bromodomain-containing protein 3,2105,101,1.04 [0.68-1.60],0.8466399726443681
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BRDT,Bromodomain testis-specific protein,2105,101,0.89 [0.52-1.51],0.6619199306231884
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BRK1,Protein BRICK1,2431,119,1.30 [0.92-1.83],0.1326522551438302
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BRME1,Break repair meiotic recombinase recruitment factor 1,2108,103,1.02 [0.64-1.64],0.9349851878784886
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BRSK2,Serine/threonine-protein kinase BRSK2,2162,104,1.28 [0.78-2.11],0.3212022010291456
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BSG,Basigin,2524,124,6.38 [3.78-10.79],4.490652483731274e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BSND,Barttin,2087,102,0.99 [0.56-1.75],0.9792523409134328
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,2516,124,3.51 [2.04-6.06],6.11414925453197e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BST2,Bone marrow stromal antigen 2,2516,124,1.39 [1.08-1.78],0.0110796418563603
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BTC,Probetacellulin,2421,119,1.12 [0.91-1.39],0.2788791542375839
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BTD,Biotinidase,2171,104,3.44 [1.34-8.80],0.0099815277034916
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BTLA,B- and T-lymphocyte attenuator,2087,102,0.91 [0.71-1.15],0.4202549181051529
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BTN1A1,Butyrophilin subfamily 1 member A1,2158,104,1.14 [0.75-1.74],0.5296174972683965
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BTN2A1,Butyrophilin subfamily 2 member A1,2510,121,5.37 [3.69-7.80],1.31680572099033e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BTN3A2,Butyrophilin subfamily 3 member A2,2500,123,2.72 [1.88-3.93],9.450234999865365e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BTNL10,Butyrophilin-like protein 10,2087,102,0.65 [0.34-1.24],0.1934679750065612
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,C19orf12,Protein C19orf12,2431,119,0.98 [0.80-1.19],0.8153974253595258
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,C1GALT1C1,C1GALT1-specific chaperone 1,2105,101,1.36 [0.97-1.91],0.0719752374377352
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,C1QA,Complement C1q subcomponent subunit A,2516,124,3.80 [1.95-7.39],8.705914263247358e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",2162,104,0.99 [0.73-1.34],0.9287069024415264
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,C1QL2,Complement C1q-like protein 2,2106,103,0.81 [0.51-1.28],0.3625704999273885
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,2503,122,1.82 [1.40-2.36],6.483249237646705e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,2132,103,1.14 [0.68-1.91],0.6198777967573565
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,2162,104,1.20 [0.68-2.11],0.5326847986914369
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,2130,103,1.08 [0.72-1.61],0.7163706374795364
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,C1R,Complement C1r subcomponent,2171,104,0.69 [0.21-2.25],0.5422874012538541
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,C1RL,Complement C1r subcomponent-like protein,2164,104,1.97 [0.76-5.09],0.1609544124714843
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,C1S,Complement C1s subcomponent,2171,104,1.38 [0.54-3.47],0.5002860132341693
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,C2,Complement C2,2503,122,2.77 [1.24-6.16],0.0127210270076627
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,C2CD2L,Phospholipid transfer protein C2CD2L,2426,118,1.43 [1.03-1.97],0.0305788711277933
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,C2orf69,UPF0565 protein C2orf69,2119,101,0.84 [0.56-1.25],0.3826315559983791
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,C3,Complement C3,2063,101,0.66 [0.40-1.10],0.1090203008774431
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,C4BPB,C4b-binding protein beta chain,2497,124,1.00 [0.68-1.47],0.9960961629578816
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,C5,Complement C5,2171,104,2.87 [0.95-8.69],0.0619175001218722
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,C7,Complement component C7,2120,102,4.10 [2.63-6.37],3.8645174064271586e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,C7orf50,Uncharacterized protein C7orf50,2160,104,0.69 [0.25-1.92],0.4764319519729397
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,C8B,Complement component C8 beta chain,2171,104,1.74 [0.96-3.16],0.067576229411363
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,C9,Complement component C9,2174,105,1.38 [1.02-1.86],0.0366142771774829
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,C9orf40,Uncharacterized protein C9orf40,2165,101,0.91 [0.72-1.15],0.4305876468782423
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CA1,Carbonic anhydrase 1,2459,122,0.76 [0.58-1.00],0.0525273357439901
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CA11,Carbonic anhydrase-related protein 11,2421,119,1.36 [0.94-1.97],0.1014399841218517
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CA12,Carbonic anhydrase 12,2479,123,4.67 [3.33-6.54],3.832420543818997e-19
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CA13,Carbonic anhydrase 13,2475,120,1.01 [0.87-1.18],0.895365780789065
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CA14,Carbonic anhydrase 14,2516,125,2.21 [1.54-3.18],1.6546108353506757e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CA2,Carbonic anhydrase 2,2495,122,0.90 [0.71-1.13],0.3587267813701855
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CA3,Carbonic anhydrase 3,2528,124,1.49 [1.17-1.90],0.0013450293428333
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CA4,Carbonic anhydrase 4,2530,124,2.01 [1.10-3.67],0.0240089307212256
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CA5A,"Carbonic anhydrase 5A, mitochondrial",2451,119,1.08 [0.92-1.27],0.3358602476330915
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CA6,Carbonic anhydrase 6,2498,120,0.72 [0.56-0.93],0.0103206440100461
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CA7,Carbonic anhydrase 7,2135,102,1.29 [0.80-2.07],0.2926831845224007
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CA8,Carbonic anhydrase-related protein,2106,103,0.84 [0.37-1.90],0.6701996565451286
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CA9,Carbonic anhydrase 9,2516,125,1.74 [1.35-2.23],1.7378161449071555e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CABP2,Calcium-binding protein 2,2119,101,1.05 [0.78-1.41],0.7348710011103277
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,2108,103,0.99 [0.54-1.83],0.9852677556570392
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,2105,101,0.99 [0.70-1.40],0.9366899195690024
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,2108,103,0.90 [0.64-1.27],0.5534168203902394
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,2162,104,0.99 [0.79-1.23],0.916681792598462
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CACYBP,Calcyclin-binding protein,2131,102,0.97 [0.81-1.17],0.7646867933608261
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CADPS,Calcium-dependent secretion activator 1,2119,101,0.99 [0.62-1.59],0.977705984062596
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CALB1,Calbindin,2479,123,1.95 [1.42-2.68],3.819731557222499e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CALB2,Calretinin,2431,119,2.69 [1.75-4.15],7.334176319534684e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CALCA,Calcitonin,2471,121,1.58 [1.30-1.91],3.818335035701943e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CALCB,Calcitonin gene-related peptide 2,2160,104,2.19 [1.66-2.88],2.2654333461474812e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,2508,125,1.05 [0.90-1.22],0.5350936066631826
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,2110,105,1.00 [0.78-1.29],0.991406531836024
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CALY,Neuron-specific vesicular protein calcyon,2105,101,1.06 [0.67-1.67],0.7968132869861322
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,2421,119,1.46 [1.05-2.04],0.0257850348458457
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CAMLG,Guided entry of tail-anchored proteins factor CAMLG,2119,101,1.37 [1.00-1.88],0.0503799687399423
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,2162,104,1.03 [0.87-1.23],0.7126794913156582
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CANT1,Soluble calcium-activated nucleotidase 1,2488,122,3.74 [1.78-7.86],0.0004801872838307
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CAPG,Macrophage-capping protein,2477,125,1.15 [0.89-1.49],0.2843267411129937
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CAPN3,Calpain-3,2161,104,1.00 [0.61-1.63],0.9935840406288006
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CAPS,Calcyphosin,2160,104,1.01 [0.85-1.21],0.8773940441782389
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CARHSP1,Calcium-regulated heat-stable protein 1,2431,119,0.82 [0.59-1.14],0.2339537953607741
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CASC3,Protein CASC3,2119,101,0.90 [0.58-1.42],0.6563481016807691
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CASP1,Caspase-1,2431,119,0.86 [0.68-1.09],0.2105641138918291
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CASP10,Caspase-10,2431,119,0.97 [0.77-1.21],0.7591892807792802
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CASP2,Caspase-2,2500,123,1.02 [0.80-1.28],0.8943006898684805
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CASP3,Caspase-3,2530,124,1.01 [0.85-1.22],0.8718359849149779
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CASP4,Caspase-4,2135,102,1.01 [0.90-1.13],0.8606815056343761
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CASP7,Caspase-7,2160,104,0.98 [0.78-1.24],0.8866666690263072
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CASP8,Caspase-8,2511,125,0.95 [0.73-1.23],0.680777203163763
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CASP9,Caspase-9,2106,103,0.87 [0.63-1.21],0.413141424543184
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CASQ2,Calsequestrin-2,2105,101,1.29 [0.90-1.84],0.1615603222846152
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CAT,Catalase,2141,103,0.97 [0.68-1.37],0.8460291304302447
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CBLIF,Cobalamin binding intrinsic factor,2498,123,1.46 [1.21-1.76],7.585255815901874e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CBLN1,Cerebellin-1,2108,103,1.06 [0.86-1.31],0.5891028591758216
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CBLN4,Cerebellin-4,2516,125,0.76 [0.48-1.22],0.255362181310619
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CBS,Cystathionine beta-synthase,2110,105,0.89 [0.64-1.25],0.5005253432907046
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CBX2,Chromobox protein homolog 2,2105,101,1.00 [0.59-1.68],0.9924811592087726
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CC2D1A,Coiled-coil and C2 domain-containing protein 1A,2476,122,1.09 [0.88-1.35],0.4407860930905731
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CCAR2,Cell cycle and apoptosis regulator protein 2,2160,104,0.86 [0.59-1.26],0.4389713490387439
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CCDC134,Coiled-coil domain-containing protein 134,2161,104,1.00 [0.67-1.49],0.9840461556190516
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CCDC28A,Coiled-coil domain-containing protein 28A,2119,101,0.72 [0.38-1.36],0.3127692529831234
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CCDC50,Coiled-coil domain-containing protein 50,2162,104,1.17 [0.95-1.45],0.1443483901003646
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CCDC80,Coiled-coil domain-containing protein 80,2498,123,1.62 [1.07-2.44],0.0221932519691805
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CCER2,Coiled-coil domain-containing glutamate-rich protein 2,2110,105,1.27 [0.97-1.66],0.0776539793349435
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CCL11,Eotaxin,2530,124,2.63 [1.79-3.87],9.188264116951209e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CCL13,C-C motif chemokine 13,2524,123,1.27 [1.01-1.60],0.0427803568627072
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CCL14,C-C motif chemokine 14,2494,122,2.57 [1.91-3.45],3.891228064139998e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CCL15,C-C motif chemokine 15,2530,124,2.55 [1.93-3.38],6.01576868864735e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CCL16,C-C motif chemokine 16,2530,124,1.69 [1.23-2.32],0.0011089044615505
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CCL17,C-C motif chemokine 17,2500,121,1.08 [0.91-1.27],0.3870284190995818
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CCL18,C-C motif chemokine 18,2470,122,1.17 [0.95-1.43],0.1317290429535763
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CCL19,C-C motif chemokine 19,2516,124,1.02 [0.91-1.16],0.7052646841486785
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CCL2,C-C motif chemokine 2,2472,122,1.36 [1.00-1.84],0.0490429274299826
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CCL20,C-C motif chemokine 20,2530,124,1.17 [1.00-1.38],0.0457817783906799
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CCL21,C-C motif chemokine 21,2510,121,1.89 [1.47-2.44],8.088691557756686e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CCL22,C-C motif chemokine 22,2481,121,1.39 [1.04-1.84],0.0245461348246371
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CCL23,C-C motif chemokine 23,2510,121,1.73 [1.21-2.46],0.0023910355830047
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CCL24,C-C motif chemokine 24,2509,121,1.08 [0.90-1.31],0.4010912547634547
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CCL25,C-C motif chemokine 25,2530,124,1.81 [1.33-2.46],0.0001596008381226
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CCL26,C-C motif chemokine 26,2500,123,0.85 [0.70-1.03],0.0945073343376124
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CCL27,C-C motif chemokine 27,2498,123,0.90 [0.70-1.16],0.426826593528448
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CCL28,C-C motif chemokine 28,2496,123,1.33 [1.04-1.71],0.0228333515454932
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CCL3,C-C motif chemokine 3,2500,123,1.37 [1.18-1.57],1.7913231543517466e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CCL4,C-C motif chemokine 4,2505,121,1.22 [0.97-1.53],0.0867457234714145
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CCL5,C-C motif chemokine 5,2503,122,1.17 [1.01-1.37],0.0362041837710272
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CCL7,C-C motif chemokine 7,2500,123,1.41 [1.09-1.82],0.0095213792197878
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CCL8,C-C motif chemokine 8,2514,125,1.64 [1.25-2.15],0.0003628813196371
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CCN1,CCN family member 1,2477,123,1.29 [1.02-1.63],0.0357145773959652
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CCN2,CCN family member 2,2499,121,1.32 [1.00-1.75],0.0483499299551599
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CCN3,CCN family member 3,2524,124,2.77 [1.95-3.92],1.2038786531419578e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CCN4,CCN family member 4,2516,125,3.34 [2.43-4.58],9.325035956372669e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CCN5,CCN family member 5,2505,122,3.09 [2.12-4.52],5.2894003615988974e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CCND2,G1/S-specific cyclin-D2,2135,102,1.01 [0.61-1.68],0.9693080401083995
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CCNE1,G1/S-specific cyclin-E1,2106,103,1.13 [0.93-1.36],0.2150955996930474
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CCS,Copper chaperone for superoxide dismutase,2476,122,0.65 [0.46-0.93],0.0180307779517583
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CCT5,T-complex protein 1 subunit epsilon,2421,119,0.92 [0.63-1.35],0.6842957687356819
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD101,Immunoglobulin superfamily member 2,2165,101,1.21 [0.79-1.85],0.3726429914810285
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD109,CD109 antigen,2505,122,2.14 [1.37-3.34],0.0008521576865592
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD14,Monocyte differentiation antigen CD14,2455,120,3.42 [2.41-4.86],6.3195779168809566e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD160,CD160 antigen,2530,124,2.29 [1.78-2.95],1.1367995972948939e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD163,Scavenger receptor cysteine-rich type 1 protein M130,2503,122,1.68 [1.21-2.34],0.0021755061966407
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD164,Sialomucin core protein 24,2505,122,2.21 [1.55-3.16],1.2786682487815071e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD164L2,CD164 sialomucin-like 2 protein,2119,101,1.13 [0.67-1.89],0.6515942319456867
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD177,CD177 antigen,2498,122,1.00 [0.88-1.13],0.9888003253729948
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD1C,T-cell surface glycoprotein CD1c,2497,124,0.67 [0.39-1.15],0.1449439114049988
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD2,T-cell surface antigen CD2,2105,101,1.23 [0.82-1.84],0.3253876336728133
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD200,OX-2 membrane glycoprotein,2500,123,2.70 [1.78-4.10],3.4005210645390345e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD200R1,Cell surface glycoprotein CD200 receptor 1,2491,122,1.41 [0.91-2.18],0.1245269945533814
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD207,C-type lectin domain family 4 member K,2433,121,2.37 [1.63-3.44],6.376248711606314e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD209,CD209 antigen,2510,122,1.11 [0.72-1.72],0.6261405798821498
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD22,B-cell receptor CD22,2530,124,1.39 [0.98-1.96],0.062342723310965
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD226,CD226 antigen,2106,103,1.33 [0.86-2.08],0.2037860984534877
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD244,Natural killer cell receptor 2B4,2530,124,3.17 [1.93-5.23],5.889393982360508e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD248,Endosialin,2175,103,0.99 [0.64-1.54],0.973183174756846
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD27,CD27 antigen,2497,124,3.66 [2.84-4.72],1.3289504202416708e-23
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD274,Programmed cell death 1 ligand 1,2476,122,2.32 [1.74-3.09],1.0442842163675496e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD276,CD276 antigen,2500,121,7.09 [4.83-10.39],1.1050209912652549e-23
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD28,T-cell-specific surface glycoprotein CD28,2421,119,2.47 [1.71-3.56],1.2550630934856246e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD2AP,CD2-associated protein,2498,123,0.92 [0.71-1.18],0.4921368865262533
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD300A,CMRF35-like molecule 8,2132,103,2.87 [1.64-5.01],0.0002190490061852
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD300C,CMRF35-like molecule 6,2516,124,3.61 [2.44-5.35],1.48549775424341e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD300E,CMRF35-like molecule 2,2510,125,2.92 [2.18-3.91],5.65623929888454e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD300LF,CMRF35-like molecule 1,2516,125,1.89 [1.44-2.48],5.484255345474722e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD300LG,CMRF35-like molecule 9,2505,122,2.53 [1.75-3.67],9.201556716783064e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD302,CD302 antigen,2479,123,3.64 [2.64-5.01],2.4169895251477248e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD33,Myeloid cell surface antigen CD33,2497,124,1.05 [0.85-1.28],0.6737693790351791
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD34,Hematopoietic progenitor cell antigen CD34,2510,123,1.41 [0.74-2.67],0.2965241976371081
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD36,Platelet glycoprotein 4,2106,103,1.36 [0.92-2.01],0.1239234093940383
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,2479,123,2.26 [1.48-3.43],0.0001376944920766
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD3D,T-cell surface glycoprotein CD3 delta chain,2108,103,1.07 [0.58-1.97],0.830489959795276
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD3E,T-cell surface glycoprotein CD3 epsilon chain,2135,102,0.76 [0.40-1.43],0.3896143564463714
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD3G,T-cell surface glycoprotein CD3 gamma chain,2106,103,1.10 [0.93-1.30],0.2511939941208051
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD4,T-cell surface glycoprotein CD4,2499,123,3.09 [2.11-4.52],6.815834591854177e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD40,Tumor necrosis factor receptor superfamily member 5,2504,121,1.52 [1.17-1.97],0.0017467163597272
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD40LG,CD40 ligand,2530,124,1.01 [0.83-1.23],0.9259366907905984
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD46,Membrane cofactor protein,2484,121,3.29 [2.26-4.80],5.737322703403173e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD48,CD48 antigen,2509,121,4.22 [2.59-6.89],7.365479668784129e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD5,T-cell surface glycoprotein CD5,2514,125,2.54 [1.89-3.41],6.51256753880042e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD55,Complement decay-accelerating factor,2414,117,3.05 [2.00-4.65],2.2560174649730465e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD58,Lymphocyte function-associated antigen 3,2493,121,3.83 [1.52-9.66],0.0044698919202223
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD59,CD59 glycoprotein,2404,120,4.78 [3.22-7.10],9.255076858323995e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD5L,CD5 antigen-like,2159,104,1.87 [1.30-2.68],0.0007313604445727
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD6,T-cell differentiation antigen CD6,2524,124,1.29 [0.94-1.76],0.1116535776977125
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD63,CD63 antigen,2472,122,1.29 [0.93-1.79],0.1337317855916416
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD69,Early activation antigen CD69,2487,123,0.98 [0.82-1.18],0.8426151329763559
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD7,T-cell antigen CD7,2100,103,2.13 [1.51-3.01],1.7268082751153834e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD70,CD70 antigen,2500,123,1.45 [1.03-2.05],0.0348902750519937
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD72,B-cell differentiation antigen CD72,2132,103,2.22 [1.54-3.18],1.5638864370405328e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD74,HLA class II histocompatibility antigen gamma chain,2516,124,5.25 [3.68-7.47],4.0440433681483687e-20
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD79B,B-cell antigen receptor complex-associated protein beta chain,2530,124,2.84 [2.19-3.69],4.139270498452737e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD80,T-lymphocyte activation antigen CD80,2168,106,2.99 [1.93-4.65],1.0499353909211476e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD82,CD82 antigen,2135,102,0.93 [0.58-1.49],0.7737619920731637
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD83,CD83 antigen,2500,123,2.76 [1.91-3.97],5.1693657374328615e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD84,SLAM family member 5,2500,123,1.15 [0.70-1.88],0.5923905177515147
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD86,T-lymphocyte activation antigen CD86,2165,101,1.38 [0.75-2.52],0.300143403888055
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD8A,T-cell surface glycoprotein CD8 alpha chain,2516,124,1.56 [1.19-2.06],0.0014911427655791
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD93,Complement component C1q receptor,2423,117,3.08 [2.04-4.64],8.804812635640678e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD99,CD99 antigen,2505,122,6.33 [3.15-12.69],2.039267718781267e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD99L2,CD99 antigen-like protein 2,2505,122,4.01 [2.22-7.25],4.1930118638805465e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CDA,Cytidine deaminase,2165,106,0.87 [0.60-1.27],0.4790823705648827
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CDAN1,Codanin-1,2160,104,0.45 [0.18-1.10],0.0807617974475376
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CDC123,Cell division cycle protein 123 homolog,2087,102,0.93 [0.67-1.29],0.6646281266572327
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CDC25A,M-phase inducer phosphatase 1,2087,102,0.72 [0.41-1.25],0.2458651054710479
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CDC26,Anaphase-promoting complex subunit CDC26,2162,101,1.06 [0.80-1.41],0.6697462181098044
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CDC27,Cell division cycle protein 27 homolog,2421,119,1.16 [0.90-1.49],0.2546764261481729
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CDC37,Hsp90 co-chaperone Cdc37,2497,124,0.95 [0.79-1.15],0.6258565027733576
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CDC42BPB,Serine/threonine-protein kinase MRCK beta,2165,101,1.10 [0.91-1.32],0.3142447236409914
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CDCP1,CUB domain-containing protein 1,2476,122,1.33 [1.04-1.70],0.0253770128012287
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CDH1,Cadherin-1,2416,118,2.37 [1.87-3.01],8.061218098539119e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CDH15,Cadherin-15,2511,123,1.22 [1.03-1.44],0.0218820323903208
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CDH17,Cadherin-17,2498,123,1.59 [1.30-1.94],5.355990047592736e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CDH2,Cadherin-2,2498,123,1.76 [1.23-2.50],0.0017730607321596
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CDH22,Cadherin-22,2135,102,1.57 [0.82-3.01],0.1780931102110506
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CDH23,Cadherin-23,2160,104,0.82 [0.38-1.74],0.5981727221455775
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CDH3,Cadherin-3,2516,124,3.18 [2.27-4.46],1.951299832314229e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CDH4,Cadherin-4,2108,103,0.74 [0.46-1.19],0.2156320583700396
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CDH5,Cadherin-5,2530,124,2.33 [1.42-3.83],0.0008673900778811
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CDH6,Cadherin-6,2498,123,2.24 [1.55-3.23],1.594257836602452e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CDHR1,Cadherin-related family member 1,2431,119,1.03 [0.72-1.48],0.861785040304751
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CDHR2,Cadherin-related family member 2,2479,123,1.00 [0.78-1.27],0.9915656600906796
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CDHR5,Cadherin-related family member 5,2498,123,0.84 [0.56-1.25],0.3828445625882002
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CDK1,Cyclin-dependent kinase 1,2087,102,1.20 [0.72-2.01],0.4881791426941034
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CDK5RAP3,CDK5 regulatory subunit-associated protein 3,2162,104,0.91 [0.64-1.29],0.5835699721229891
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CDKL5,Cyclin-dependent kinase-like 5,2108,103,0.94 [0.62-1.42],0.7552900426032223
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CDKN1A,Cyclin-dependent kinase inhibitor 1,2479,123,1.11 [0.96-1.28],0.1652527351973671
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CDKN2D,Cyclin-dependent kinase 4 inhibitor D,2479,123,0.98 [0.83-1.16],0.8204566025635294
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CDNF,Cerebral dopamine neurotrophic factor,2479,123,1.67 [1.34-2.09],6.647133420411139e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CDON,Cell adhesion molecule-related/down-regulated by oncogenes,2505,121,1.44 [0.80-2.60],0.222186989399594
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CDSN,Corneodesmosin,2520,124,1.61 [1.15-2.26],0.0057590630473078
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,2492,123,1.78 [0.93-3.40],0.0827201446182755
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,2165,101,0.87 [0.69-1.10],0.2478920201487272
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,2135,102,0.85 [0.63-1.15],0.2970025966699111
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,2165,101,1.18 [0.75-1.87],0.4786480762185431
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,2135,102,1.14 [0.76-1.70],0.5235898423977796
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,2500,123,1.13 [0.95-1.34],0.1680084565735306
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,2421,119,1.37 [1.02-1.83],0.036147968716218
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,2395,117,1.45 [1.13-1.86],0.0035990569851782
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,2175,103,1.41 [0.91-2.19],0.1265614409511494
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,2451,119,1.32 [0.97-1.80],0.078538778665171
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CEBPA,CCAAT/enhancer-binding protein alpha,2106,103,0.98 [0.58-1.67],0.9407053673676662
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CEBPB,CCAAT/enhancer-binding protein beta,2451,119,1.00 [0.66-1.51],0.9866608564048106
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CELA2A,Chymotrypsin-like elastase family member 2A,2175,103,0.89 [0.69-1.15],0.3716030001272821
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CELA3A,Chymotrypsin-like elastase family member 3A,2526,124,0.95 [0.76-1.19],0.6595320129427527
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,2132,103,1.97 [1.09-3.57],0.0256420305117091
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CEMIP2,Cell surface hyaluronidase,2106,103,1.77 [1.16-2.70],0.0085453831096251
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CEND1,Cell cycle exit and neuronal differentiation protein 1,2108,103,0.91 [0.64-1.29],0.5851462206315544
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CENPF,Centromere protein F,2135,102,0.85 [0.59-1.23],0.3955720374390008
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CENPJ,Centromere protein J,2135,102,0.96 [0.73-1.26],0.7717704862385999
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CEP112,Centrosomal protein of 112 kDa,2105,101,1.04 [0.72-1.52],0.8214921332443806
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CEP152,Centrosomal protein of 152 kDa,2087,102,1.49 [1.08-2.07],0.015933631239259
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CEP164,Centrosomal protein of 164 kDa,2444,122,1.01 [0.80-1.29],0.903419951319748
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CEP170,Centrosomal protein of 170 kDa,2110,105,1.08 [0.85-1.39],0.5173862463044652
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CEP20,Centrosomal protein 20,2421,119,1.00 [0.81-1.25],0.9663256823126268
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CEP290,Centrosomal protein of 290 kDa,2135,102,1.06 [0.75-1.49],0.7566980003059076
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CEP350,Centrosome-associated protein 350,2087,102,1.48 [0.98-2.24],0.0628281353882437
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CEP43,Centrosomal protein 43,2433,116,0.95 [0.75-1.21],0.6734433763961194
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CEP85,Centrosomal protein of 85 kDa,2421,119,1.15 [0.91-1.45],0.2556853174072527
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CERT,Ceramide transfer protein,2431,119,1.05 [0.80-1.37],0.7260468724786431
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CES1,Liver carboxylesterase 1,2505,122,0.94 [0.80-1.09],0.4154609244839833
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CES2,Cocaine esterase,2479,123,1.43 [1.11-1.84],0.0053714303859575
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CES3,Carboxylesterase 3,2479,123,0.79 [0.61-1.02],0.0652552823742487
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CETN2,Centrin-2,2431,119,1.10 [0.87-1.38],0.4328840451378607
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CETN3,Centrin-3,2165,101,0.89 [0.69-1.14],0.3551374491164114
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CFB,Complement factor B,2134,103,1.97 [1.12-3.49],0.0194708852886602
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CFC1,Cryptic protein,2421,119,1.44 [1.10-1.89],0.0073660212676502
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CFD,Complement factor D,2171,104,4.30 [2.52-7.34],9.023607835412205e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CFH,Complement factor H,2052,100,2.92 [1.26-6.76],0.0121587107442009
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CFHR2,Complement factor H-related protein 2,2156,103,1.16 [0.81-1.65],0.4155522445153314
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CFHR4,Complement factor H-related protein 4,2168,104,0.96 [0.75-1.24],0.7711019340263684
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CFHR5,Complement factor H-related protein 5,2137,102,1.13 [0.73-1.75],0.5751995452730787
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CFI,Complement factor I,2171,104,2.42 [0.93-6.30],0.0694173902319951
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CFP,Properdin,2171,104,0.84 [0.34-2.04],0.6951160876871253
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CGA,Glycoprotein hormones alpha chain,2505,122,1.75 [1.43-2.13],3.067409581593758e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,2174,105,1.73 [1.02-2.92],0.0410856937834584
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CGN,Cingulin,2119,101,0.79 [0.46-1.34],0.3814441313896883
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CGREF1,Cell growth regulator with EF hand domain protein 1,2498,123,2.26 [1.64-3.10],4.78991605699989e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,2421,119,1.07 [0.80-1.44],0.6377678336264704
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CHAD,Chondroadherin,2132,103,0.46 [0.32-0.65],1.6193194190988992e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",2160,104,2.89 [2.04-4.10],2.143763585830172e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CHCHD6,MICOS complex subunit MIC25,2161,104,1.75 [1.18-2.57],0.0050181723744088
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CHEK2,Serine/threonine-protein kinase Chk2,2451,119,0.92 [0.55-1.53],0.7366637076545464
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CHGA,Chromogranin-A,2175,103,1.48 [1.29-1.69],2.4370178932397923e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CHGB,Secretogranin-1,2505,123,2.89 [2.10-3.97],5.7001238652561817e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CHI3L1,Chitinase-3-like protein 1,2442,119,1.57 [1.34-1.84],1.6288793258082682e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CHIT1,Chitotriosidase-1,2513,121,1.05 [0.94-1.18],0.3884954262282019
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CHL1,Neural cell adhesion molecule L1-like protein,2497,120,1.60 [0.98-2.62],0.0625451937693173
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CHM,Rab proteins geranylgeranyltransferase component A 1,2119,101,0.88 [0.64-1.23],0.4603701340214993
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CHMP1A,Charged multivesicular body protein 1a,2476,122,1.02 [0.83-1.26],0.8301772564152354
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CHMP6,Charged multivesicular body protein 6,2168,106,0.91 [0.66-1.26],0.5733143231772477
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CHP1,Calcineurin B homologous protein 1,2108,103,0.99 [0.75-1.30],0.936757724010851
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CHRDL1,Chordin-like protein 1,2509,121,5.52 [3.66-8.34],4.48651244358727e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CHRDL2,Chordin-like protein 2,2498,123,0.90 [0.65-1.25],0.5487431400907554
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CHRM1,Muscarinic acetylcholine receptor M1,2119,101,0.75 [0.42-1.34],0.3375593113890727
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CIAPIN1,Anamorsin,2497,124,1.07 [0.83-1.39],0.6007819275797908
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CILP,Cartilage intermediate layer protein 1,2175,103,2.01 [1.42-2.85],8.972881809867559e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CINP,Cyclin-dependent kinase 2-interacting protein,2135,102,0.76 [0.47-1.25],0.2800564311268005
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CIRBP,Cold-inducible RNA-binding protein,2165,101,1.02 [0.84-1.26],0.8161117382023146
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CIT,Citron Rho-interacting kinase,2119,101,0.98 [0.65-1.48],0.9384009239652886
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CKAP4,Cytoskeleton-associated protein 4,2519,124,3.41 [2.65-4.39],2.239331210442044e-21
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CKB,Creatine kinase B-type,2175,103,2.08 [1.58-2.73],1.395185605695289e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",2492,121,1.28 [0.99-1.64],0.0555224494870106
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CLASP1,CLIP-associating protein 1,2087,102,0.91 [0.70-1.19],0.5084017810081554
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CLC,Galectin-10,2494,123,1.20 [0.96-1.50],0.1033260863862512
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CLEC10A,C-type lectin domain family 10 member A,2476,122,2.20 [1.44-3.37],0.0002907915810154
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CLEC11A,C-type lectin domain family 11 member A,2500,121,1.15 [0.83-1.60],0.3998393941240221
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CLEC12A,C-type lectin domain family 12 member A,2106,103,1.81 [0.73-4.49],0.1980564387316748
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CLEC14A,C-type lectin domain family 14 member A,2505,122,3.37 [2.25-5.05],4.0248952251851956e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CLEC1A,C-type lectin domain family 1 member A,2451,119,2.48 [1.69-3.64],3.404231990321356e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CLEC1B,C-type lectin domain family 1 member B,2516,124,1.05 [0.89-1.24],0.5627807189740665
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CLEC2L,C-type lectin domain family 2 member L,2119,101,0.85 [0.54-1.33],0.4716566879053973
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CLEC3B,Tetranectin,2123,103,0.31 [0.13-0.74],0.0079302651306518
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CLEC4A,C-type lectin domain family 4 member A,2500,123,0.67 [0.45-1.00],0.0486249408903297
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CLEC4C,C-type lectin domain family 4 member C,2500,123,0.95 [0.69-1.31],0.746524493612641
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CLEC4D,C-type lectin domain family 4 member D,2500,123,1.63 [1.31-2.04],1.2640789743800322e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CLEC4G,C-type lectin domain family 4 member G,2500,123,1.26 [0.79-2.03],0.332793769393823
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CLEC4M,C-type lectin domain family 4 member M,2173,103,0.74 [0.49-1.11],0.1392906867623598
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CLEC5A,C-type lectin domain family 5 member A,2493,123,2.31 [1.51-3.53],0.0001229262404966
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CLEC6A,C-type lectin domain family 6 member A,2421,119,1.76 [1.34-2.33],6.132857661319788e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CLEC7A,C-type lectin domain family 7 member A,2530,124,1.84 [1.36-2.49],9.03240706585236e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CLGN,Calmegin,2119,101,1.53 [1.02-2.29],0.0388960194080976
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CLIC5,Chloride intracellular channel protein 5,2119,101,1.39 [0.85-2.27],0.183689857568571
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CLINT1,Clathrin interactor 1,2087,102,0.98 [0.64-1.51],0.9230598072146284
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CLIP2,CAP-Gly domain-containing linker protein 2,2500,123,1.02 [0.88-1.17],0.8059033637879097
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CLMP,CXADR-like membrane protein,2516,125,5.90 [3.45-10.08],8.967360581812368e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CLNS1A,Methylosome subunit pICln,2119,101,0.52 [0.28-0.98],0.0437279255223069
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",2471,121,1.09 [0.92-1.29],0.3046851535143264
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CLPS,Colipase,2498,122,0.99 [0.81-1.20],0.8837369478587744
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CLSPN,Claspin,2426,118,0.75 [0.44-1.28],0.2965686125501471
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CLSTN1,Calsyntenin-1,2431,119,0.99 [0.72-1.36],0.9458435682540756
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CLSTN2,Calsyntenin-2,2530,124,2.03 [1.54-2.69],5.251776008651849e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CLSTN3,Calsyntenin-3,2160,104,2.03 [1.15-3.55],0.0138977120232162
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CLTA,Clathrin light chain A,2451,119,0.87 [0.60-1.27],0.4720048630006613
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CLU,Clusterin,2171,104,1.29 [0.62-2.67],0.4970625780898841
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CLUL1,Clusterin-like protein 1,2494,123,1.08 [0.77-1.51],0.6554059720748537
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CMC1,COX assembly mitochondrial protein homolog,2168,106,0.93 [0.76-1.15],0.5070631396327862
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CMIP,C-Maf-inducing protein,2161,104,1.03 [0.83-1.28],0.7996554554027013
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CNDP1,Beta-Ala-His dipeptidase,2503,122,1.25 [0.89-1.77],0.1955985972088323
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CNGB3,Cyclic nucleotide-gated cation channel beta-3,2108,103,1.20 [0.96-1.50],0.1026195428685581
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",2107,105,1.00 [0.78-1.27],0.9850283919415146
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CNPY2,Protein canopy homolog 2,2451,119,1.07 [0.83-1.38],0.579752008172937
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CNPY4,Protein canopy homolog 4,2479,123,1.07 [0.86-1.32],0.5593360223156392
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CNST,Consortin,2498,123,0.98 [0.85-1.13],0.7416810887318595
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CNTF,Ciliary neurotrophic factor,2108,103,0.64 [0.37-1.10],0.1096326907093494
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CNTN1,Contactin-1,2530,124,2.39 [1.35-4.23],0.0027104778969383
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CNTN2,Contactin-2,2516,125,1.58 [1.13-2.20],0.0068365168318398
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CNTN3,Contactin-3,2505,122,1.82 [1.06-3.13],0.0296954546664442
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CNTN4,Contactin-4,2505,122,2.31 [1.22-4.40],0.0106277465572547
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CNTN5,Contactin-5,2504,121,0.88 [0.57-1.34],0.5395384256911877
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CNTNAP2,Contactin-associated protein-like 2,2500,123,1.73 [1.26-2.36],0.0006421177110553
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CNTNAP4,Contactin-associated protein-like 4,2119,101,0.95 [0.79-1.16],0.6318345373126402
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,COCH,Cochlin,2168,106,1.25 [0.86-1.84],0.2460215933930863
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,COL15A1,Collagen alpha-1(XV) chain,2175,103,1.43 [0.79-2.58],0.2399756368860172
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,COL18A1,Collagen alpha-1(XVIII) chain,2510,124,9.34 [5.44-16.01],4.669959019206786e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,COL1A1,Collagen alpha-1(I) chain,2530,124,0.85 [0.45-1.61],0.613504159169075
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,COL24A1,Collagen alpha-1(XXIV) chain,2165,101,1.31 [0.94-1.84],0.1153547386400147
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,COL28A1,Collagen alpha-1(XXVIII) chain,2119,101,1.21 [0.97-1.51],0.0859386933506666
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,COL2A1,Collagen alpha-1(II) chain,2110,105,0.99 [0.78-1.25],0.9135666984002794
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,COL3A1,Collagen alpha-1(III) chain,2175,103,1.42 [0.67-3.00],0.363036242446615
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,COL4A1,Collagen alpha-1(IV) chain,2498,123,2.03 [1.56-2.63],9.881417940381617e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,COL4A4,Collagen alpha-4(IV) chain,2130,102,1.05 [0.72-1.53],0.8009264538779342
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,COL5A1,Collagen alpha-1(V) chain,2132,103,1.62 [1.24-2.13],0.0004330148207136
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,COL6A3,Collagen alpha-3(VI) chain,2530,124,3.81 [2.82-5.15],3.321805229832388e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,COL9A1,Collagen alpha-1(IX) chain,2500,123,1.26 [0.92-1.72],0.1492728751795612
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,COL9A2,Collagen alpha-2(IX) chain,2135,102,1.03 [0.64-1.67],0.8901713256703209
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,COLEC12,Collectin-12,2500,121,6.25 [4.15-9.40],1.4552428539484113e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,COMMD1,COMM domain-containing protein 1,2110,105,1.14 [0.84-1.56],0.3953220552126149
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,COMMD9,COMM domain-containing protein 9,2161,104,0.95 [0.60-1.51],0.8370644551490056
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,COMP,Cartilage oligomeric matrix protein,2472,121,1.01 [0.65-1.58],0.9658818731131236
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,COMT,Catechol O-methyltransferase,2427,115,1.02 [0.83-1.25],0.8800807890570252
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,COPB2,Coatomer subunit beta',2105,101,0.95 [0.61-1.48],0.8199435695877627
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,COPE,Coatomer subunit epsilon,2431,119,1.15 [0.85-1.55],0.3723466003212737
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",2110,105,1.30 [0.84-2.03],0.2393829301709018
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CORO1A,Coronin-1A,2455,121,1.06 [0.89-1.27],0.5052010660648998
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CORO6,Coronin-6,2108,103,1.22 [0.83-1.79],0.3176205860549322
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",2479,123,1.27 [1.01-1.59],0.038591309693396
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,COX6B1,Cytochrome c oxidase subunit 6B1,2168,106,0.91 [0.51-1.63],0.7563564513992577
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CPA1,Carboxypeptidase A1,2530,124,0.92 [0.75-1.13],0.4206338189235969
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CPA2,Carboxypeptidase A2,2509,123,1.37 [1.14-1.67],0.0011122447521345
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CPA4,Carboxypeptidase A4,2087,101,0.99 [0.64-1.52],0.9573695766353604
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CPB1,Carboxypeptidase B,2530,124,0.98 [0.78-1.22],0.8294172760031324
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CPB2,Carboxypeptidase B2,2166,104,1.89 [0.81-4.39],0.1388797745391242
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CPE,Carboxypeptidase E,2497,124,0.84 [0.57-1.24],0.3749796206179784
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CPLX2,Complexin-2,2087,102,0.88 [0.46-1.68],0.7043836617422197
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CPM,Carboxypeptidase M,2503,124,2.49 [1.64-3.77],1.6822649988512543e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",2106,103,0.59 [0.28-1.22],0.1540333174400615
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CPPED1,Serine/threonine-protein phosphatase CPPED1,2516,124,0.80 [0.63-1.03],0.0803902023479396
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CPQ,Carboxypeptidase Q,2173,103,2.17 [1.32-3.56],0.0021899589808482
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CPTP,Ceramide-1-phosphate transfer protein,2105,101,0.82 [0.46-1.46],0.4942789197183412
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CPVL,Probable serine carboxypeptidase CPVL,2511,124,2.02 [1.36-3.02],0.0005358303773793
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CPXM1,Probable carboxypeptidase X1,2497,124,1.14 [0.92-1.42],0.227056472557996
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CPXM2,Inactive carboxypeptidase-like protein X2,2168,106,6.27 [3.54-11.12],3.4151855729741216e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CR1,Complement receptor type 1,2166,105,2.08 [1.29-3.36],0.0027145957401883
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CR2,Complement receptor type 2,2503,122,1.56 [1.15-2.12],0.0046434413321955
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CRACR2A,EF-hand calcium-binding domain-containing protein 4B,2421,119,1.20 [1.01-1.42],0.0365076856162123
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CRADD,Death domain-containing protein CRADD,2471,121,1.03 [0.82-1.29],0.8063519251043392
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CREB3,Cyclic AMP-responsive element-binding protein 3,2087,102,0.96 [0.66-1.38],0.8063307711074402
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CREBZF,CREB/ATF bZIP transcription factor,2087,102,0.87 [0.39-1.99],0.74947653281042
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CREG1,Protein CREG1,2466,124,0.77 [0.53-1.13],0.1790622962256159
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CRELD1,Protein disulfide isomerase CRELD1,2132,103,2.85 [1.76-4.63],2.1665842425779173e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CRELD2,Protein disulfide isomerase CRELD2,2509,121,1.56 [1.20-2.04],0.0009289194620407
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CRH,Corticoliberin,2418,118,0.89 [0.73-1.08],0.2450147391352629
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CRHBP,Corticotropin-releasing factor-binding protein,2500,121,3.31 [1.90-5.77],2.513400611217833e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CRHR1,Corticotropin-releasing factor receptor 1,2451,119,0.66 [0.48-0.92],0.0131378135478943
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CRIM1,Cysteine-rich motor neuron 1 protein,2510,121,14.63 [7.86-27.23],2.6354820851904885e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CRIP2,Cysteine-rich protein 2,2476,122,2.12 [1.48-3.02],3.401710880947133e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CRISP2,Cysteine-rich secretory protein 2,2516,125,0.98 [0.74-1.29],0.8605100316117605
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CRISP3,Cysteine-rich secretory protein 3,2155,104,0.84 [0.43-1.64],0.6080096521779023
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CRKL,Crk-like protein,2502,121,1.03 [0.88-1.20],0.7398442976443458
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CRLF1,Cytokine receptor-like factor 1,2510,121,4.27 [2.28-8.00],5.630305360025447e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CRNN,Cornulin,2411,121,1.08 [0.86-1.36],0.5029361106726178
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CRTAC1,Cartilage acidic protein 1,2530,124,1.03 [0.62-1.69],0.919977452842608
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CRTAM,Cytotoxic and regulatory T-cell molecule,2476,122,1.77 [1.31-2.41],0.0002466113772345
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CRTAP,Cartilage-associated protein,2119,101,0.78 [0.49-1.24],0.293986452718956
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CRX,Cone-rod homeobox protein,2451,119,1.04 [0.89-1.21],0.6582966662348011
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CRYBB1,Beta-crystallin B1,2168,106,1.04 [0.79-1.39],0.7685624485382547
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CRYBB2,Beta-crystallin B2,2160,104,1.05 [0.86-1.28],0.6343839687577348
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CRYGD,Gamma-crystallin D,2160,104,1.04 [0.86-1.27],0.6643840934872414
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CRYM,Ketimine reductase mu-crystallin,2108,103,0.99 [0.76-1.31],0.9666994665143748
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CRYZL1,Quinone oxidoreductase-like protein 1,2110,105,0.97 [0.78-1.21],0.8057786953524001
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CSDE1,Cold shock domain-containing protein E1,2105,101,0.98 [0.82-1.16],0.774385645048393
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CSF1,Macrophage colony-stimulating factor 1,2510,121,5.24 [3.24-8.50],1.7237436453094462e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CSF1R,Macrophage colony-stimulating factor 1 receptor,2174,105,1.84 [1.23-2.74],0.002847507079851
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CSF2,Granulocyte-macrophage colony-stimulating factor,2105,101,1.13 [0.68-1.86],0.6430872084255539
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,2476,122,1.55 [1.25-1.92],5.082023196641414e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CSF2RB,Cytokine receptor common subunit beta,2106,103,0.91 [0.58-1.41],0.6635843357280717
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CSF3,Granulocyte colony-stimulating factor,2444,122,0.91 [0.65-1.27],0.5677873699467757
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CSF3R,Granulocyte colony-stimulating factor receptor,2106,103,1.30 [0.75-2.25],0.3501646626181233
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CSH1,Chorionic somatomammotropin hormone 1,2174,105,0.90 [0.46-1.73],0.7475793879341366
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CSNK1D,Casein kinase I isoform delta,2106,103,1.01 [0.74-1.38],0.9499862211713104
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CSNK2A1,Casein kinase II subunit alpha,2162,104,0.95 [0.61-1.46],0.806236076477648
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CSPG4,Chondroitin sulfate proteoglycan 4,2175,103,3.25 [1.95-5.41],6.059667826511585e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CSPG5,Chondroitin sulfate proteoglycan 5,2108,103,1.63 [1.19-2.21],0.0020059424972402
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CSRP3,Cysteine and glycine-rich protein 3,2105,101,1.25 [1.05-1.48],0.0114484614067139
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CST1,Cystatin-SN,1896,88,0.85 [0.69-1.04],0.1212733169109218
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CST3,Cystatin-C,2494,121,4.10 [2.78-6.06],1.2117733081761305e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CST5,Cystatin-D,2453,121,1.56 [1.19-2.05],0.0014350097540773
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CST6,Cystatin-M,2429,121,1.69 [1.26-2.26],0.0005100259175167
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CST7,Cystatin-F,2505,121,1.06 [0.90-1.25],0.4540816440304287
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CSTB,Cystatin-B,2470,117,1.69 [1.18-2.42],0.0041974949338162
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CTAG1A_CTAG1B,Cancer/testis antigen 1,2132,102,0.81 [0.53-1.22],0.3074652405040806
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CTBS,Di-N-acetylchitobiase,2140,103,1.42 [0.74-2.70],0.2919446924255234
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CTF1,Cardiotrophin-1,2451,119,0.93 [0.76-1.13],0.4535064808298814
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CTHRC1,Collagen triple helix repeat-containing protein 1,2175,103,2.61 [1.55-4.39],0.0003115375123699
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CTLA4,Cytotoxic T-lymphocyte protein 4,2175,103,1.28 [0.73-2.22],0.3884515953974929
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CTNNA1,Catenin alpha-1,2108,103,0.60 [0.28-1.29],0.1920343170428225
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CTRB1,Chymotrypsinogen B,2505,122,0.89 [0.71-1.12],0.3223584696823967
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CTRC,Chymotrypsin-C,2504,121,0.71 [0.58-0.87],0.0010724282075167
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CTRL,Chymotrypsin-like protease CTRL-1,2160,104,0.72 [0.58-0.89],0.0020107264008269
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CTSB,Cathepsin B,2500,124,2.12 [1.62-2.77],4.082664395407849e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CTSC,Dipeptidyl peptidase 1,2491,121,0.99 [0.70-1.41],0.9688890973914626
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CTSD,Cathepsin D,2346,112,1.60 [1.15-2.22],0.0048592212712093
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CTSE,Cathepsin E,2132,103,1.65 [1.19-2.29],0.0025565408934302
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CTSF,Cathepsin F,2497,124,1.16 [0.78-1.72],0.4602317422062058
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CTSH,Pro-cathepsin H,2447,119,1.24 [0.99-1.55],0.0556983557349685
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CTSL,Cathepsin L1,2498,123,2.31 [1.34-4.00],0.0027693631856223
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CTSO,Cathepsin O,2530,124,2.89 [1.88-4.43],1.262048030653113e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CTSS,Cathepsin S,1989,97,3.36 [1.58-7.15],0.0016198198160359
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CTSV,Cathepsin L2,2506,124,0.76 [0.52-1.11],0.1551627487975563
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CTSZ,Cathepsin Z,2497,122,2.58 [1.66-3.99],2.236999546988759e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CUZD1,CUB and zona pellucida-like domain-containing protein 1,2119,101,1.15 [0.80-1.67],0.4473951205844743
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CWC15,Spliceosome-associated protein CWC15 homolog,2152,100,1.01 [0.74-1.37],0.9537489369677986
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CX3CL1,Fractalkine,2476,122,2.97 [2.04-4.31],1.1811142677240316e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CXADR,Coxsackievirus and adenovirus receptor,2500,123,2.16 [1.64-2.85],4.5084549553925807e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CXCL1,Growth-regulated alpha protein,2501,121,1.15 [0.98-1.36],0.0951174493286675
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CXCL10,C-X-C motif chemokine 10,2510,121,1.22 [0.97-1.54],0.0835225382040637
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CXCL11,C-X-C motif chemokine 11,2516,124,1.14 [0.94-1.37],0.1848082640819811
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CXCL12,Stromal cell-derived factor 1,2444,122,1.45 [1.00-2.12],0.0526165745758254
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CXCL13,C-X-C motif chemokine 13,2516,124,1.25 [1.01-1.54],0.0431271881178789
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CXCL14,C-X-C motif chemokine 14,2444,122,1.23 [0.98-1.54],0.0801197398410137
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CXCL16,C-X-C motif chemokine 16,2529,124,5.51 [3.04-9.99],1.943554596207354e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CXCL17,C-X-C motif chemokine 17,2530,124,1.12 [0.79-1.60],0.5200686722660837
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CXCL3,C-X-C motif chemokine 3,2504,121,1.05 [0.89-1.25],0.5345823928639761
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CXCL5,C-X-C motif chemokine 5,2490,121,1.02 [0.89-1.17],0.7652274860941133
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CXCL6,C-X-C motif chemokine 6,2530,124,1.36 [1.10-1.67],0.0038126437207781
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CXCL8,Interleukin-8,2475,124,1.26 [1.06-1.51],0.0105019931301088
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CXCL9,C-X-C motif chemokine 9,2510,121,1.49 [1.20-1.84],0.0003152001926787
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CYB5A,Cytochrome b5,2087,102,1.08 [0.83-1.41],0.5593335774594403
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CYB5R2,NADH-cytochrome b5 reductase 2,2139,100,1.34 [0.98-1.85],0.0707998774492444
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",2105,101,0.76 [0.57-1.02],0.0645585757579391
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CYTH3,Cytohesin-3,2087,102,0.94 [0.71-1.26],0.6824085900541412
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CYTL1,Cytokine-like protein 1,2175,103,2.10 [1.09-4.05],0.0274995906798415
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DAAM1,Disheveled-associated activator of morphogenesis 1,2132,103,0.91 [0.72-1.15],0.4295236226020154
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DAB2,Disabled homolog 2,2516,125,0.99 [0.86-1.14],0.9334207622805556
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DAG1,Dystroglycan,2510,121,1.71 [1.21-2.40],0.0020841194508043
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DAND5,DAN domain family member 5,2106,103,0.91 [0.68-1.22],0.5343484030026484
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DAPK2,Death-associated protein kinase 2,2106,103,0.92 [0.65-1.31],0.6513174308061904
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,2500,123,0.95 [0.84-1.07],0.4084814201085467
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DARS1,"Aspartate--tRNA ligase, cytoplasmic",2471,121,0.97 [0.77-1.21],0.7645416632841513
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DBH,Dopamine beta-hydroxylase,2171,105,0.94 [0.80-1.09],0.4073463256309204
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DBI,Acyl-CoA-binding protein,2490,120,1.17 [0.94-1.46],0.1609032949106886
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DBN1,Drebrin,2106,103,1.13 [0.78-1.62],0.5222978014422817
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DBNL,Drebrin-like protein,2510,121,1.03 [0.87-1.23],0.7199153588208789
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",2497,124,3.70 [2.45-5.58],4.4037495423416486e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DCC,Netrin receptor DCC,2119,101,1.16 [0.50-2.66],0.7284921030692595
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DCDC2C,Doublecortin domain-containing protein 2C,2087,102,0.95 [0.70-1.31],0.7730801265277571
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DCLRE1C,Protein artemis,2087,102,0.90 [0.46-1.74],0.7501289669116135
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DCN,Decorin,2451,119,5.14 [2.90-9.10],2.0314144477662643e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DCTD,Deoxycytidylate deaminase,2132,103,0.94 [0.77-1.16],0.5808312936573523
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DCTN1,Dynactin subunit 1,2516,125,1.07 [0.83-1.37],0.6022281034311819
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DCTN2,Dynactin subunit 2,2479,123,1.10 [0.93-1.29],0.2837611416067579
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DCTN6,Dynactin subunit 6,2431,119,1.03 [0.82-1.28],0.8176726645459373
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DCTPP1,dCTP pyrophosphatase 1,2498,123,1.11 [0.68-1.81],0.6857977939618675
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DCUN1D1,DCN1-like protein 1,2108,103,0.86 [0.64-1.16],0.327906508643457
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DCUN1D2,DCN1-like protein 2,2087,102,0.69 [0.51-0.94],0.0201600251563107
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DCXR,L-xylulose reductase,2497,124,0.83 [0.64-1.09],0.1793398504611224
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DDA1,DET1- and DDB1-associated protein 1,2105,101,0.94 [0.53-1.66],0.8178631251110673
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",2479,123,1.38 [0.99-1.93],0.0595134560049073
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DDC,Aromatic-L-amino-acid decarboxylase,2498,123,0.77 [0.56-1.06],0.1052989036744116
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DDHD2,Phospholipase DDHD2,2162,104,1.09 [0.81-1.45],0.5764514729410859
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DDI2,Protein DDI1 homolog 2,2132,103,0.89 [0.70-1.14],0.3529313248330438
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DDR1,Epithelial discoidin domain-containing receptor 1,2516,124,4.70 [2.86-7.74],1.1926793832065743e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DDT,D-dopachrome decarboxylase,2175,103,0.83 [0.52-1.31],0.4189575709176535
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DDX1,ATP-dependent RNA helicase DDX1,2165,101,0.98 [0.63-1.53],0.924894430473105
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DDX25,ATP-dependent RNA helicase DDX25,2119,101,0.90 [0.49-1.67],0.7468097668919613
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DDX39A,ATP-dependent RNA helicase DDX39A,2106,103,1.09 [0.48-2.48],0.837126409628101
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DDX4,Probable ATP-dependent RNA helicase DDX4,2106,103,0.87 [0.58-1.31],0.5057934561941579
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DDX53,Probable ATP-dependent RNA helicase DDX53,2119,101,0.87 [0.50-1.53],0.6290214511413534
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DDX58,Antiviral innate immune response receptor RIG-I,2421,119,0.94 [0.71-1.26],0.6993402182269207
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",2500,123,1.00 [0.85-1.19],0.9826639936417328
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DEFA1_DEFA1B,Neutrophil defensin 1,2451,119,1.83 [1.47-2.28],4.6934447580763815e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DEFB103A_DEFB103B,Beta-defensin 103,2091,103,1.16 [0.80-1.69],0.4429905773349621
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DEFB104A_DEFB104B,Beta-defensin 104,2108,103,1.08 [0.74-1.58],0.6951251925811812
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DEFB116,Beta-defensin 116,2108,103,0.74 [0.53-1.04],0.0813728523070717
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DEFB118,Beta-defensin 118,2108,103,1.06 [0.78-1.43],0.7141016370997922
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DEFB4A_DEFB4B,Beta-defensin 4A,2460,122,1.04 [0.94-1.16],0.4163087388771784
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DENND2B,DENN domain-containing protein 2B,2105,101,1.29 [0.96-1.73],0.0858805736680163
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DENR,Density-regulated protein,2106,103,0.87 [0.61-1.23],0.4300505522931359
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DFFA,DNA fragmentation factor subunit alpha,2530,124,1.03 [0.81-1.32],0.8044566623322945
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DGCR6,Protein DGCR6,2108,103,0.80 [0.47-1.36],0.4145532302863919
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DGKA,Diacylglycerol kinase alpha,2106,103,1.06 [0.75-1.49],0.7533220549001357
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DGKZ,Diacylglycerol kinase zeta,2444,122,0.98 [0.62-1.55],0.9282991258949884
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DHODH,Dihydroorotate dehydrogenase,2105,101,0.87 [0.55-1.37],0.5511869572086732
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DHPS,Deoxyhypusine synthase,2161,104,1.05 [0.67-1.64],0.8345635823322742
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,2160,104,1.03 [0.69-1.54],0.8877217778376839
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DIABLO,"Diablo homolog, mitochondrial",2493,123,0.92 [0.80-1.06],0.273861764037375
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DIPK1C,Divergent protein kinase domain 1C,2119,101,0.66 [0.38-1.16],0.1531123440141793
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DIPK2B,Divergent protein kinase domain 2B,2132,103,1.29 [0.69-2.42],0.4219284957965783
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DKK1,Dickkopf-related protein 1,2516,124,1.19 [0.91-1.55],0.1972482374625339
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DKK3,Dickkopf-related protein 3,2530,124,3.96 [2.42-6.47],4.2084602461898986e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DKK4,Dickkopf-related protein 4,2472,122,2.48 [1.95-3.17],2.0954621398119561e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DKKL1,Dickkopf-like protein 1,2479,123,1.06 [0.87-1.29],0.5850887143163217
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DLG4,Disks large homolog 4,2160,104,0.97 [0.74-1.26],0.810045872944966
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DLGAP5,Disks large-associated protein 5,2162,104,1.26 [0.89-1.78],0.1946573092350771
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DLK1,Protein delta homolog 1,2530,124,1.02 [0.78-1.32],0.893949816370302
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DLL1,Delta-like protein 1,2497,124,6.45 [4.38-9.50],3.4772342410792986e-21
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DLL4,Delta-like protein 4,2110,105,1.14 [0.96-1.35],0.1439244778013561
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DMD,Dystrophin,2110,105,1.75 [1.29-2.37],0.0002855847932535
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DMP1,Dentin matrix acidic phosphoprotein 1,2110,105,0.53 [0.41-0.68],6.066607075073262e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DNAJA1,DnaJ homolog subfamily A member 1,2087,102,0.93 [0.56-1.55],0.7840035361008848
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DNAJA2,DnaJ homolog subfamily A member 2,2525,124,1.02 [0.84-1.24],0.8349874633006978
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DNAJA4,DnaJ homolog subfamily A member 4,2160,104,0.97 [0.74-1.25],0.7910096960202349
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DNAJB1,DnaJ homolog subfamily B member 1,2479,123,1.06 [0.87-1.28],0.5794363741574444
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DNAJB14,DnaJ homolog subfamily B member 14,2165,101,1.10 [0.82-1.47],0.5286726347866884
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DNAJB2,DnaJ homolog subfamily B member 2,2132,103,0.84 [0.58-1.20],0.3391348374285365
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DNAJB6,DnaJ homolog subfamily B member 6,2111,102,0.95 [0.75-1.19],0.6312141653454049
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DNAJB8,DnaJ homolog subfamily B member 8,2451,119,1.21 [0.92-1.59],0.1818793494284162
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DNAJC21,DnaJ homolog subfamily C member 21,2160,104,0.69 [0.42-1.16],0.1638590068964394
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DNAJC6,Putative tyrosine-protein phosphatase auxilin,2110,105,1.11 [0.89-1.39],0.3496430649618397
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DNAJC9,DnaJ homolog subfamily C member 9,2165,101,1.01 [0.78-1.31],0.925696150243018
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DNER,Delta and Notch-like epidermal growth factor-related receptor,2497,120,0.56 [0.31-1.02],0.0582652711065805
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DNLZ,DNL-type zinc finger protein,2108,103,0.91 [0.70-1.18],0.4902342181338981
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DNM1,Dynamin-1,2165,101,0.95 [0.80-1.12],0.550547886641865
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DNM3,Dynamin-3,2162,104,1.38 [1.02-1.86],0.0356298266524206
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DNMBP,Dynamin-binding protein,2476,122,1.36 [1.07-1.72],0.010932026450739
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DNPEP,Aspartyl aminopeptidase,2160,104,0.84 [0.62-1.15],0.2766783525893475
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,2503,121,0.90 [0.65-1.23],0.5043063718279328
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DOC2B,Double C2-like domain-containing protein beta,2119,101,0.81 [0.45-1.43],0.4658480514328612
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DOCK9,Dedicator of cytokinesis protein 9,2108,103,0.84 [0.68-1.03],0.0998154138907817
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DOK1,Docking protein 1,2160,104,0.99 [0.87-1.14],0.9431572872107086
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DOK2,Docking protein 2,2498,123,1.01 [0.88-1.14],0.9271011192018666
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DPEP1,Dipeptidase 1,2471,121,0.90 [0.64-1.26],0.5481878587000459
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DPEP2,Dipeptidase 2,2479,123,1.61 [0.96-2.71],0.0700199534568037
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DPP10,Inactive dipeptidyl peptidase 10,2500,123,1.37 [0.98-1.90],0.0621105817211029
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DPP4,Dipeptidyl peptidase 4,2457,119,0.71 [0.43-1.19],0.1976371153597657
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DPP6,Dipeptidyl aminopeptidase-like protein 6,2479,123,2.29 [1.57-3.33],1.7313679022901808e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DPP7,Dipeptidyl peptidase 2,2481,122,1.05 [0.81-1.35],0.7286156801629327
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DPT,Dermatopontin,2530,124,3.06 [1.57-5.95],0.0010014521135329
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DPY30,Protein dpy-30 homolog,2510,125,1.52 [1.21-1.90],0.000260853837745
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DRAXIN,Draxin,2476,122,2.06 [1.46-2.93],4.550419826373519e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DRG2,Developmentally-regulated GTP-binding protein 2,2479,123,1.06 [0.80-1.40],0.7066785078764755
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DSC2,Desmocollin-2,2480,120,4.08 [2.92-5.70],1.7698458552386895e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DSCAM,Down syndrome cell adhesion molecule,2162,104,1.96 [1.25-3.08],0.0036131791610593
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DSG2,Desmoglein-2,2505,122,3.33 [2.07-5.34],6.588385119365618e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DSG3,Desmoglein-3,2508,125,1.24 [0.81-1.90],0.3144128107564344
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DSG4,Desmoglein-4,2470,122,0.65 [0.47-0.90],0.0089386416723623
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DTD1,D-aminoacyl-tRNA deacylase 1,2132,103,0.91 [0.73-1.13],0.3910603676333881
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DTNB,Dystrobrevin beta,2158,104,2.17 [1.59-2.94],7.544024265774145e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DTX2,Probable E3 ubiquitin-protein ligase DTX2,2119,101,0.66 [0.43-1.03],0.0675079226475077
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DTX3,Probable E3 ubiquitin-protein ligase DTX3,2479,123,3.66 [2.24-5.98],2.24588936811144e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DTYMK,Thymidylate kinase,2168,106,0.98 [0.74-1.29],0.8769738611389537
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DUOX2,Dual oxidase 2,2451,119,0.92 [0.71-1.19],0.5273395979694844
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DUSP13,Dual specificity protein phosphatase 13 isoform A,2161,104,0.68 [0.43-1.07],0.0953494391662167
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DUSP29,Dual specificity phosphatase 29,2119,101,1.04 [0.78-1.39],0.7866119249940628
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DUSP3,Dual specificity protein phosphatase 3,2431,119,0.78 [0.62-0.99],0.0441459740920198
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",2165,101,1.04 [0.86-1.24],0.6976472355804075
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DXO,Decapping and exoribonuclease protein,2160,104,0.96 [0.62-1.48],0.8482825822902911
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,2161,104,1.17 [0.75-1.82],0.4824804571726996
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DYNLT1,Dynein light chain Tctex-type 1,2119,101,0.94 [0.73-1.20],0.5997808604769987
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DYNLT3,Dynein light chain Tctex-type 3,2161,104,0.54 [0.34-0.85],0.0072280505034019
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,2476,122,1.05 [0.89-1.25],0.5544852195697534
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EBI3_IL27,Interleukin-27,2513,125,4.00 [2.55-6.28],1.6549072871296667e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ECE1,Endothelin-converting enzyme 1,2431,119,1.22 [0.77-1.92],0.3948491363286756
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",2168,106,1.03 [0.83-1.29],0.7869578569605917
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ECHS1,"Enoyl-CoA hydratase, mitochondrial",2110,105,1.07 [0.89-1.30],0.4760209855468461
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ECI2,Enoyl-CoA delta isomerase 2,2105,101,1.02 [0.75-1.37],0.9048365125354624
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ECM1,Extracellular matrix protein 1,2114,102,0.85 [0.51-1.42],0.534733624038378
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ECSCR,Endothelial cell-specific chemotaxis regulator,2108,103,0.88 [0.58-1.33],0.5432113906781968
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EDA2R,Tumor necrosis factor receptor superfamily member 27,2516,125,4.08 [3.22-5.16],2.244027912338613e-31
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EDAR,Tumor necrosis factor receptor superfamily member EDAR,2500,123,1.08 [0.90-1.29],0.4304313971600045
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EDDM3B,Epididymal secretory protein E3-beta,2161,104,1.09 [0.80-1.49],0.5797073494171255
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,2105,101,1.37 [0.87-2.14],0.172407879874341
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EDF1,Endothelial differentiation-related factor 1,2162,104,1.00 [0.75-1.35],0.9911854586750274
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,2451,119,1.61 [1.04-2.49],0.0321267316357188
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EDN1,Endothelin-1,2110,105,4.11 [2.47-6.83],5.5370547964999634e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EDNRB,Endothelin receptor type B,2106,103,1.06 [0.65-1.72],0.8123112528368248
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EEF1D,Elongation factor 1-delta,2168,106,1.12 [0.92-1.37],0.2483880187852408
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EFCAB14,EF-hand calcium-binding domain-containing protein 14,2165,101,3.77 [2.45-5.80],1.6149701629943927e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EFCAB2,Dynein regulatory complex protein 8,2135,102,0.90 [0.51-1.60],0.7239867860317606
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,2502,122,4.84 [3.31-7.10],5.806045487911583e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EFHD1,EF-hand domain-containing protein D1,2162,104,1.96 [1.30-2.95],0.0013755154035712
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EFNA1,Ephrin-A1,2502,122,5.65 [3.93-8.13],1.0427903835820776e-20
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EFNA4,Ephrin-A4,2472,122,5.25 [3.89-7.09],2.0792674040765563e-27
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EFNB2,Ephrin-B2,2119,101,1.26 [0.97-1.65],0.0865620498732404
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EGF,Pro-epidermal growth factor,2498,121,1.01 [0.87-1.18],0.8782801001122905
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EGFL7,Epidermal growth factor-like protein 7,2421,119,2.42 [1.72-3.39],3.081129908788282e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EGFLAM,Pikachurin,2165,101,1.75 [1.06-2.87],0.0279600181883941
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EGFR,Epidermal growth factor receptor,2530,124,2.41 [0.97-5.96],0.0578635787338058
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EGLN1,Egl nine homolog 1,2500,123,1.10 [0.84-1.42],0.48868743686936
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EHBP1,EH domain-binding protein 1,2168,106,1.03 [0.81-1.33],0.791048967117824
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EHD3,EH domain-containing protein 3,2110,105,0.96 [0.82-1.13],0.6155186088510961
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",2160,104,0.73 [0.49-1.11],0.1405829694113759
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",2156,100,1.00 [0.84-1.20],0.9953945146020408
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,2105,101,0.87 [0.64-1.17],0.3558055942055137
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,2110,105,0.75 [0.46-1.22],0.2477564081697713
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EIF4B,Eukaryotic translation initiation factor 4B,2476,122,0.86 [0.64-1.15],0.3036037998500664
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EIF4E,Eukaryotic translation initiation factor 4E,2106,103,0.96 [0.78-1.19],0.727284412602065
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,2498,123,1.01 [0.79-1.29],0.9466734463147296
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,2530,124,1.03 [0.87-1.22],0.7037842436250381
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,2162,104,1.06 [0.81-1.40],0.6725260729051032
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EIF5,Eukaryotic translation initiation factor 5,2105,101,1.28 [0.93-1.76],0.1296378790705876
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EIF5A,Eukaryotic translation initiation factor 5A-1,2444,122,1.16 [0.70-1.91],0.5718708988177714
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ELAC1,Zinc phosphodiesterase ELAC protein 1,2162,104,0.98 [0.77-1.23],0.8308466671531682
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ELAVL4,ELAV-like protein 4,2108,103,1.11 [0.90-1.37],0.3361618297233415
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ELN,Elastin,2168,106,3.36 [2.06-5.49],1.18824756634145e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ELOA,Elongin-A,2479,123,0.84 [0.62-1.16],0.2928449268934663
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ELOB,Elongin-B,2105,101,1.08 [0.66-1.77],0.7522692398931362
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ENAH,Protein enabled homolog,2444,122,1.33 [0.98-1.81],0.0672294732965511
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ENDOU,Poly(U)-specific endoribonuclease,2000,94,1.63 [1.18-2.24],0.0028711142916676
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ENG,Endoglin,2530,124,6.52 [2.84-14.95],9.501337142200589e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ENO1,Alpha-enolase,2502,122,0.99 [0.80-1.22],0.9210837603781272
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ENO2,Gamma-enolase,2516,124,0.98 [0.76-1.25],0.8611533664083988
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ENO3,Beta-enolase,2110,105,0.72 [0.53-0.98],0.0340391743857527
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ENOPH1,Enolase-phosphatase E1,2161,104,0.61 [0.45-0.83],0.0014887283050792
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ENOX2,Ecto-NOX disulfide-thiol exchanger 2,2105,101,1.18 [0.62-2.23],0.6199028015610646
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ENPEP,Glutamyl aminopeptidase,2105,101,1.07 [0.73-1.57],0.7230097701233792
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,2530,124,2.31 [1.37-3.90],0.001738096094415
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,2510,121,0.79 [0.59-1.06],0.1132550441605017
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,2110,105,1.56 [0.93-2.63],0.0952696352937502
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,2421,118,1.18 [0.98-1.42],0.0727977244040759
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ENSA,Alpha-endosulfine,2161,104,0.70 [0.46-1.05],0.0848905222554738
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,2421,119,1.23 [0.87-1.73],0.2331658561127517
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,2451,119,0.60 [0.29-1.22],0.1569560949093589
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,2451,119,2.63 [1.30-5.34],0.0073612977606051
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ENTR1,Endosome-associated-trafficking regulator 1,2110,105,0.90 [0.68-1.20],0.4895686204066435
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EP300,Histone acetyltransferase p300,2106,103,0.83 [0.45-1.53],0.5532050993774813
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EPB41L5,Band 4.1-like protein 5,2119,101,1.21 [0.94-1.55],0.1481472692779581
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EPCAM,Epithelial cell adhesion molecule,2498,120,0.99 [0.82-1.19],0.9249914412134886
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EPGN,Epigen,2161,104,0.99 [0.62-1.60],0.9809501596191054
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EPHA1,Ephrin type-A receptor 1,2503,121,2.77 [1.71-4.48],3.304626990605045e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EPHA10,Ephrin type-A receptor 10,2431,119,1.02 [0.80-1.30],0.8760783233210373
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EPHA2,Ephrin type-A receptor 2,2400,121,4.53 [3.31-6.18],2.7451091983797578e-21
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EPHA4,Ephrin type-A receptor 4,2132,103,2.90 [1.57-5.37],0.0006698849207673
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EPHB4,Ephrin type-B receptor 4,2530,124,7.20 [4.76-10.87],6.6760877335229625e-21
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EPHB6,Ephrin type-B receptor 6,2471,121,3.59 [2.44-5.28],8.653971038722278e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EPHX2,Bifunctional epoxide hydrolase 2,2451,119,0.95 [0.72-1.25],0.6927243285888945
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EPN1,Epsin-1,2135,102,0.53 [0.29-0.97],0.0399902946171747
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EPO,Erythropoietin,2500,123,1.20 [1.00-1.45],0.0554174154942061
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EPPK1,Epiplakin,2110,105,1.17 [0.91-1.50],0.2219725662270297
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,2513,125,1.68 [1.07-2.64],0.0250490335145516
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ERBB2,Receptor tyrosine-protein kinase erbB-2,2497,124,1.33 [0.72-2.45],0.3621952723144694
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ERBB3,Receptor tyrosine-protein kinase erbB-3,2493,121,3.62 [1.78-7.35],0.0003673969689326
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ERBB4,Receptor tyrosine-protein kinase erbB-4,2497,124,3.85 [2.20-6.74],2.261228437056218e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ERBIN,Erbin,2479,123,1.01 [0.86-1.18],0.8994243258148101
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ERC2,ERC protein 2,2119,101,1.00 [0.75-1.34],0.9967410232544064
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ERCC1,DNA excision repair protein ERCC-1,2087,102,0.95 [0.49-1.83],0.8779680504107278
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EREG,Proepiregulin,2471,121,1.07 [0.89-1.30],0.4651320975840228
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ERI1,3'-5' exoribonuclease 1,2135,102,0.97 [0.55-1.72],0.9200489136610668
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ERMAP,Erythroid membrane-associated protein,2106,103,2.12 [1.43-3.14],0.0001967712219662
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,2161,104,1.09 [0.65-1.83],0.7460169572939427
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ERP29,Endoplasmic reticulum resident protein 29,2132,103,0.91 [0.78-1.07],0.2777660925965841
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ERP44,Endoplasmic reticulum resident protein 44,2477,123,1.17 [0.64-2.15],0.6099933584229011
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ERVV-1,Endogenous retrovirus group V member 1 Env polyprotein,2105,101,1.23 [0.79-1.93],0.3601243816614563
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ESAM,Endothelial cell-selective adhesion molecule,2530,124,3.69 [2.55-5.34],4.4362015665794356e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ESM1,Endothelial cell-specific molecule 1,2500,121,1.68 [1.09-2.58],0.018710510643139
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ESPL1,Separin,2087,102,0.81 [0.55-1.18],0.2748151576396928
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ESR1,Estrogen receptor,2106,103,0.87 [0.58-1.31],0.5130491286189899
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ESYT2,Extended synaptotagmin-2,2160,104,1.07 [0.85-1.34],0.5734246461569513
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EVI2B,Protein EVI2B,2087,102,0.66 [0.34-1.25],0.1990957960102658
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EVI5,Ecotropic viral integration site 5 protein homolog,2106,103,1.02 [0.83-1.26],0.8557908981938364
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EVPL,Envoplakin,2135,102,1.57 [0.91-2.70],0.1048279696847815
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EXOSC10,Exosome component 10,2105,101,0.74 [0.48-1.15],0.1774662130628377
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EXTL1,Exostosin-like 1,2105,101,1.39 [1.06-1.82],0.0158737108968418
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EZR,Ezrin,2516,124,0.98 [0.51-1.87],0.9506548528667595
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,F10,Coagulation factor X,2174,105,0.54 [0.31-0.95],0.0326258429341992
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,F11,Coagulation factor XI,2144,102,2.24 [1.23-4.09],0.0083753005767573
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,F11R,Junctional adhesion molecule A,2505,122,1.29 [0.97-1.70],0.0751124743244458
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,F12,Coagulation factor XII,2171,104,1.05 [0.66-1.67],0.8399826067533595
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,F13B,Coagulation factor XIII B chain,2159,104,1.37 [0.66-2.82],0.3961542112068322
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,F2,Prothrombin,2171,104,0.45 [0.13-1.55],0.2073816200071114
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,F2R,Proteinase-activated receptor 1,2509,121,1.66 [1.26-2.20],0.0003447814234473
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,F3,Tissue factor,2500,125,2.91 [1.74-4.87],4.557638036060456e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,F7,Coagulation factor VII,2499,122,0.86 [0.53-1.37],0.5201576964436815
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,F9,Coagulation factor IX,2503,122,1.12 [0.45-2.77],0.8122377813944219
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FABP1,"Fatty acid-binding protein, liver",2500,121,1.56 [1.35-1.80],2.2561666930972202e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FABP2,"Fatty acid-binding protein, intestinal",2498,123,1.36 [1.15-1.61],0.0003010914701003
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FABP3,"Fatty acid-binding protein, heart",2168,106,2.36 [1.85-3.01],4.77782064353401e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FABP4,"Fatty acid-binding protein, adipocyte",2530,124,2.24 [1.78-2.81],3.552251851913792e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FABP5,Fatty acid-binding protein 5,2508,123,1.38 [1.09-1.75],0.0081239952149469
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FABP6,Gastrotropin,2448,118,1.19 [0.92-1.53],0.1949226022162586
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FABP9,Fatty acid-binding protein 9,2500,123,1.16 [0.88-1.53],0.3024616822563444
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FADD,FAS-associated death domain protein,2498,123,0.93 [0.75-1.15],0.501684188378143
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FAM13A,Protein FAM13A,2165,101,1.08 [0.82-1.43],0.592396888021681
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FAM171A2,Protein FAM171A2,2162,104,1.00 [0.89-1.13],0.98443255509339
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FAM171B,Protein FAM171B,2161,104,1.34 [0.67-2.68],0.4060757785284615
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FAM172A,Cotranscriptional regulator FAM172A,2110,105,0.86 [0.63-1.19],0.3689885688273214
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FAM20A,Pseudokinase FAM20A,2168,106,2.07 [1.09-3.92],0.0256696640683752
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FAM3B,Protein FAM3B,2479,123,4.08 [2.53-6.58],8.622078345382412e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FAM3C,Protein FAM3C,2498,123,5.80 [3.94-8.52],4.0465882375850274e-19
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FAM3D,Protein FAM3D,2165,101,1.54 [1.24-1.91],7.401490816841241e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FAP,Prolyl endopeptidase FAP,2530,124,1.25 [0.74-2.09],0.4049285421177824
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FARSA,Phenylalanine--tRNA ligase alpha subunit,2119,101,0.97 [0.73-1.29],0.8356760767445541
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FAS,Tumor necrosis factor receptor superfamily member 6,2525,124,2.03 [1.57-2.64],9.863474316288525e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FASLG,Tumor necrosis factor ligand superfamily member 6,2530,124,1.62 [1.06-2.47],0.0245953294024576
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FBLN2,Fibulin-2,2175,103,2.67 [1.65-4.33],6.356773070757795e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FBN2,Fibrillin-2,2119,101,1.42 [1.02-1.96],0.0366576355664338
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FBP1,"Fructose-1,6-bisphosphatase 1",2498,123,0.88 [0.72-1.07],0.2062050267169059
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,2168,106,1.22 [0.95-1.57],0.121751538624286
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FCAR,Immunoglobulin alpha Fc receptor,2500,123,1.64 [1.29-2.09],5.775047451033857e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,2162,104,1.50 [0.81-2.80],0.1978757246443741
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FCER2,Low affinity immunoglobulin epsilon Fc receptor,2505,122,1.54 [1.23-1.93],0.0001840302346666
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,2491,122,1.49 [1.09-2.05],0.0134042785701601
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,2421,119,1.10 [0.84-1.43],0.4964693456982002
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,2497,122,1.30 [0.93-1.81],0.1203089714224099
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FCN1,Ficolin-1,2171,105,1.93 [1.31-2.85],0.0008897171996943
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FCN2,Ficolin-2,2486,122,0.86 [0.58-1.27],0.4409175571497968
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FCRL1,Fc receptor-like protein 1,2498,123,1.27 [0.91-1.78],0.15803352057277
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FCRL2,Fc receptor-like protein 2,2520,122,1.42 [1.08-1.86],0.0123327521362947
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FCRL3,Fc receptor-like protein 3,2444,122,1.11 [0.85-1.46],0.4472751300179366
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FCRL5,Fc receptor-like protein 5,2505,122,1.28 [0.99-1.66],0.0574149769868999
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FCRL6,Fc receptor-like protein 6,2500,123,1.39 [1.10-1.77],0.0065693045981975
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FCRLB,Fc receptor-like B,2421,119,1.73 [1.36-2.19],5.907466005038547e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FDX1,"Adrenodoxin, mitochondrial",2105,101,1.17 [0.88-1.56],0.2720502116196491
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FDX2,"Ferredoxin-2, mitochondrial",2105,101,1.36 [0.99-1.86],0.0583235839063708
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FEN1,Flap endonuclease 1,2421,119,0.92 [0.71-1.18],0.5055850587958566
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FES,Tyrosine-protein kinase Fes/Fps,2421,119,0.85 [0.60-1.21],0.357997734651283
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FETUB,Fetuin-B,2503,122,1.11 [0.68-1.81],0.6648670629873743
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FGA,Fibrinogen alpha chain,2125,102,1.86 [1.05-3.30],0.0327447492365495
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",2162,104,1.02 [0.81-1.29],0.8752834347369162
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FGF12,Fibroblast growth factor 12,2106,103,0.77 [0.45-1.32],0.3477399873342019
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FGF16,Fibroblast growth factor 16,2106,103,0.54 [0.33-0.86],0.0101376044604248
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FGF19,Fibroblast growth factor 19,2510,121,1.18 [0.97-1.44],0.1037855179889965
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FGF2,Fibroblast growth factor 2,2500,123,1.21 [0.97-1.51],0.0848325664400304
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FGF20,Fibroblast growth factor 20,2106,103,1.11 [0.73-1.68],0.6383811907424819
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FGF21,Fibroblast growth factor 21,2513,125,1.16 [1.03-1.32],0.0172648526303778
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FGF23,Fibroblast growth factor 23,2508,125,1.63 [1.36-1.94],7.99816614675542e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FGF3,Fibroblast growth factor 3,2106,103,1.04 [0.50-2.16],0.9227259587573908
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FGF5,Fibroblast growth factor 5,2444,122,2.52 [1.89-3.36],2.7184501569407176e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FGF6,Fibroblast growth factor 6,2106,103,1.19 [0.84-1.70],0.3296879964111387
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FGF7,Fibroblast growth factor 7,2087,102,0.90 [0.68-1.19],0.4523005987597878
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FGF9,Fibroblast growth factor 9,2084,102,0.87 [0.54-1.39],0.5561358790156441
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FGFBP1,Fibroblast growth factor-binding protein 1,2497,124,0.51 [0.35-0.74],0.0003427477497741
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FGFBP2,Fibroblast growth factor-binding protein 2,2175,103,0.43 [0.30-0.63],1.024115045449985e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FGFBP3,Fibroblast growth factor-binding protein 3,2160,104,1.01 [0.62-1.65],0.9712331082626016
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FGFR2,Fibroblast growth factor receptor 2,2497,124,3.85 [2.51-5.91],6.771453087574892e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FGFR4,Fibroblast growth factor receptor 4,2132,103,0.93 [0.64-1.35],0.709362374502023
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FGL1,Fibrinogen-like protein 1,2174,105,1.59 [1.23-2.07],0.0004675799467578
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FGR,Tyrosine-protein kinase Fgr,2431,119,0.95 [0.73-1.24],0.7048468335194195
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FH,"Fumarate hydratase, mitochondrial",2108,103,1.08 [0.89-1.31],0.4115728575945627
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FHIP2A,FHF complex subunit HOOK interacting protein 2A,2105,101,0.80 [0.52-1.22],0.2966631416157276
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FHIT,Bis(5'-adenosyl)-triphosphatase,2431,119,0.88 [0.70-1.11],0.2726843386561706
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FIS1,Mitochondrial fission 1 protein,2498,121,1.03 [0.83-1.27],0.7915196751177506
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,2162,104,0.99 [0.81-1.20],0.8816836341919678
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,2507,122,1.04 [0.91-1.20],0.537888585069082
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,2476,122,1.30 [0.87-1.94],0.1978716699425828
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,2476,122,1.04 [0.87-1.25],0.6577741139802763
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,2426,118,1.16 [0.86-1.56],0.3351697988181935
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FKBPL,FK506-binding protein-like,2165,101,1.11 [0.79-1.55],0.558220216096154
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FLI1,Friend leukemia integration 1 transcription factor,2421,119,1.02 [0.88-1.19],0.7724625461510337
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,2476,122,3.88 [2.26-6.65],8.221366728107884e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FLT1,Vascular endothelial growth factor receptor 1,2477,123,1.74 [1.08-2.80],0.0229175785258493
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FLT3,Receptor-type tyrosine-protein kinase FLT3,2421,119,1.02 [0.59-1.75],0.9419042293202436
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FLT3LG,Fms-related tyrosine kinase 3 ligand,2530,124,1.91 [1.23-2.97],0.0039296798000471
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FLT4,Vascular endothelial growth factor receptor 3,2497,124,1.00 [0.64-1.57],0.9982290134512548
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FMNL1,Formin-like protein 1,2431,119,0.99 [0.78-1.25],0.929828198547724
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FMR1,Synaptic functional regulator FMR1,2421,119,1.29 [0.83-2.01],0.2531553480146384
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FN1,Fibronectin,2171,104,0.62 [0.31-1.23],0.1726634716918547
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FNDC1,Fibronectin type III domain-containing protein 1,2160,104,1.29 [0.88-1.89],0.1877478302058
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,2161,104,0.96 [0.52-1.78],0.8998098396832381
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FOLH1,Glutamate carboxypeptidase 2,2106,103,1.12 [0.95-1.33],0.1767660039397995
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FOLR1,Folate receptor alpha,2488,124,3.70 [2.47-5.54],2.332316533853371e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FOLR2,Folate receptor beta,2516,124,2.10 [1.24-3.54],0.0054479596954515
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FOLR3,Folate receptor gamma,2490,123,0.98 [0.90-1.06],0.5888577271166167
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FOS,Proto-oncogene c-Fos,2084,102,1.24 [0.71-2.15],0.4485550114611364
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FOSB,Protein fosB,2431,119,1.20 [0.84-1.73],0.3107447811802065
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FOXJ3,Forkhead box protein J3,2106,103,0.85 [0.55-1.31],0.4551779215059885
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FOXO1,Forkhead box protein O1,2500,123,1.05 [0.87-1.27],0.593790740442133
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FOXO3,Forkhead box protein O3,2421,119,1.11 [0.94-1.31],0.2299738742755463
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FRMD4B,FERM domain-containing protein 4B,2105,101,1.11 [0.85-1.45],0.4333575693905704
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FRMD7,FERM domain-containing protein 7,2119,101,1.34 [0.74-2.43],0.3299597764998539
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FRZB,Secreted frizzled-related protein 3,2469,122,1.98 [1.02-3.85],0.043647905810779
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FSHB,Follitropin subunit beta,2110,105,1.88 [1.37-2.58],8.313901771250619e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FST,Follistatin,2509,121,1.49 [1.06-2.09],0.0205686520927279
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FSTL1,Follistatin-related protein 1,2110,105,5.32 [2.55-11.12],8.786792578131098e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FSTL3,Follistatin-related protein 3,2498,121,4.62 [3.35-6.36],6.524646217382575e-21
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FTCD,Formimidoyltransferase-cyclodeaminase,2157,104,0.91 [0.76-1.10],0.3442902137198449
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FUCA1,Tissue alpha-L-fucosidase,2517,124,1.01 [0.83-1.21],0.94594579445577
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FUOM,Fucose mutarotase,2132,103,0.83 [0.64-1.09],0.1778159498136869
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FURIN,Furin,2497,124,0.72 [0.46-1.13],0.1549608567154757
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FUS,RNA-binding protein FUS,2413,119,0.93 [0.59-1.44],0.7344190266916089
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",2131,102,0.92 [0.66-1.27],0.5973919610430527
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,2516,124,1.76 [1.26-2.45],0.0008577587720672
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FUT8,"Alpha-(1,6)-fucosyltransferase",2476,122,1.18 [0.90-1.56],0.226226599127239
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FXN,"Frataxin, mitochondrial",2516,125,1.03 [0.82-1.28],0.8248074155071206
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FXYD5,FXYD domain-containing ion transport regulator 5,2444,122,1.09 [0.86-1.39],0.4622354831607435
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FYB1,FYN-binding protein 1,2498,122,0.98 [0.82-1.16],0.7878169742136065
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FZD10,Frizzled-10,2119,101,0.84 [0.56-1.26],0.4076769858131298
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FZD8,Frizzled-8,2108,103,1.31 [0.92-1.87],0.1305706272660502
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GABARAP,Gamma-aminobutyric acid receptor-associated protein,2161,104,1.34 [0.95-1.89],0.0939975488852749
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,2135,102,0.90 [0.66-1.22],0.4859559239505756
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,2108,103,1.18 [0.89-1.55],0.2444400734654744
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GAD1,Glutamate decarboxylase 1,2087,102,0.88 [0.42-1.83],0.7334811024470405
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GAD2,Glutamate decarboxylase 2,2106,103,0.93 [0.59-1.47],0.7437024106231058
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,2135,102,1.03 [0.70-1.52],0.8834004612076166
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,2110,105,0.92 [0.64-1.32],0.6574454737171855
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GAGE2A,G antigen 2A,2087,102,0.76 [0.53-1.08],0.1261052166360053
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GAL,Galanin peptides,2510,121,1.09 [0.86-1.38],0.4679502077051476
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,2479,123,2.17 [1.29-3.67],0.003744691716491
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,2516,125,0.67 [0.38-1.16],0.1529872940291738
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,2444,122,2.19 [1.58-3.03],2.190378441088037e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,2168,106,1.24 [0.65-2.37],0.5116404528257774
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GALNT7,N-acetylgalactosaminyltransferase 7,2479,123,2.41 [1.17-4.97],0.0174831519118639
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GAMT,Guanidinoacetate N-methyltransferase,2105,101,1.08 [0.64-1.82],0.7748831034104428
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,2082,99,0.95 [0.46-1.97],0.897028209830157
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GART,Trifunctional purine biosynthetic protein adenosine-3,2162,104,1.10 [0.51-2.40],0.80378877623571
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GAS2,Growth arrest-specific protein 2,2135,102,0.73 [0.47-1.12],0.1461154248074878
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GAS6,Growth arrest-specific protein 6,2517,124,3.27 [1.78-6.01],0.0001334700059757
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GASK1A,Golgi-associated kinase 1A,2105,101,0.93 [0.60-1.42],0.7296546107962323
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GAST,Gastrin,2160,104,1.20 [1.08-1.34],0.0009271305338887
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GATA3,Trans-acting T-cell-specific transcription factor GATA-3,2087,102,0.50 [0.24-1.05],0.06808113767573
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",2110,105,0.90 [0.70-1.15],0.4032015522890488
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GBA,Lysosomal acid glucosylceramidase,2119,101,1.16 [0.85-1.57],0.3455045404956737
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GBP1,Guanylate-binding protein 1,2157,104,1.25 [0.94-1.66],0.1237309528655606
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GBP2,Guanylate-binding protein 2,2444,122,1.18 [0.94-1.48],0.157071276113664
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GBP4,Guanylate-binding protein 4,2431,119,1.16 [0.84-1.61],0.3757380344077112
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GBP6,Guanylate-binding protein 6,2105,101,1.23 [0.87-1.73],0.2472147576894766
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GC,Vitamin D-binding protein,2171,104,1.63 [0.80-3.31],0.1796091828580856
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GCC1,GRIP and coiled-coil domain-containing protein 1,2160,104,0.97 [0.81-1.15],0.7126760287661745
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GCG,Pro-glucagon,2421,119,1.25 [1.10-1.42],0.0004834664294659
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,2072,100,1.46 [1.07-1.98],0.0156764394409338
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GCLM,Glutamate--cysteine ligase regulatory subunit,2105,101,0.93 [0.60-1.42],0.7287953333329433
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",2479,123,3.27 [2.15-4.96],2.7543859758989897e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GDF15,Growth/differentiation factor 15,2530,124,2.80 [2.34-3.34],4.371588202904328e-30
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GDF2,Growth/differentiation factor 2,2498,123,1.16 [0.75-1.77],0.5066291633540885
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GDNF,Glial cell line-derived neurotrophic factor,2431,119,2.12 [1.46-3.07],6.975900703504967e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GET3,ATPase GET3,2168,106,1.26 [0.94-1.68],0.1182108835500551
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GFAP,Glial fibrillary acidic protein,2418,118,1.18 [0.84-1.65],0.336758841733707
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GFER,FAD-linked sulfhydryl oxidase ALR,2421,119,1.27 [0.99-1.64],0.058962349913899
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,2421,119,1.13 [1.00-1.27],0.0457129107678227
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GFRA1,GDNF family receptor alpha-1,2513,125,6.35 [4.22-9.56],7.664071118420706e-19
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GFRA2,GDNF family receptor alpha-2,2479,123,2.12 [0.99-4.55],0.054193890909768
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GFRA3,GDNF family receptor alpha-3,2472,121,2.90 [1.73-4.86],5.298511033083808e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GFRAL,GDNF family receptor alpha-like,2094,103,0.76 [0.55-1.05],0.0965152472567347
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GGA1,ADP-ribosylation factor-binding protein GGA1,2431,119,0.86 [0.64-1.15],0.3103970994522664
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GGACT,Gamma-glutamylaminecyclotransferase,2168,106,1.04 [0.79-1.37],0.7680492983534973
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GGCT,Gamma-glutamylcyclotransferase,2166,106,1.02 [0.68-1.54],0.929476704935938
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GGH,Gamma-glutamyl hydrolase,2458,119,0.85 [0.52-1.38],0.5082402396339043
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GGT1,Glutathione hydrolase 1 proenzyme,2502,122,1.19 [0.90-1.56],0.2140620068022327
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GGT5,Glutathione hydrolase 5 proenzyme,2476,122,7.26 [4.49-11.72],5.238984596693185e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GH1,Somatotropin,2498,123,1.13 [1.03-1.23],0.0064464087716844
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GH2,Growth hormone variant,2421,119,0.98 [0.88-1.08],0.6550287431321332
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GHR,Growth hormone receptor,2132,103,0.38 [0.20-0.71],0.0025883974711014
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GHRHR,Growth hormone-releasing hormone receptor,2431,119,1.08 [0.79-1.46],0.6329079372105462
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GHRL,Appetite-regulating hormone,2498,123,1.08 [0.90-1.31],0.4100516489854982
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GID8,Glucose-induced degradation protein 8 homolog,2162,104,0.89 [0.48-1.66],0.7160645868339146
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GIGYF2,GRB10-interacting GYF protein 2,2162,104,1.24 [0.98-1.57],0.0691149019097592
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GIMAP7,GTPase IMAP family member 7,2132,103,0.88 [0.48-1.62],0.6797229110349672
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GIMAP8,GTPase IMAP family member 8,2087,102,0.78 [0.51-1.20],0.2562618092379538
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GIP,Gastric inhibitory polypeptide,2110,105,1.19 [0.85-1.66],0.3106652920065293
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GIPC2,PDZ domain-containing protein GIPC2,2160,104,2.91 [1.81-4.67],1.0288344532732253e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GIPC3,PDZ domain-containing protein GIPC3,2165,101,0.96 [0.79-1.17],0.7122000403236449
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GIPR,Gastric inhibitory polypeptide receptor,2106,103,0.98 [0.61-1.56],0.924756118087695
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GIT1,ARF GTPase-activating protein GIT1,2106,103,0.98 [0.80-1.19],0.8036724179920551
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GJA8,Gap junction alpha-8 protein,2087,102,0.97 [0.69-1.35],0.8375785147635239
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GKN1,Gastrokine-1,2391,116,1.51 [0.82-2.79],0.1894999076270736
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GLA,Alpha-galactosidase A,2131,102,1.24 [0.76-2.02],0.396245972131987
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GLB1,Beta-galactosidase,2476,122,0.88 [0.60-1.28],0.500234306473146
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GLI2,Zinc finger protein GLI2,2106,103,0.85 [0.43-1.68],0.6410609411464747
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GLO1,Lactoylglutathione lyase,2451,119,1.07 [0.80-1.42],0.6474207104806684
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GLOD4,Glyoxalase domain-containing protein 4,2497,121,1.02 [0.63-1.64],0.9371880117531493
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GLP1R,Glucagon-like peptide 1 receptor,2108,103,1.02 [0.60-1.71],0.950427675656388
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GLRX,Glutaredoxin-1,2484,123,0.92 [0.69-1.21],0.5326533575385575
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GLRX5,"Glutaredoxin-related protein 5, mitochondrial",2132,103,0.87 [0.70-1.09],0.2272325551686446
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GLT8D2,Glycosyltransferase 8 domain-containing protein 2,2431,119,1.25 [0.96-1.63],0.0994034999501696
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GLYR1,Putative oxidoreductase GLYR1,2161,104,0.90 [0.61-1.32],0.5820238364966841
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GM2A,Ganglioside GM2 activator,2129,102,2.93 [2.14-4.00],1.4869889025226808e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GMFG,Glia maturation factor gamma,2168,106,0.99 [0.76-1.28],0.912125440740803
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GMPR,GMP reductase 1,2530,124,0.76 [0.55-1.05],0.094198512909518
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GMPR2,GMP reductase 2,2132,103,0.91 [0.68-1.22],0.5267819895931694
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GNAS,Neuroendocrine secretory protein 55,2162,104,1.05 [0.85-1.30],0.632475188175067
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,2421,119,1.00 [0.78-1.28],0.9687398194987232
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,2119,101,0.96 [0.67-1.38],0.8182727615076554
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GNLY,Granulysin,2505,122,1.06 [0.79-1.41],0.7076923795000898
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GNPDA1,Glucosamine-6-phosphate isomerase 1,2110,105,0.82 [0.44-1.55],0.5471279084869616
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GNPDA2,Glucosamine-6-phosphate isomerase 2,2132,103,0.54 [0.32-0.90],0.0170983997051152
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GOLGA3,Golgin subfamily A member 3,2162,104,1.04 [0.81-1.33],0.759279931154579
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GOLM2,Protein GOLM2,2516,124,2.11 [1.50-2.95],1.603749848882952e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,2500,123,1.02 [0.87-1.19],0.800084748279306
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GORASP2,Golgi reassembly-stacking protein 2,2165,101,0.97 [0.64-1.46],0.8760853977572234
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GOT1,"Aspartate aminotransferase, cytoplasmic",2175,103,0.79 [0.52-1.19],0.2607335603650235
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GP1BA,Platelet glycoprotein Ib alpha chain,2486,122,1.55 [0.99-2.41],0.0531915323861241
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GP1BB,Platelet glycoprotein Ib beta chain,2105,101,1.02 [0.77-1.35],0.8982869175543146
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GP2,Pancreatic secretory granule membrane major glycoprotein GP2,2421,118,0.97 [0.81-1.16],0.719327298421085
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GP5,Platelet glycoprotein V,2132,103,1.06 [0.62-1.83],0.8260591142859928
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GP6,Platelet glycoprotein VI,2498,122,1.08 [0.89-1.30],0.4339274712875736
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GPA33,Cell surface A33 antigen,2479,123,0.88 [0.78-1.00],0.0454135504569649
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GPC1,Glypican-1,2516,125,2.13 [1.29-3.53],0.0032152696155151
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GPC5,Glypican-5,2476,122,0.74 [0.56-0.98],0.0369703451205244
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GPD1,Glycerol-3-phosphate dehydrogenase,2161,104,0.87 [0.64-1.20],0.3977125842427591
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GPHA2,Glycoprotein hormone alpha-2,2165,101,1.05 [0.67-1.62],0.8414832675764852
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GPI,Glucose-6-phosphate isomerase,2174,105,1.03 [0.69-1.53],0.8913456432135185
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,2165,101,1.34 [1.00-1.80],0.049030019078665
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GPKOW,G-patch domain and KOW motifs-containing protein,2431,119,1.28 [0.87-1.89],0.2112771616861555
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GPNMB,Transmembrane glycoprotein NMB,2439,119,3.09 [1.83-5.23],2.653507081367975e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GPR101,Probable G-protein coupled receptor 101,2108,103,0.99 [0.69-1.41],0.9406200114151648
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GPR158,Probable G-protein coupled receptor 158,2162,104,1.28 [0.78-2.12],0.3313536545799926
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GPR15L,Protein GPR15L,2165,101,1.19 [0.89-1.60],0.2404734559106761
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GPR37,Prosaposin receptor GPR37,2451,119,2.55 [2.03-3.20],9.344238074231354e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GPRC5C,G-protein coupled receptor family C group 5 member C,2161,104,1.54 [1.17-2.03],0.0021640255032135
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GRAP2,GRB2-related adapter protein 2,2498,123,0.99 [0.88-1.12],0.8544195296448549
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,2168,106,1.11 [0.82-1.52],0.4952544779570447
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GRIK2,"Glutamate receptor ionotropic, kainate 2",2162,104,0.73 [0.43-1.24],0.2424855450271667
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",2108,103,1.09 [0.76-1.57],0.6326314231020055
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GRK5,G protein-coupled receptor kinase 5,2451,119,0.87 [0.63-1.22],0.4259952499225258
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GRN,Progranulin,2491,122,3.48 [1.96-6.18],2.051640700906477e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GRP,Gastrin-releasing peptide,2110,105,1.31 [0.93-1.84],0.1172792345221828
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GRPEL1,"GrpE protein homolog 1, mitochondrial",2479,123,1.45 [1.16-1.82],0.0012062124667322
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GRSF1,G-rich sequence factor 1,2075,102,0.94 [0.75-1.20],0.636603350268938
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GSAP,Gamma-secretase-activating protein,2421,119,1.03 [0.86-1.25],0.7312489940349707
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GSN,Gelsolin,2167,105,0.38 [0.20-0.73],0.0034950750502388
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GSR,"Glutathione reductase, mitochondrial",2163,105,1.02 [0.49-2.11],0.9575658418227322
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GSTA1,Glutathione S-transferase A1,2494,123,0.78 [0.65-0.94],0.0070520061235483
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GSTA3,Glutathione S-transferase A3,2421,119,0.84 [0.69-1.03],0.0870270800897325
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GSTM4,Glutathione S-transferase Mu 4,2105,101,1.08 [0.85-1.37],0.520771260283332
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GSTP1,Glutathione S-transferase P,2413,119,0.90 [0.69-1.16],0.4146283568489539
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GSTT2B,Glutathione S-transferase theta-2B,2160,104,1.01 [0.93-1.09],0.8730083638500665
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,2135,102,0.94 [0.70-1.26],0.6713048535319586
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GTPBP2,GTP-binding protein 2,2119,101,0.95 [0.75-1.21],0.6685853776481739
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GUCA2A,Guanylin,2493,122,2.98 [2.14-4.15],1.1463526098064435e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GUCY2C,Heat-stable enterotoxin receptor,2135,102,0.97 [0.76-1.26],0.8404980067215874
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GUK1,Guanylate kinase,2105,101,1.41 [0.86-2.29],0.1696285366629442
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GUSB,Beta-glucuronidase,2513,124,0.93 [0.74-1.16],0.5290661471316642
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GYS1,"Glycogen [starch] synthase, muscle",2451,119,0.95 [0.80-1.14],0.6163640305795559
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GZMA,Granzyme A,2530,124,1.72 [1.09-2.71],0.0203968852623064
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GZMB,Granzyme B,2500,123,0.76 [0.58-1.00],0.0466642798506889
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GZMH,Granzyme H,2451,119,1.00 [0.81-1.24],0.9678880038933856
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,H2AP,Huntingtin-interacting protein M,2087,102,0.89 [0.58-1.37],0.6099984499087139
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",2105,101,1.13 [0.87-1.45],0.3582523705882929
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",2511,125,0.80 [0.64-1.00],0.0517761812346429
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HAO1,Hydroxyacid oxidase 1,2516,125,0.96 [0.84-1.08],0.4637590540069884
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HARS1,"Histidine--tRNA ligase, cytoplasmic",2505,122,1.01 [0.82-1.25],0.9326466813103228
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HAVCR1,Hepatitis A virus cellular receptor 1,2514,125,2.24 [1.93-2.61],2.6384523173416523e-25
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HAVCR2,Hepatitis A virus cellular receptor 2,2505,122,3.25 [2.29-4.63],5.3626289309001806e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HBEGF,Proheparin-binding EGF-like growth factor,2511,125,1.07 [0.87-1.31],0.5514703034682742
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HBQ1,Hemoglobin subunit theta-1,2516,125,0.70 [0.53-0.92],0.0092911982072897
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HBZ,Hemoglobin subunit zeta,2168,106,0.87 [0.73-1.04],0.1353612675717362
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HCG22,Protein PBMUCL2,2105,101,1.03 [0.77-1.36],0.8579424076012215
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HCLS1,Hematopoietic lineage cell-specific protein,2530,124,0.89 [0.66-1.19],0.4262410743434682
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HDAC8,Histone deacetylase 8,2106,103,0.89 [0.59-1.33],0.5648208262679402
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HDAC9,Histone deacetylase 9,2108,103,0.74 [0.50-1.09],0.1294932075483888
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HDDC2,5'-deoxynucleotidase HDDC2,2165,101,1.09 [0.70-1.70],0.6895355089016364
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HDGF,Hepatoma-derived growth factor,2510,125,1.01 [0.85-1.20],0.9433952191105196
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HDGFL2,Hepatoma-derived growth factor-related protein 2,2160,104,1.19 [0.89-1.59],0.2323381429632848
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HEBP1,Heme-binding protein 1,2451,119,0.91 [0.65-1.27],0.5711194227814562
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HEG1,Protein HEG homolog 1,2132,103,1.41 [0.75-2.67],0.291510946303393
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HEPACAM2,HEPACAM family member 2,2160,104,0.75 [0.50-1.13],0.1708490030114155
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HEPH,Hephaestin,2168,106,7.71 [3.80-15.68],1.6377255221051535e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HEXIM1,Protein HEXIM1,2500,123,1.12 [0.91-1.36],0.2851991186857942
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HGF,Hepatocyte growth factor,2530,124,1.50 [1.01-2.22],0.0452407958073472
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HGFAC,Hepatocyte growth factor activator,2155,103,2.65 [1.26-5.55],0.0099661034237744
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,2421,119,0.98 [0.79-1.21],0.8219233857817732
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HHEX,Hematopoietically-expressed homeobox protein HHEX,2160,104,1.08 [0.84-1.39],0.5508461462453421
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HIF1A,Hypoxia-inducible factor 1-alpha,2106,103,1.09 [0.83-1.43],0.5198667669932737
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HIP1,Huntingtin-interacting protein 1,2105,101,1.03 [0.58-1.84],0.9134913134544452
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HIP1R,Huntingtin-interacting protein 1-related protein,2158,104,1.33 [1.06-1.68],0.0148036462177037
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HJV,Hemojuvelin,2162,104,1.68 [1.16-2.44],0.0061513690542434
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HK2,Hexokinase-2,2451,119,1.18 [0.66-2.13],0.5781270280697278
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HLA-A,"HLA class I histocompatibility antigen, A alpha chain",2162,104,2.19 [1.22-3.93],0.0087765608310813
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HLA-DRA,"HLA class II histocompatibility antigen, DR alpha chain",2491,122,1.67 [1.12-2.50],0.0114928707415317
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HLA-E,"HLA class I histocompatibility antigen, alpha chain E",2500,123,3.19 [2.27-4.47],1.9213777982136305e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HMBS,Porphobilinogen deaminase,2516,125,0.69 [0.47-1.00],0.0525700963497175
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HMCN2,Hemicentin-2,2129,102,1.14 [0.82-1.58],0.4497242097940628
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",2110,105,0.89 [0.59-1.34],0.5695385467318653
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",2105,101,0.88 [0.54-1.45],0.6175600254389833
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HMMR,Hyaluronan mediated motility receptor,2084,102,1.06 [0.73-1.54],0.7557581956830127
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HMOX1,Heme oxygenase 1,2478,122,0.90 [0.66-1.24],0.5377654619107508
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HMOX2,Heme oxygenase 2,2431,119,1.23 [0.90-1.69],0.2008581311692432
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HNF1A,Hepatocyte nuclear factor 1-alpha,2119,101,0.97 [0.74-1.27],0.8066209621725128
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HNMT,Histamine N-methyltransferase,2465,121,1.35 [1.01-1.80],0.0400438052589483
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HNRNPK,Heterogeneous nuclear ribonucleoprotein K,2445,119,0.97 [0.78-1.21],0.8040137006824736
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,2162,104,1.33 [0.96-1.85],0.0882236635496299
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HPCAL1,Hippocalcin-like protein 1,2530,124,1.00 [0.81-1.24],0.9854930641158236
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HPGDS,Hematopoietic prostaglandin D synthase,2421,119,0.51 [0.33-0.80],0.0034424025023108
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HPSE,Heparanase,2153,102,1.09 [0.89-1.34],0.3890999819576679
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HRAS,GTPase Hras,2130,102,1.03 [0.85-1.24],0.772694898197208
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,2110,105,2.36 [1.52-3.65],0.0001201283357237
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HRG,Histidine-rich glycoprotein,2159,104,1.68 [0.94-3.00],0.0772216368511353
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HS1BP3,HCLS1-binding protein 3,2110,105,1.02 [0.82-1.26],0.8823162762942272
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,2479,123,1.37 [0.92-2.03],0.1245794230587221
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,2516,125,1.29 [0.87-1.91],0.2005498625640761
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,2106,103,1.77 [1.19-2.64],0.0051713009926261
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HSBP1,Heat shock factor-binding protein 1,2110,105,1.03 [0.84-1.27],0.7539301915080046
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,2500,123,1.04 [0.72-1.50],0.8538047851248058
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,2160,104,0.99 [0.74-1.33],0.9710788006937876
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HSD17B3,Testosterone 17-beta-dehydrogenase 3,2105,101,1.07 [0.74-1.57],0.7146755153675368
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HSDL2,Hydroxysteroid dehydrogenase-like protein 2,2110,105,1.38 [0.94-2.03],0.0985336985931388
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HSP90B1,Endoplasmin,2420,119,1.14 [0.91-1.42],0.2543751379500258
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HSPA1A,Heat shock 70 kDa protein 1A,2503,121,0.97 [0.77-1.23],0.8289215419385431
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HSPA2,Heat shock-related 70 kDa protein 2,2161,104,2.15 [1.57-2.95],2.116871081543484e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HSPB1,Heat shock protein beta-1,2461,122,0.96 [0.76-1.20],0.7234175572779962
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HSPB6,Heat shock protein beta-6,2516,125,3.12 [2.30-4.23],2.69601599710072e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,2482,122,3.72 [2.62-5.28],1.810371493846709e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HTR1A,5-hydroxytryptamine receptor 1A,2108,103,0.94 [0.74-1.21],0.644821379881283
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HTR1B,5-hydroxytryptamine receptor 1B,2108,103,0.76 [0.47-1.25],0.2829839332019381
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HTRA2,"Serine protease HTRA2, mitochondrial",2497,124,1.12 [0.86-1.45],0.403377109288718
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HYAL1,Hyaluronidase-1,2479,119,3.65 [2.17-6.11],9.243218451101544e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HYOU1,Hypoxia up-regulated protein 1,2530,124,5.92 [3.31-10.57],1.868118343976953e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ICA1,Islet cell autoantigen 1,2444,122,1.03 [0.84-1.26],0.7776666293839096
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ICAM1,Intercellular adhesion molecule 1,2487,122,2.25 [1.44-3.53],0.0003947129985806
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ICAM2,Intercellular adhesion molecule 2,2530,124,4.60 [2.79-7.57],2.1037604235083637e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ICAM3,Intercellular adhesion molecule 3,2530,124,2.51 [1.49-4.24],0.0005709400750857
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ICAM4,Intercellular adhesion molecule 4,2500,123,1.06 [0.78-1.45],0.6913672013016521
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ICAM5,Intercellular adhesion molecule 5,2498,123,1.28 [0.90-1.82],0.1693961539678435
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ICOSLG,ICOS ligand,2479,123,2.93 [1.30-6.60],0.0092931857055254
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ID4,DNA-binding protein inhibitor ID-4,2135,102,0.83 [0.50-1.38],0.4659127507566926
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IDI2,Isopentenyl-diphosphate delta-isomerase 2,2431,119,1.60 [1.26-2.03],0.0001142867820062
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IDO1,"Indoleamine 2,3-dioxygenase 1",2110,105,0.95 [0.71-1.27],0.7360750854775633
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IDS,Iduronate 2-sulfatase,2530,124,0.92 [0.15-5.50],0.9261799916464296
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IDUA,Alpha-L-iduronidase,2516,125,1.64 [1.15-2.33],0.0058021264347362
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,2104,94,1.86 [1.13-3.05],0.0138001065925972
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,2135,102,0.97 [0.65-1.44],0.8726112271874336
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,2135,102,0.87 [0.52-1.45],0.5878999655691013
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IFNAR1,Interferon alpha/beta receptor 1,2165,101,1.94 [1.03-3.65],0.0398377702276838
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IFNG,Interferon gamma,2444,122,1.07 [0.93-1.24],0.3548274346977834
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IFNGR1,Interferon gamma receptor 1,2510,121,7.08 [4.03-12.45],1.031418426784754e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IFNGR2,Interferon gamma receptor 2,2476,122,1.22 [0.92-1.62],0.166350903772835
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IFNL1,Interferon lambda-1,2431,119,1.43 [1.10-1.85],0.0078235172284997
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IFNL2,Interferon lambda-2,2108,103,1.17 [0.88-1.56],0.274275710704105
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IFNLR1,Interferon lambda receptor 1,2500,123,1.34 [0.91-1.97],0.134822502859107
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IFNW1,Interferon omega-1,2105,101,0.97 [0.53-1.77],0.9120005804234936
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IFT20,Intraflagellar transport protein 20 homolog,2119,101,0.88 [0.55-1.41],0.6003412623462104
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IGBP1,Immunoglobulin-binding protein 1,2162,104,1.01 [0.74-1.38],0.9519986773933872
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IGDCC3,Immunoglobulin superfamily DCC subclass member 3,2108,103,0.81 [0.51-1.28],0.3678491533517251
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IGDCC4,Immunoglobulin superfamily DCC subclass member 4,2175,103,1.13 [0.58-2.22],0.7172341197662053
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IGF1R,Insulin-like growth factor 1 receptor,2479,123,6.10 [3.83-9.71],2.5959930464350613e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,2105,101,0.52 [0.29-0.92],0.0239738659151381
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IGF2R,Cation-independent mannose-6-phosphate receptor,2505,122,2.89 [1.52-5.52],0.0012403828140571
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IGFBP1,Insulin-like growth factor-binding protein 1,2528,124,1.25 [1.11-1.42],0.0004177325495846
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IGFBP2,Insulin-like growth factor-binding protein 2,2525,124,2.07 [1.66-2.57],5.481929125174716e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IGFBP3,Insulin-like growth factor-binding protein 3,2503,122,0.53 [0.38-0.74],0.0001652437334184
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IGFBP4,Insulin-like growth factor-binding protein 4,2475,118,2.89 [2.32-3.61],4.602680406128804e-21
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IGFBP6,Insulin-like growth factor-binding protein 6,2489,122,2.68 [1.96-3.66],5.570081073450628e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IGFBP7,Insulin-like growth factor-binding protein 7,2530,124,2.92 [2.23-3.82],9.097947291118143e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IGFBPL1,Insulin-like growth factor-binding protein-like 1,2498,123,2.36 [1.69-3.30],4.560219673056165e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IGFL4,Insulin growth factor-like family member 4,2106,103,0.78 [0.55-1.10],0.1567655596773079
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IGHMBP2,DNA-binding protein SMUBP-2,2105,101,1.09 [0.77-1.54],0.6287844967265549
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IGLC2,Immunoglobulin lambda constant 2,2166,104,2.24 [1.33-3.78],0.0025390148021439
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IGLON5,IgLON family member 5,2087,102,1.09 [0.90-1.33],0.3777121967616027
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IGSF21,Immunoglobulin superfamily member 21,2110,105,1.17 [0.78-1.75],0.4529451122597902
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IGSF3,Immunoglobulin superfamily member 3,2479,123,1.62 [1.19-2.21],0.002422492416231
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IGSF8,Immunoglobulin superfamily member 8,2498,123,2.07 [1.53-2.81],2.7374485955069497e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IGSF9,Protein turtle homolog A,2168,106,1.05 [0.87-1.27],0.6042076963073166
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IKBKG,NF-kappa-B essential modulator,2500,123,1.03 [0.86-1.23],0.7280651056190003
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IKZF2,Zinc finger protein Helios,2421,119,1.05 [0.88-1.25],0.5762657815897259
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL10,Interleukin-10,2444,122,1.20 [1.00-1.45],0.0534611675263103
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL10RA,Interleukin-10 receptor subunit alpha,2444,122,1.14 [0.89-1.46],0.311244218169781
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL10RB,Interleukin-10 receptor subunit beta,2510,121,5.21 [3.35-8.09],2.181242195951795e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL11,Interleukin-11,2444,122,1.10 [0.86-1.40],0.4547326020475464
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL12A_IL12B,Interleukin-12,2479,123,1.37 [1.14-1.64],0.0007584222906138
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL12B,Interleukin-12 subunit beta,2530,124,1.55 [1.18-2.03],0.0015644349865838
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL12RB1,Interleukin-12 receptor subunit beta-1,2444,122,1.85 [1.24-2.77],0.0027022985279112
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL12RB2,Interleukin-12 receptor subunit beta-2,2106,103,1.05 [0.65-1.67],0.8508208997185437
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL13,Interleukin-13,2444,122,0.96 [0.66-1.38],0.8153041213572866
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL13RA1,Interleukin-13 receptor subunit alpha-1,2457,120,1.64 [0.87-3.09],0.1294478651132109
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL13RA2,Interleukin-13 receptor subunit alpha-2,2108,103,0.97 [0.49-1.90],0.9250507463112176
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL15,Interleukin-15,2500,123,2.67 [1.75-4.09],5.4681012114867725e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL15RA,Interleukin-15 receptor subunit alpha,2444,122,2.06 [1.39-3.06],0.0003204166422347
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL16,Pro-interleukin-16,2530,124,1.25 [0.90-1.73],0.1863296081151267
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL17A,Interleukin-17A,2439,121,0.85 [0.57-1.26],0.4187934467971091
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL17C,Interleukin-17C,2444,122,1.49 [1.26-1.76],2.8772987614961547e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL17D,Interleukin-17D,2444,122,1.58 [1.16-2.15],0.0038032970302551
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL17F,Interleukin-17F,2444,122,1.00 [0.79-1.26],0.9786570458242344
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL17RA,Interleukin-17 receptor A,2505,122,1.25 [0.88-1.78],0.2128295492327191
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL17RB,Interleukin-17 receptor B,2475,123,1.44 [1.08-1.92],0.0130194204461309
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL18,Interleukin-18,2492,121,1.93 [1.38-2.70],0.000122587908847
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL18BP,Interleukin-18-binding protein,2503,122,3.78 [2.58-5.52],6.7792209354383545e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL18R1,Interleukin-18 receptor 1,2530,124,3.13 [2.10-4.65],1.780983166224565e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL18RAP,Interleukin-18 receptor accessory protein,2461,119,0.93 [0.83-1.03],0.1703788356807835
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL19,Interleukin-19,2440,118,1.21 [1.01-1.46],0.0374363126770583
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL1A,Interleukin-1 alpha,2444,122,1.03 [0.80-1.34],0.80021815918396
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL1B,Interleukin-1 beta,2430,122,0.96 [0.73-1.25],0.7491706753290888
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL1R1,Interleukin-1 receptor type 1,2502,122,9.65 [6.11-15.25],2.804889175209165e-22
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL1R2,Interleukin-1 receptor type 2,2496,121,2.28 [1.09-4.78],0.0294179706004291
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL1RAP,Interleukin-1 receptor accessory protein,2505,122,1.13 [0.81-1.57],0.4838728941190551
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL1RL1,Interleukin-1 receptor-like 1,2525,124,1.96 [1.37-2.79],0.0002079660090736
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL1RL2,Interleukin-1 receptor-like 2,2444,122,1.09 [0.71-1.67],0.684025193789717
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL1RN,Interleukin-1 receptor antagonist protein,2491,120,1.19 [0.92-1.54],0.1885883824508037
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL2,Interleukin-2,2444,122,1.55 [0.93-2.58],0.0919970124507693
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL20,Interleukin-20,2444,122,1.27 [1.02-1.59],0.0327342970965995
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL20RA,Interleukin-20 receptor subunit alpha,2444,122,1.28 [0.95-1.73],0.1103531083770575
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL20RB,Interleukin-20 receptor subunit beta,2106,103,1.07 [0.69-1.65],0.7597012461685134
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL21R,Interleukin-21 receptor,2106,103,0.60 [0.36-1.00],0.0502759478858077
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL22,Interleukin-22,2161,104,1.12 [0.87-1.45],0.3870706725146214
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL22RA1,Interleukin-22 receptor subunit alpha-1,2444,122,1.33 [0.99-1.79],0.060986564334053
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL24,Interleukin-24,2444,122,1.12 [0.82-1.53],0.4733052371618594
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL25,Interleukin-25,2080,102,0.80 [0.45-1.40],0.4349050083370864
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL2RA,Interleukin-2 receptor subunit alpha,2482,121,2.57 [1.93-3.41],7.370848509074455e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL2RB,Interleukin-2 receptor subunit beta,2444,122,1.25 [0.85-1.84],0.257447604491177
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL2RG,Cytokine receptor common subunit gamma,2161,104,2.21 [1.50-3.25],5.797828538293109e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL3,Interleukin-3,2087,102,0.76 [0.60-0.97],0.028188471591021
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL31,Interleukin-31,2106,103,0.83 [0.55-1.25],0.3634982609846259
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL31RA,Interleukin-31 receptor subunit alpha,2098,103,1.08 [0.66-1.75],0.7700637843857152
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL32,Interleukin-32,2500,123,1.14 [0.84-1.53],0.4020090820883714
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL33,Interleukin-33,2444,122,1.49 [1.02-2.18],0.0382186643969325
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL34,Interleukin-34,2426,119,1.49 [0.96-2.33],0.0750123738024429
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL36A,Interleukin-36 alpha,2106,103,0.77 [0.51-1.16],0.2128176871302857
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL36G,Interleukin-36 gamma,2100,103,0.94 [0.70-1.26],0.6685066445961054
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL3RA,Interleukin-3 receptor subunit alpha,2444,122,1.89 [1.19-2.98],0.0066574121893178
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL4,Interleukin-4,2444,122,1.12 [0.92-1.36],0.272538644003643
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL4R,Interleukin-4 receptor subunit alpha,2500,123,3.20 [2.30-4.44],3.926606053510738e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL5,Interleukin-5,2444,122,1.02 [0.91-1.15],0.7125539929223139
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL5RA,Interleukin-5 receptor subunit alpha,2500,123,1.45 [1.12-1.89],0.0049576221627782
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL6,Interleukin-6,2479,123,1.06 [0.88-1.27],0.5599636944202644
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL6R,Interleukin-6 receptor subunit alpha,2484,122,1.87 [1.18-2.94],0.0071736695323674
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL6ST,Interleukin-6 receptor subunit beta,2498,123,8.09 [3.55-18.45],6.662279893162253e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL7,Interleukin-7,2500,123,0.91 [0.71-1.18],0.4783155961148191
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL7R,Interleukin-7 receptor subunit alpha,2505,122,1.39 [1.02-1.90],0.038109858112711
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL9,Interleukin-9,2135,102,0.89 [0.61-1.28],0.52159361869244
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,2428,119,1.09 [0.83-1.43],0.5293107115711686
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IMMT,MICOS complex subunit MIC60,2161,104,1.58 [1.11-2.24],0.0114309497457488
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IMPA1,Inositol monophosphatase 1,2476,122,0.95 [0.72-1.25],0.7033668854824655
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IMPACT,Protein IMPACT,2160,104,0.98 [0.69-1.38],0.8905610253133781
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IMPG1,Interphotoreceptor matrix proteoglycan 1,2108,103,0.73 [0.36-1.48],0.3820142449084199
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ING1,Inhibitor of growth protein 1,2426,118,1.00 [0.74-1.36],0.9746981402798416
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,INHBB,Inhibin beta B chain,2132,103,2.63 [1.97-3.49],3.4610215352443557e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,INHBC,Inhibin beta C chain,2505,122,1.43 [0.92-2.23],0.1118704939308144
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,INPP1,Inositol polyphosphate 1-phosphatase,2479,123,0.98 [0.73-1.33],0.919586470888908
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",2110,105,1.18 [0.85-1.62],0.3194047453666941
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",2162,104,0.70 [0.41-1.20],0.1951801007320454
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",2479,123,1.04 [0.89-1.23],0.5984402980287169
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,INSL3,Insulin-like 3,2160,104,0.93 [0.76-1.13],0.4431331988087322
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,INSL4,Early placenta insulin-like peptide,2161,104,1.97 [1.55-2.50],2.485224547310916e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,INSL5,Insulin-like peptide INSL5,2165,101,1.27 [1.07-1.52],0.0076174818871064
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,INSR,Insulin receptor,2106,103,5.17 [2.05-12.99],0.0004838917729587
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IPCEF1,Interactor protein for cytohesin exchange factors 1,2472,122,0.97 [0.80-1.16],0.7136002886146322
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IQGAP2,Ras GTPase-activating-like protein IQGAP2,2479,123,1.17 [0.90-1.54],0.2440810178948952
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",2451,119,1.16 [0.99-1.36],0.0645719184941462
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IRAK1,Interleukin-1 receptor-associated kinase 1,2444,122,1.14 [0.91-1.43],0.2588672654538084
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IRAK4,Interleukin-1 receptor-associated kinase 4,2500,123,1.02 [0.87-1.19],0.8362774814710898
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,2397,116,0.90 [0.59-1.40],0.6525549353816661
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ISM1,Isthmin-1,2500,123,1.16 [0.81-1.67],0.4168826131408922
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ISM2,Isthmin-2,2175,103,1.44 [1.10-1.87],0.0069191184778421
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IST1,IST1 homolog,2150,101,1.00 [0.81-1.22],0.9807610107522342
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ITGA11,Integrin alpha-11,2500,123,0.80 [0.51-1.24],0.3164887785255088
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ITGA2,Integrin alpha-2,2132,103,0.68 [0.40-1.15],0.1484029096498464
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ITGA5,Integrin alpha-5,2505,122,3.12 [1.84-5.29],2.359850464661901e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ITGA6,Integrin alpha-6,2500,123,0.97 [0.70-1.33],0.8316917014186952
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ITGAL,Integrin alpha-L,2106,103,1.13 [0.72-1.76],0.5933578898978894
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ITGAM,Integrin alpha-M,2505,122,1.52 [0.97-2.38],0.0692598305070616
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ITGAV,Integrin alpha-V,2516,125,0.39 [0.17-0.90],0.0276499026393242
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ITGAX,Integrin alpha-X,2135,102,0.94 [0.62-1.43],0.7870890129468253
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ITGB1,Integrin beta-1,2495,122,3.32 [1.82-6.06],9.686120843632014e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ITGB1BP1,Integrin beta-1-binding protein 1,2421,119,1.35 [0.92-1.98],0.1231915878711863
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ITGB1BP2,Integrin beta-1-binding protein 2,2451,119,1.01 [0.87-1.17],0.9170157595663768
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ITGB2,Integrin beta-2,2496,120,2.04 [1.26-3.30],0.0039609204444039
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ITGB5,Integrin beta-5,2497,124,1.07 [0.73-1.56],0.7423180813868607
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ITGB6,Integrin beta-6,2444,122,3.57 [2.18-5.87],4.814027378865226e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ITGB7,Integrin beta-7,2516,125,1.29 [0.95-1.76],0.1039516645343403
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ITGBL1,Integrin beta-like protein 1,2175,103,2.20 [1.66-2.91],3.1335769241674666e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,2171,104,1.47 [0.56-3.88],0.4346218722783627
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,2503,122,2.99 [1.96-4.57],3.528172809334657e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,2171,104,1.89 [0.92-3.86],0.0820927556944704
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,2161,104,1.05 [0.68-1.62],0.8260902447578281
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ITM2A,Integral membrane protein 2A,2500,123,1.25 [0.97-1.61],0.0779960316956304
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ITPA,Inosine triphosphate pyrophosphatase,2105,101,0.99 [0.74-1.33],0.9584255530165195
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",2110,105,1.24 [0.98-1.56],0.0684327607222433
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",2108,103,0.87 [0.53-1.42],0.5750545273936913
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",2431,119,0.90 [0.64-1.27],0.5561993096936946
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IZUMO1,Izumo sperm-egg fusion protein 1,2087,102,1.17 [0.80-1.71],0.431186779033287
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,JAM2,Junctional adhesion molecule B,2516,124,5.60 [3.79-8.28],5.499251365484621e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,JAM3,Junctional adhesion molecule C,2132,103,1.41 [1.06-1.87],0.0187079880134074
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,JCHAIN,Immunoglobulin J chain,2444,122,1.29 [0.99-1.67],0.0585243978772785
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,2087,102,0.78 [0.54-1.13],0.1903488070958349
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,JPT2,Jupiter microtubule associated homolog 2,2165,101,1.09 [0.86-1.37],0.4780387957402749
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,JUN,Transcription factor AP-1,2444,122,1.45 [1.18-1.79],0.0005247011305985
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,2479,123,2.32 [1.64-3.28],2.014357775105995e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KAZN,Kazrin,2165,101,1.06 [0.89-1.28],0.5069516375932441
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KCNC4,Potassium voltage-gated channel subfamily C member 4,2108,103,0.91 [0.62-1.34],0.620811352562733
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KCNH2,Potassium voltage-gated channel subfamily H member 2,2119,101,0.83 [0.61-1.13],0.2349888775065718
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KCNIP4,Kv channel-interacting protein 4,2431,119,0.88 [0.63-1.25],0.4828171524531844
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KCTD5,BTB/POZ domain-containing protein KCTD5,2123,103,1.22 [0.87-1.72],0.24775534171952
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KDM3A,Lysine-specific demethylase 3A,2106,103,1.06 [0.86-1.31],0.5997139274748052
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KDR,Vascular endothelial growth factor receptor 2,2497,124,1.21 [0.65-2.23],0.5508578526811023
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KEL,Kell blood group glycoprotein,2431,119,1.01 [0.66-1.56],0.9502029427845264
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KHDC3L,KH domain-containing protein 3,2087,102,1.05 [0.81-1.36],0.7168124631818853
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KHK,Ketohexokinase,2110,105,0.95 [0.71-1.27],0.7396673728884261
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KIAA0319,Dyslexia-associated protein KIAA0319,2160,104,1.74 [0.98-3.10],0.0607862843054774
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KIAA1549,UPF0606 protein KIAA1549,2135,102,1.30 [0.98-1.72],0.0700432005765
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KIAA1549L,UPF0606 protein KIAA1549L,2135,102,1.12 [0.56-2.24],0.7554866654388182
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KIAA2013,Uncharacterized protein KIAA2013,2161,104,0.72 [0.45-1.14],0.1643391288532168
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KIF1C,Kinesin-like protein KIF1C,2105,101,1.98 [1.22-3.22],0.0055539812099902
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KIF20B,Kinesin-like protein KIF20B,2108,103,1.05 [0.84-1.33],0.6523131908560976
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KIF22,Kinesin-like protein KIF22,2105,101,0.90 [0.76-1.05],0.1675360567464665
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KIFBP,KIF-binding protein,2479,123,1.08 [0.89-1.30],0.4315160083561095
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,2161,104,1.37 [1.13-1.66],0.0014552365013578
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,2421,119,1.28 [1.06-1.55],0.0116574993768881
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,2165,101,1.04 [0.93-1.15],0.5282756396898103
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,2421,119,0.97 [0.85-1.11],0.677853109291604
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,2087,102,1.02 [0.81-1.28],0.85939948053501
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KIRREL1,Kin of IRRE-like protein 1,2108,103,1.03 [0.72-1.47],0.8697352188909644
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KIRREL2,Kin of IRRE-like protein 2,2431,119,1.12 [0.74-1.69],0.6023873111724825
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KIT,Mast/stem cell growth factor receptor Kit,2503,122,0.89 [0.52-1.51],0.6580598125022654
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KITLG,Kit ligand,2498,123,1.40 [0.95-2.05],0.0892653325657874
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KLB,Beta-klotho,2431,119,1.12 [0.91-1.39],0.2812873731285161
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KLF4,Krueppel-like factor 4,2108,103,1.04 [0.66-1.63],0.8722491418147384
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KLHL41,Kelch-like protein 41,2162,104,1.10 [0.78-1.55],0.5962257940887328
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KLK1,Kallikrein-1,2474,123,0.96 [0.85-1.09],0.5331835122085689
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KLK10,Kallikrein-10,2491,124,1.66 [1.15-2.40],0.0063618044440273
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KLK11,Kallikrein-11,2473,124,4.62 [3.11-6.84],2.6427278574391046e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KLK12,Kallikrein-12,2421,119,1.09 [0.96-1.24],0.1638617175980022
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KLK13,Kallikrein-13,2432,122,0.98 [0.71-1.33],0.8776076721881231
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KLK14,Kallikrein-14,2516,125,1.54 [1.11-2.13],0.0091171184690571
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KLK15,Kallikrein-15,2155,104,1.34 [0.93-1.92],0.1143228348701664
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KLK3,Prostate-specific antigen,2175,103,0.89 [0.76-1.05],0.1607596560065433
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KLK4,Kallikrein-4,2516,125,2.14 [1.81-2.52],1.3661982716781562e-19
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KLK6,Kallikrein-6,2493,124,2.30 [1.46-3.63],0.0003111771652123
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KLK7,Kallikrein-7,2080,101,0.51 [0.31-0.85],0.0092941570511181
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KLK8,Kallikrein-8,2402,121,1.74 [1.18-2.57],0.0054508221029142
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KLKB1,Plasma kallikrein,2128,104,1.25 [0.58-2.69],0.5686787294242788
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KLRB1,Killer cell lectin-like receptor subfamily B member 1,2530,124,3.62 [2.59-5.07],6.052545377277007e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KLRC1,NKG2-A/NKG2-B type II integral membrane protein,2108,103,1.05 [0.77-1.45],0.7498836246821207
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KLRD1,Natural killer cells antigen CD94,2530,124,1.62 [1.17-2.25],0.0040349685335341
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KLRF1,Killer cell lectin-like receptor subfamily F member 1,2106,103,1.36 [1.04-1.79],0.027034804664364
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KLRK1,NKG2-D type II integral membrane protein,2160,104,1.78 [1.21-2.63],0.0035225991245375
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KRT14,"Keratin, type I cytoskeletal 14",2363,113,1.42 [0.88-2.29],0.1508409306793505
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KRT17,"Keratin, type I cytoskeletal 17",2105,101,1.32 [0.87-2.01],0.1884793045332225
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KRT18,"Keratin, type I cytoskeletal 18",2479,123,1.10 [0.94-1.28],0.2291271844586981
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KRT19,"Keratin, type I cytoskeletal 19",2497,123,1.86 [1.55-2.24],5.3541755441968736e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KRT5,"Keratin, type II cytoskeletal 5",2431,119,1.03 [0.77-1.37],0.8513949754715192
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KRT6C,"Keratin, type II cytoskeletal 6C",2105,101,0.91 [0.53-1.54],0.7191808780794618
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KRT8,"Keratin, type II cytoskeletal 8",2108,103,1.14 [1.01-1.29],0.0337200996137683
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KYAT1,Kynurenine--oxoglutarate transaminase 1,2497,123,0.84 [0.63-1.11],0.2135312203446313
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KYNU,Kynureninase,2530,124,0.67 [0.49-0.92],0.0118263441872658
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,L1CAM,Neural cell adhesion molecule L1,2497,124,1.50 [0.91-2.49],0.1132063345448346
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,2168,106,0.96 [0.77-1.19],0.6938238830743129
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LACRT,Extracellular glycoprotein lacritin,2149,103,1.03 [0.66-1.62],0.8874861676585843
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LACTB2,Endoribonuclease LACTB2,2498,123,0.94 [0.74-1.21],0.6497472213484545
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LAG3,Lymphocyte activation gene 3 protein,2479,123,2.11 [1.68-2.66],1.8490350421729136e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,2500,121,2.70 [2.16-3.38],5.237958908716615e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,2476,122,1.17 [0.99-1.38],0.0630323497629636
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LAMA1,Laminin subunit alpha-1,2105,101,0.76 [0.48-1.20],0.2413914856476906
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LAMA4,Laminin subunit alpha-4,2510,121,1.98 [1.30-2.99],0.0013007761259429
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LAMB1,Laminin subunit beta-1,2110,105,2.58 [1.45-4.60],0.0012752244298486
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LAMP1,Lysosome-associated membrane glycoprotein 1,2126,101,2.05 [1.03-4.09],0.0414214838488133
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LAMP2,Lysosome-associated membrane glycoprotein 2,2429,120,1.98 [0.91-4.35],0.0869743833132404
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LAMP3,Lysosome-associated membrane glycoprotein 3,2524,124,1.68 [1.26-2.24],0.0004362257175337
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LAMTOR5,Ragulator complex protein LAMTOR5,2161,104,0.97 [0.60-1.59],0.9115985534123002
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LAP3,Cytosol aminopeptidase,2444,122,1.14 [0.84-1.54],0.4096690670669196
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LARP1,La-related protein 1,2161,104,1.11 [0.84-1.47],0.4663295081776296
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LAT,Linker for activation of T-cells family member 1,2530,124,1.10 [0.89-1.36],0.3901294268773858
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LAT2,Linker for activation of T-cells family member 2,2479,123,1.06 [0.93-1.20],0.3735511846648288
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LATS1,Serine/threonine-protein kinase LATS1,2106,103,0.95 [0.76-1.19],0.6754406952497449
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LAYN,Layilin,2471,121,3.93 [2.95-5.25],1.493893655293908e-20
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LBP,Lipopolysaccharide-binding protein,2503,122,1.32 [1.00-1.74],0.0482171929882358
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LBR,Delta(14)-sterol reductase LBR,2516,124,1.10 [0.89-1.35],0.382669389829534
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LCAT,Phosphatidylcholine-sterol acyltransferase,2174,105,0.78 [0.34-1.80],0.5652256530009602
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LCN15,Lipocalin-15,2162,104,1.51 [1.27-1.79],3.342213388122477e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LCN2,Neutrophil gelatinase-associated lipocalin,2420,118,2.23 [1.73-2.89],1.0978335714675823e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LCP1,Plastin-2,2175,103,0.72 [0.48-1.08],0.1152494262219768
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LDLR,Low-density lipoprotein receptor,2505,122,0.87 [0.64-1.17],0.3508044926675135
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LDLRAP1,Low density lipoprotein receptor adapter protein 1,2162,104,0.97 [0.80-1.17],0.7451255687005356
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LECT2,Leukocyte cell-derived chemotaxin-2,2168,106,1.31 [1.02-1.67],0.0341947318784815
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LEFTY2,Left-right determination factor 2,2513,125,1.38 [1.04-1.84],0.0278156683799863
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LEG1,Protein LEG1 homolog,2052,98,1.11 [0.85-1.45],0.4633478361940799
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LELP1,Late cornified envelope-like proline-rich protein 1,2108,103,1.08 [0.82-1.42],0.570538944945455
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LEO1,RNA polymerase-associated protein LEO1,2162,104,1.15 [0.67-1.99],0.608653320633243
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LEP,Leptin,2498,123,1.06 [0.83-1.35],0.6363219143182712
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LEPR,Leptin receptor,2498,123,1.56 [0.98-2.49],0.0635931244791067
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LETM1,Mitochondrial proton/calcium exchanger protein,2162,104,1.26 [0.91-1.73],0.1632717515505123
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LGALS1,Galectin-1,2498,123,1.75 [1.17-2.61],0.005916996448842
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LGALS3,Galectin-3,2501,121,2.61 [1.61-4.22],9.179726995992536e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LGALS3BP,Galectin-3-binding protein,2171,104,1.97 [1.19-3.26],0.0081700147235942
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LGALS4,Galectin-4,2500,121,2.39 [1.93-2.97],3.205149015412382e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LGALS7_LGALS7B,Galectin-7,2488,122,1.62 [1.17-2.23],0.0032660291238737
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LGALS8,Galectin-8,2516,124,1.13 [0.87-1.47],0.3495392735632231
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LGALS9,Galectin-9,2504,121,4.52 [2.89-7.08],4.060899699560405e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LGMN,Legumain,2510,121,1.56 [1.03-2.37],0.0353255653874529
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LHB,Lutropin subunit beta,2421,119,1.14 [0.98-1.34],0.0909888616920166
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,2496,120,0.80 [0.63-1.03],0.082266968616765
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LIF,Leukemia inhibitory factor,2431,119,1.05 [0.78-1.43],0.7347563568106675
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LIFR,Leukemia inhibitory factor receptor,2500,123,12.07 [7.44-19.60],6.970190766496508e-24
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,2505,122,2.04 [1.29-3.22],0.0022377949596406
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,2175,103,1.00 [0.87-1.15],0.9786407205792912
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,2105,101,1.15 [0.76-1.74],0.5022414401460338
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,2498,123,2.29 [1.40-3.75],0.0009782811199202
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,2168,106,1.08 [0.85-1.37],0.5458871598901083
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,2530,124,2.61 [1.50-4.55],0.0007258541867506
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,2520,124,1.96 [1.24-3.11],0.0040895772776855
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,2444,122,2.72 [1.99-3.73],4.0531704838921557e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,2530,124,1.16 [0.91-1.46],0.2339511151762766
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LIPF,Gastric triacylglycerol lipase,2110,105,1.03 [0.79-1.34],0.8465226240616498
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LMNB1,Lamin-B1,2162,101,1.02 [0.76-1.37],0.8717188239716636
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LMNB2,Lamin-B2,2160,104,2.42 [1.49-3.94],0.0003512674789888
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LMOD1,Leiomodin-1,2162,104,2.73 [2.02-3.67],4.086729592786615e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LMOD2,Leiomodin-2,2108,103,0.84 [0.60-1.19],0.3262234613527
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LONP1,"Lon protease homolog, mitochondrial",2110,105,1.05 [0.85-1.30],0.6266764040451512
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LPA,Apolipoprotein(a),2126,103,0.91 [0.83-1.01],0.0776715717338754
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LPCAT2,Lysophosphatidylcholine acyltransferase 2,2479,123,1.06 [0.78-1.45],0.7070234564029462
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LPL,Lipoprotein lipase,2498,123,0.88 [0.64-1.21],0.4305012381731764
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LPO,Lactoperoxidase,2414,120,1.46 [1.15-1.85],0.0019535310402777
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LPP,Lipoma-preferred partner,2105,101,0.98 [0.72-1.32],0.8736297838217615
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,2105,101,1.03 [0.77-1.38],0.831044470875155
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,2119,101,1.11 [0.74-1.68],0.6148732407380499
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LRG1,Leucine-rich alpha-2-glycoprotein,2171,104,3.54 [1.85-6.76],0.0001305536760628
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,2511,125,2.77 [1.97-3.92],6.5927210254915875e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,2100,103,0.97 [0.50-1.90],0.9357052729243808
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LRP1,Prolow-density lipoprotein receptor-related protein 1,2479,123,1.73 [1.01-2.96],0.0465559776180912
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LRP11,Low-density lipoprotein receptor-related protein 11,2498,123,2.49 [1.70-3.64],2.7913034477073853e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LRP2,Low-density lipoprotein receptor-related protein 2,2119,101,1.12 [0.65-1.93],0.6888107872409225
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LRP2BP,LRP2-binding protein,2119,101,0.85 [0.64-1.13],0.2693309275770614
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LRPAP1,Alpha-2-macroglobulin receptor-associated protein,2516,124,1.20 [0.93-1.53],0.1617698294406782
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LRRC25,Leucine-rich repeat-containing protein 25,2479,123,1.46 [1.12-1.91],0.0053371929978961
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LRRC37A2,Leucine-rich repeat-containing protein 37A2,2165,101,1.30 [0.84-2.02],0.2343007151943773
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LRRC38,Leucine-rich repeat-containing protein 38,2119,101,1.54 [1.06-2.24],0.0227254593879877
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LRRC59,Leucine-rich repeat-containing protein 59,2168,106,1.17 [0.81-1.68],0.3984378815776404
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,2161,104,1.20 [0.84-1.72],0.3208572303428448
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LRRN1,Leucine-rich repeat neuronal protein 1,2444,122,0.71 [0.48-1.05],0.086605645689257
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,2119,101,1.34 [0.87-2.06],0.1785837894130769
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,2162,104,0.66 [0.32-1.39],0.2791947719683397
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LSM1,U6 snRNA-associated Sm-like protein LSm1,2421,119,1.06 [0.78-1.43],0.7060149787421102
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LSM8,U6 snRNA-associated Sm-like protein LSm8,2135,102,1.10 [0.92-1.33],0.3016516135543889
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LSP1,Lymphocyte-specific protein 1,2500,123,1.19 [0.80-1.78],0.3927126054969622
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LTA,Lymphotoxin-alpha,2500,123,1.40 [0.94-2.08],0.0971218143285381
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LTA4H,Leukotriene A-4 hydrolase,2516,125,0.76 [0.58-1.01],0.0571719292755477
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LTB,Lymphotoxin-beta,2161,104,1.01 [0.60-1.72],0.9597170955128524
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LTBP2,Latent-transforming growth factor beta-binding protein 2,2530,124,4.33 [3.14-5.96],2.772845479734048e-19
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LTBP3,Latent-transforming growth factor beta-binding protein 3,2421,119,1.45 [1.21-1.74],5.85773208168234e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LTBR,Tumor necrosis factor receptor superfamily member 3,2488,121,4.26 [3.04-5.97],3.830772154877978e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LTO1,Protein LTO1 homolog,2444,122,1.02 [0.66-1.57],0.9363659536385148
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LUZP2,Leucine zipper protein 2,2161,104,1.33 [0.94-1.89],0.1012433836936354
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LXN,Latexin,2463,122,0.85 [0.67-1.08],0.1835729134324757
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LY6D,Lymphocyte antigen 6D,2484,120,2.10 [1.57-2.80],4.558484825212593e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LY75,Lymphocyte antigen 75,2500,123,1.65 [1.11-2.47],0.0139742112727305
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LY9,T-lymphocyte surface antigen Ly-9,2462,119,2.90 [1.80-4.66],1.075792030510906e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LY96,Lymphocyte antigen 96,2476,122,1.92 [1.32-2.77],0.0005566272484449
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LYAR,Cell growth-regulating nucleolar protein,2421,119,0.92 [0.65-1.29],0.626897668529699
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LYN,Tyrosine-protein kinase Lyn,2479,123,1.02 [0.85-1.24],0.8173849276722531
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LYPD1,Ly6/PLAUR domain-containing protein 1,2431,119,0.87 [0.64-1.18],0.3598984238281876
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LYPD3,Ly6/PLAUR domain-containing protein 3,2476,122,1.85 [1.20-2.85],0.0050717010287524
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LYPD8,Ly6/PLAUR domain-containing protein 8,2421,119,1.27 [1.04-1.56],0.0207319022556226
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LYPLA2,Acyl-protein thioesterase 2,2108,103,0.81 [0.65-1.02],0.0745760302431833
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,2119,101,0.97 [0.80-1.17],0.7523660423739957
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,2171,104,3.48 [1.41-8.63],0.0070502288533092
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LYZL2,Lysozyme-like protein 2,2087,102,0.89 [0.51-1.54],0.669139397041362
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LZTFL1,Leucine zipper transcription factor-like protein 1,2132,103,0.82 [0.62-1.09],0.1756054634989173
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,M6PR,Cation-dependent mannose-6-phosphate receptor,2110,105,0.94 [0.58-1.53],0.8135837627136545
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,2463,121,1.31 [1.04-1.65],0.0194899241655738
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MAEA,E3 ubiquitin-protein transferase MAEA,2421,119,0.99 [0.64-1.52],0.952023545567578
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MAG,Myelin-associated glycoprotein,2119,101,0.68 [0.45-1.01],0.0576231481166452
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MAGEA3,Melanoma-associated antigen 3,2135,102,1.12 [0.88-1.41],0.3492077227399337
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MAGED1,Melanoma-associated antigen D1,2421,119,1.28 [0.95-1.73],0.1062672479353318
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MAMDC2,MAM domain-containing protein 2,2168,106,3.41 [2.30-5.06],9.069480095403903e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MAMDC4,Apical endosomal glycoprotein,2161,104,1.12 [0.82-1.54],0.483540777051734
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",2110,105,2.94 [1.39-6.21],0.0046078980538386
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MAN2B2,Epididymis-specific alpha-mannosidase,2168,106,0.93 [0.68-1.25],0.6225647844624242
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",2087,102,1.28 [0.89-1.84],0.178422113774262
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MANF,Mesencephalic astrocyte-derived neurotrophic factor,2510,121,1.01 [0.89-1.16],0.8375759810321286
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MANSC1,MANSC domain-containing protein 1,2497,124,5.17 [3.18-8.41],3.7171948388804e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MANSC4,MANSC domain-containing protein 4,2105,101,0.87 [0.66-1.15],0.3317572157436702
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,2108,103,0.90 [0.48-1.67],0.7312060384751585
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,2105,101,1.03 [0.78-1.35],0.8573720049146262
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MAP2,Microtubule-associated protein 2,2160,104,1.79 [1.30-2.48],0.0004176241891453
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,2165,101,1.24 [0.91-1.69],0.1791234990772575
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,2500,123,1.01 [0.86-1.19],0.917328276591225
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MAP3K5,Mitogen-activated protein kinase kinase kinase 5,2421,119,1.10 [0.93-1.30],0.2505158139151513
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,2471,121,0.99 [0.85-1.14],0.8690679383394938
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MAPK13,Mitogen-activated protein kinase 13,2087,102,1.00 [0.65-1.53],0.9943888215583506
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MAPK9,Mitogen-activated protein kinase 9,2500,123,1.29 [0.90-1.85],0.1593345727147884
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MAPKAPK2,MAP kinase-activated protein kinase 2,2135,102,1.02 [0.79-1.33],0.8673282045356848
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MAPRE3,Microtubule-associated protein RP/EB family member 3,2087,102,0.99 [0.87-1.13],0.8990606506812473
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MAPT,Microtubule-associated protein tau,2431,119,1.19 [0.86-1.64],0.2876830803635966
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MARCO,Macrophage receptor MARCO,2498,123,1.18 [0.65-2.14],0.5912561658956628
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MARS1,"Methionine--tRNA ligase, cytoplasmic",2131,102,0.98 [0.78-1.23],0.8809069855334065
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MASP1,Mannan-binding lectin serine protease 1,2471,121,1.84 [0.94-3.63],0.0768005093471054
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MATN2,Matrilin-2,2505,121,2.36 [1.42-3.91],0.0009147986119609
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MATN3,Matrilin-3,2472,122,0.75 [0.47-1.19],0.2238571344138261
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MAVS,Mitochondrial antiviral-signaling protein,2421,119,1.15 [0.97-1.38],0.1137713860428061
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MAX,Protein max,2431,119,1.01 [0.87-1.18],0.8624316659100887
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MB,Myoglobin,2530,124,1.69 [1.36-2.10],2.422557110088031e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MBL2,Mannose-binding protein C,2142,103,0.96 [0.81-1.13],0.5990926277951589
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MCAM,Cell surface glycoprotein MUC18,2503,122,2.69 [1.85-3.92],2.2609426946505058e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",2162,104,0.69 [0.41-1.16],0.1609837882474492
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MCEMP1,Mast cell-expressed membrane protein 1,2106,103,0.86 [0.68-1.09],0.2066328894576142
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MCFD2,Multiple coagulation factor deficiency protein 2,2484,122,1.37 [0.97-1.92],0.0703633557257409
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MCTS1,Malignant T-cell-amplified sequence 1,2165,101,1.48 [0.83-2.62],0.1839801525278879
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,2476,122,1.51 [1.21-1.89],0.0003060259504449
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MDH1,"Malate dehydrogenase, cytoplasmic",2160,105,0.75 [0.46-1.24],0.2618329017163097
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MDK,Midkine,2487,123,1.90 [1.54-2.35],3.535790693577079e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MDM1,Nuclear protein MDM1,2119,101,0.90 [0.48-1.69],0.7449692372813337
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",2110,105,1.00 [0.81-1.23],0.9873774425354768
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MED18,Mediator of RNA polymerase II transcription subunit 18,2421,119,1.05 [0.84-1.31],0.6686099620788571
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MED21,Mediator of RNA polymerase II transcription subunit 21,2105,101,0.91 [0.59-1.40],0.6546400400403952
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MEGF10,Multiple epidermal growth factor-like domains protein 10,2500,121,1.58 [1.07-2.33],0.0205649418550281
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MEGF11,Multiple epidermal growth factor-like domains protein 11,2105,101,0.80 [0.40-1.60],0.5295385253820074
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MEGF9,Multiple epidermal growth factor-like domains protein 9,2525,124,2.60 [1.21-5.58],0.0142108322963459
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MELTF,Melanotransferrin,2168,106,1.86 [1.00-3.49],0.0518500906702826
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MENT,Protein MENT,2132,103,0.31 [0.16-0.62],0.0007700154852255
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MEP1A,Meprin A subunit alpha,2165,101,0.77 [0.59-0.99],0.0431022407487865
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MEP1B,Meprin A subunit beta,2498,123,0.84 [0.74-0.96],0.0095971708879973
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MEPE,Matrix extracellular phosphoglycoprotein,2500,121,1.13 [0.60-2.11],0.7037370245562211
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MERTK,Tyrosine-protein kinase Mer,2530,124,3.44 [2.02-5.88],5.961371676302965e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MESD,LRP chaperone MESD,2505,122,1.01 [0.89-1.16],0.8420963136664585
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MET,Hepatocyte growth factor receptor,2509,121,2.46 [1.15-5.24],0.0199827179357588
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,METAP1,Methionine aminopeptidase 1,2431,119,1.07 [0.63-1.83],0.8065798443987272
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,METAP1D,"Methionine aminopeptidase 1D, mitochondrial",2500,123,1.02 [0.84-1.24],0.830781774067353
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,METAP2,Methionine aminopeptidase 2,2513,125,1.02 [0.75-1.37],0.9195706679655908
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MFAP3,Microfibril-associated glycoprotein 3,2451,119,1.17 [0.86-1.59],0.3255989720342052
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MFAP3L,Microfibrillar-associated protein 3-like,2119,101,0.85 [0.60-1.20],0.3504354706916738
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MFAP4,Microfibril-associated glycoprotein 4,2132,103,3.84 [2.29-6.43],3.316955503379686e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MFAP5,Microfibrillar-associated protein 5,2530,124,1.62 [1.12-2.34],0.0100985904300205
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MFGE8,Lactadherin,2505,122,1.44 [1.06-1.96],0.0206921199582441
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MGLL,Monoglyceride lipase,2509,121,0.96 [0.80-1.15],0.6456070126891652
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MGMT,Methylated-DNA--protein-cysteine methyltransferase,2500,123,1.03 [0.90-1.18],0.6789321920636294
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MIA,Melanoma-derived growth regulatory protein,2497,124,1.52 [1.03-2.23],0.0346809045946071
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MICALL2,MICAL-like protein 2,2119,101,1.23 [0.96-1.58],0.103281400824904
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,2500,123,1.10 [0.97-1.24],0.1224814991812246
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MIF,Macrophage migration inhibitory factor,2501,122,1.01 [0.79-1.30],0.9199299092129338
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MILR1,Allergin-1,2444,122,1.61 [1.21-2.15],0.0011271025049091
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,2161,104,0.96 [0.80-1.14],0.6249904325633803
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MINK1,Misshapen-like kinase 1,2160,104,0.94 [0.76-1.16],0.5502904283682026
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MITD1,MIT domain-containing protein 1,2476,122,1.01 [0.85-1.19],0.9364988133582856
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MKI67,Proliferation marker protein Ki-67,2106,103,0.82 [0.48-1.40],0.4640332243011784
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MLLT1,Protein ENL,2087,102,0.97 [0.71-1.31],0.8260477025638225
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MLN,Promotilin,2500,123,1.31 [1.09-1.58],0.0038562153412383
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MME,Neprilysin,2479,123,1.21 [1.00-1.46],0.044288310422363
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MMP1,Interstitial collagenase,2420,115,1.49 [1.23-1.81],5.708881273592885e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MMP10,Stromelysin-2,2495,121,1.93 [1.49-2.51],7.436288443393479e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MMP12,Macrophage metalloelastase,2500,125,1.52 [1.19-1.95],0.0009889395466356
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MMP13,Collagenase 3,2431,119,1.70 [1.04-2.80],0.0358307135495506
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MMP15,Matrix metalloproteinase-15,2168,106,1.21 [0.92-1.59],0.167880798670414
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MMP3,Stromelysin-1,2505,122,1.40 [1.05-1.86],0.0224410416731765
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MMP7,Matrilysin,2448,119,2.87 [2.06-4.02],6.6303965698416e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MMP8,Neutrophil collagenase,2513,124,1.09 [0.89-1.35],0.3981100285623549
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MMP9,Matrix metalloproteinase-9,2502,122,1.11 [0.85-1.45],0.4354994289392628
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MMUT,"Methylmalonyl-CoA mutase, mitochondrial",2105,101,0.98 [0.66-1.45],0.9020599039925944
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MN1,Transcriptional activator MN1,2119,101,0.93 [0.65-1.32],0.6739553983410811
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MNAT1,CDK-activating kinase assembly factor MAT1,2135,102,0.77 [0.47-1.28],0.3125572313136913
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MNDA,Myeloid cell nuclear differentiation antigen,2494,123,0.92 [0.78-1.09],0.3265315447194317
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MOCS2,Molybdopterin synthase catalytic subunit,2132,103,1.13 [0.85-1.50],0.3961036809007001
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MOG,Myelin-oligodendrocyte glycoprotein,2516,125,2.00 [1.35-2.95],0.0005412905777199
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MORC3,MORC family CW-type zinc finger protein 3,2160,104,0.69 [0.32-1.50],0.3508345963999077
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MORF4L1,Mortality factor 4-like protein 1,2135,102,0.85 [0.51-1.44],0.5543869235550769
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MORF4L2,Mortality factor 4-like protein 2,2087,102,0.85 [0.48-1.49],0.5705331795191269
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MORN4,MORN repeat-containing protein 4,2087,102,1.05 [0.85-1.30],0.6258036471483635
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MPHOSPH8,M-phase phosphoprotein 8,2451,119,0.99 [0.80-1.23],0.931020696759587
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MPI,Mannose-6-phosphate isomerase,2479,123,1.14 [0.94-1.38],0.1751560544650505
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,2509,121,1.06 [0.86-1.32],0.5778681483121961
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MPO,Myeloperoxidase,2505,122,1.24 [0.90-1.70],0.1823223469767717
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MPRIP,Myosin phosphatase Rho-interacting protein,2157,104,0.85 [0.54-1.32],0.4636610498075059
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MRC1,Macrophage mannose receptor 1,2174,105,3.34 [1.83-6.10],8.356436256035029e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MRI1,Methylthioribose-1-phosphate isomerase,2119,101,1.17 [0.88-1.55],0.2766390001961625
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MRPL24,"39S ribosomal protein L24, mitochondrial",2105,101,1.16 [0.73-1.83],0.5390296243172075
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MRPL28,"39S ribosomal protein L28, mitochondrial",2162,104,0.77 [0.41-1.44],0.4100321918747066
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MRPL46,"39S ribosomal protein L46, mitochondrial",2431,119,0.88 [0.48-1.60],0.6729002238313262
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MRPL52,"39S ribosomal protein L52, mitochondrial",2084,102,0.87 [0.41-1.85],0.7239638765541137
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",2162,104,1.07 [0.85-1.36],0.5503599357787894
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MRPS16,"28S ribosomal protein S16, mitochondrial",2106,103,0.63 [0.28-1.42],0.2673001086479518
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MSLN,Mesothelin,2474,123,1.39 [1.08-1.77],0.0090615673872398
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MSLNL,Mesothelin-like protein,2119,101,1.19 [0.71-2.00],0.5108273858793093
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MSMB,Beta-microseminoprotein,2501,124,1.47 [1.19-1.81],0.000366223030683
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MSR1,Macrophage scavenger receptor types I and II,2516,124,1.69 [1.23-2.32],0.0013203310965997
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MSRA,Mitochondrial peptide methionine sulfoxide reductase,2497,124,0.97 [0.78-1.21],0.783926522986993
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MST1,Hepatocyte growth factor-like protein,2142,103,1.10 [0.80-1.52],0.5424474509842416
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MSTN,Growth/differentiation factor 8,2451,119,0.81 [0.60-1.08],0.1425410934107244
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MTDH,Protein LYRIC,2106,103,1.07 [0.88-1.30],0.4930037127240719
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",2160,104,0.90 [0.42-1.92],0.7774699930128701
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,2135,102,0.98 [0.83-1.16],0.8329228779175167
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MTIF3,"Translation initiation factor IF-3, mitochondrial",2165,101,0.98 [0.79-1.22],0.8608637824239443
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MTPN,Myotrophin,2451,119,0.73 [0.40-1.31],0.2851705095162032
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MTR,Methionine synthase,2105,101,0.96 [0.71-1.30],0.8101212287241215
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MTSS1,Protein MTSS 1,2165,101,1.11 [0.94-1.31],0.2234887206424441
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MTSS2,Protein MTSS 2,2161,104,1.03 [0.86-1.25],0.7234389696412991
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MTUS1,Microtubule-associated tumor suppressor 1,2135,102,0.78 [0.55-1.10],0.1633657187217366
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MUC13,Mucin-13,2431,119,2.07 [1.67-2.58],7.041475309597937e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MUC16,Mucin-16,2479,123,1.00 [0.91-1.09],0.9594199011353228
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MUC2,Mucin-2,2175,103,0.95 [0.78-1.16],0.6113369946706948
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MUCL3,Mucin-like protein 3,2087,102,0.80 [0.48-1.32],0.3797813202496035
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MVK,Mevalonate kinase,2444,122,1.14 [0.96-1.35],0.1455104022382951
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MXRA8,Matrix remodeling-associated protein 8,2132,103,0.69 [0.38-1.26],0.2219274400863247
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MYBPC1,"Myosin-binding protein C, slow-type",2168,106,1.37 [1.11-1.70],0.0031108738089011
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MYBPC2,"Myosin-binding protein C, fast-type",2110,105,1.23 [1.03-1.46],0.0202307616115972
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MYCBP2,E3 ubiquitin-protein ligase MYCBP2,2162,104,0.94 [0.70-1.26],0.6932211791974869
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MYDGF,Myeloid-derived growth factor,2168,106,1.05 [0.87-1.28],0.6118662446649337
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MYH4,Myosin-4,2105,101,1.08 [0.71-1.64],0.7059663016657958
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MYH7B,Myosin-7B,2087,102,0.70 [0.40-1.23],0.2179302910057734
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MYH9,Myosin-9,2175,103,1.01 [0.85-1.19],0.929252150483446
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MYL1,"Myosin light chain 1/3, skeletal muscle isoform",2105,101,1.28 [0.94-1.74],0.1156235448339435
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MYL3,Myosin light chain 3,2110,105,1.21 [0.96-1.54],0.1088715452563046
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MYL4,Myosin light chain 4,2110,105,1.20 [0.85-1.67],0.2986722972615806
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MYL6B,Myosin light chain 6B,2119,101,1.01 [0.82-1.26],0.8989715997108537
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",2119,101,1.60 [1.28-2.00],3.545869339259822e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MYO6,Unconventional myosin-VI,2162,104,0.98 [0.57-1.68],0.9312611688417752
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MYO9B,Unconventional myosin-IXb,2444,122,1.16 [0.92-1.45],0.2085187614453979
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MYOC,Myocilin,2505,122,0.86 [0.61-1.22],0.3994325474285285
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MYOM1,Myomesin-1,2108,103,1.08 [0.75-1.57],0.6656774940974464
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MYOM2,Myomesin-2,2105,101,1.43 [1.11-1.86],0.0065418768902226
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MYOM3,Myomesin-3,2132,103,1.15 [0.95-1.40],0.1465382776627645
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MZB1,Marginal zone B- and B1-cell-specific protein,2506,121,1.43 [1.07-1.91],0.0146326825054027
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MZT1,Mitotic-spindle organizing protein 1,2421,119,1.17 [0.89-1.54],0.2527058506880015
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NAA10,N-alpha-acetyltransferase 10,2105,101,0.93 [0.63-1.35],0.687477044562746
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NAA80,N-alpha-acetyltransferase 80,2119,101,0.97 [0.83-1.13],0.6864527153515174
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NAAA,N-acylethanolamine-hydrolyzing acid amidase,2464,121,0.98 [0.74-1.30],0.9051637290504926
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NACC1,Nucleus accumbens-associated protein 1,2161,104,1.03 [0.73-1.44],0.8759653714463531
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NADK,NAD kinase,2498,123,1.01 [0.77-1.33],0.9492540493290572
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NAGA,Alpha-N-acetylgalactosaminidase,2100,103,1.11 [0.78-1.57],0.5579650669834106
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NAGK,N-acetyl-D-glucosamine kinase,2107,105,0.69 [0.50-0.97],0.0317208017670409
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,2132,103,1.88 [0.84-4.22],0.1240208288872048
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NAMPT,Nicotinamide phosphoribosyltransferase,2421,119,0.88 [0.63-1.22],0.4336647712235854
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NAP1L4,Nucleosome assembly protein 1-like 4,2162,101,0.89 [0.55-1.45],0.6446455245450771
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NAPRT,Nicotinate phosphoribosyltransferase,2160,104,0.45 [0.24-0.86],0.0161439549107193
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NARS1,"Asparagine--tRNA ligase, cytoplasmic",2162,104,0.93 [0.62-1.39],0.7295011364065844
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NBL1,Neuroblastoma suppressor of tumorigenicity 1,2497,124,5.41 [3.44-8.50],2.755261753142027e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NBN,Nibrin,2444,122,1.02 [0.76-1.36],0.9159209016215244
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NCAM1,Neural cell adhesion molecule 1,2503,122,1.25 [0.80-1.96],0.3221136354725175
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NCAM2,Neural cell adhesion molecule 2,2505,122,1.45 [0.81-2.59],0.2081399090230558
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NCAN,Neurocan core protein,2516,124,0.61 [0.42-0.90],0.0113414365789706
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NCF2,Neutrophil cytosol factor 2,2496,123,0.93 [0.77-1.13],0.4522964229547902
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NCK2,Cytoplasmic protein NCK2,2510,121,1.01 [0.87-1.18],0.8941036347849736
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NCLN,Nicalin,2444,122,1.22 [0.96-1.55],0.1091746439462527
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NCR1,Natural cytotoxicity triggering receptor 1,2497,123,3.55 [2.53-4.97],1.9435676343745472e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,2165,101,4.14 [2.71-6.31],4.221559090224768e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NCS1,Neuronal calcium sensor 1,2516,125,4.48 [2.78-7.25],8.821794876142042e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NDRG1,Protein NDRG1,2431,119,0.82 [0.61-1.11],0.2039670820605439
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,2161,104,1.19 [0.92-1.55],0.1833353055739388
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,2103,103,1.07 [0.62-1.83],0.8174958432621622
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,2165,101,0.97 [0.78-1.20],0.7705629715931759
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",2421,119,1.25 [1.05-1.48],0.0131667463828768
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NEB,Nebulin,2105,101,1.50 [1.00-2.24],0.0490217418162018
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NECAP2,Adaptin ear-binding coat-associated protein 2,2105,101,0.92 [0.68-1.26],0.6101886610839474
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NECTIN1,Nectin-1,2106,103,1.38 [0.84-2.26],0.2027676144235626
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NECTIN2,Nectin-2,2498,123,4.02 [2.82-5.72],1.2426128749786844e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NECTIN4,Nectin-4,2497,124,2.77 [2.10-3.67],7.013686230691298e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,2106,103,0.68 [0.48-0.97],0.0346289652476806
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NEDD9,Enhancer of filamentation 1,2106,103,1.32 [0.82-2.14],0.2573571548673184
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NEFL,Neurofilament light polypeptide,2423,118,2.81 [2.29-3.46],6.13395098808995e-23
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NEK7,Serine/threonine-protein kinase Nek7,2135,102,0.81 [0.60-1.10],0.1790755666566907
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NELL1,Protein kinase C-binding protein NELL1,2497,124,0.40 [0.30-0.53],1.2530684645918368e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NELL2,Protein kinase C-binding protein NELL2,2510,121,1.53 [0.94-2.48],0.085618302614143
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NENF,Neudesin,2161,104,1.08 [0.92-1.26],0.3572315963836493
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NEO1,Neogenin,2162,104,1.60 [0.88-2.89],0.1234098391889756
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NEXN,Nexilin,2174,105,0.98 [0.75-1.27],0.853373016125038
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NFASC,Neurofascin,2530,124,5.17 [3.37-7.91],4.4066132583468326e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NFAT5,Nuclear factor of activated T-cells 5,2106,103,1.11 [0.90-1.38],0.320756370072052
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",2500,123,1.03 [0.88-1.21],0.7134501711542125
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",2444,122,1.09 [0.85-1.38],0.5043371028938901
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NFE2,Transcription factor NF-E2 45 kDa subunit,2110,105,1.08 [0.84-1.39],0.5706878796611485
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NFIC,Nuclear factor 1 C-type,2162,104,1.07 [0.67-1.70],0.7801885940802787
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NFKB1,Nuclear factor NF-kappa-B p105 subunit,2105,101,1.06 [0.81-1.38],0.6804720605181612
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NFKB2,Nuclear factor NF-kappa-B p100 subunit,2135,102,1.00 [0.69-1.45],0.9961321940129384
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NFKBIE,NF-kappa-B inhibitor epsilon,2421,119,1.24 [0.89-1.71],0.1976359392839447
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",2165,101,1.01 [0.84-1.21],0.9313353929610124
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NFX1,Transcriptional repressor NF-X1,2105,101,1.05 [0.81-1.37],0.7097013238711598
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NFYA,Nuclear transcription factor Y subunit alpha,2105,101,1.36 [0.95-1.95],0.0923476127340161
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NGF,Beta-nerve growth factor,2476,122,3.85 [1.33-11.12],0.0128912391400515
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NGFR,Tumor necrosis factor receptor superfamily member 16,2168,106,1.68 [1.20-2.34],0.0024215865745587
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NGRN,Neugrin,2160,104,2.29 [1.03-5.06],0.041302871442596
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NHLRC3,NHL repeat-containing protein 3,2084,99,2.72 [1.48-5.01],0.0013353860695756
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NID1,Nidogen-1,2499,122,1.69 [1.11-2.57],0.0152409672515705
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NID2,Nidogen-2,2505,122,1.08 [0.87-1.34],0.4839109648036278
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NINJ1,Ninjurin-1,2421,119,1.34 [1.08-1.66],0.0084456763613598
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NIT1,Deaminated glutathione amidase,2110,105,0.81 [0.53-1.24],0.3230776544284908
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NIT2,Omega-amidase NIT2,2159,106,0.97 [0.74-1.27],0.810978769236735
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NLGN1,Neuroligin-1,2119,101,0.92 [0.66-1.28],0.6196597845380936
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NLGN2,Neuroligin-2,2108,103,0.70 [0.42-1.19],0.1869447851034706
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NME1,Nucleoside diphosphate kinase A,2106,103,0.54 [0.21-1.42],0.2126145728089228
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NME3,Nucleoside diphosphate kinase 3,2505,121,1.99 [1.06-3.72],0.0319109392897783
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NMI,N-myc-interactor,2154,104,1.02 [0.78-1.33],0.9093645957039188
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,2476,122,0.96 [0.78-1.18],0.6983599560692165
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NMRK2,Nicotinamide riboside kinase 2,2087,102,0.96 [0.55-1.68],0.8883862459500791
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NMT1,Glycylpeptide N-tetradecanoyltransferase 1,2162,104,0.86 [0.62-1.20],0.3812706656236925
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NOMO1,Nodal modulator 1,2505,122,2.03 [1.05-3.91],0.0346586774770666
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NOP56,Nucleolar protein 56,2105,101,1.02 [0.86-1.21],0.8179349740503288
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NOS1,"Nitric oxide synthase, brain",2431,119,1.66 [1.33-2.09],1.0474720725146766e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NOS2,"Nitric oxide synthase, inducible",2105,101,1.02 [0.63-1.66],0.9343421014382892
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NOS3,"Nitric oxide synthase, endothelial",2431,119,1.43 [1.12-1.83],0.0042636847053658
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NOTCH1,Neurogenic locus notch homolog protein 1,2530,124,15.08 [6.28-36.21],1.270646990729243e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NOTCH2,Neurogenic locus notch homolog protein 2,2175,103,3.48 [1.75-6.92],0.0003829076993759
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NOTCH3,Neurogenic locus notch homolog protein 3,2530,124,2.25 [1.48-3.40],0.0001283000451524
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NPC2,NPC intracellular cholesterol transporter 2,2141,103,4.63 [2.98-7.18],8.619417354811024e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NPDC1,Neural proliferation differentiation and control protein 1,2498,123,3.10 [2.30-4.17],9.076903476560497e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NPHS1,Nephrin,2106,103,0.92 [0.53-1.61],0.7763545659117623
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NPHS2,Podocin,2106,103,0.98 [0.81-1.18],0.8287209024246736
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NPL,N-acetylneuraminate lyase,2168,106,1.16 [0.80-1.67],0.434349747503431
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NPPB,Natriuretic peptides B,2451,119,1.31 [1.18-1.46],3.047570535808011e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NPPC,C-type natriuretic peptide,2500,123,1.18 [0.93-1.50],0.1665212252016288
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NPR1,Atrial natriuretic peptide receptor 1,2105,101,0.73 [0.42-1.26],0.2577164850479733
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NPTN,Neuroplastin,2421,119,1.07 [0.88-1.31],0.4916773280405773
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NPTX1,Neuronal pentraxin-1,2505,122,1.16 [0.82-1.66],0.4041164343960348
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NPTX2,Neuronal pentraxin-2,2175,103,1.73 [1.02-2.93],0.0421509186844675
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NPTXR,Neuronal pentraxin receptor,2498,123,1.01 [0.66-1.54],0.9624147122571428
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NPY,Pro-neuropeptide Y,2516,125,2.12 [1.63-2.76],2.2210498648699787e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NRCAM,Neuronal cell adhesion molecule,2498,123,2.72 [1.74-4.25],1.1212700039734389e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NRGN,Neurogranin,2174,105,0.93 [0.76-1.15],0.5136162102710298
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NRN1,Neuritin,2162,104,0.76 [0.40-1.45],0.4054131394460204
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NRP1,Neuropilin-1,2505,122,3.60 [2.12-6.13],2.275945366673727e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NRP2,Neuropilin-2,2505,122,1.91 [1.14-3.19],0.014119601138239
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NRTN,Neurturin,2444,122,1.04 [0.76-1.41],0.8189682036043933
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NRXN3,Neurexin-3,2119,101,0.94 [0.53-1.67],0.8389452391494907
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NSFL1C,NSFL1 cofactor p47,2516,124,0.92 [0.72-1.19],0.53286507835279
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",2168,106,1.05 [0.80-1.37],0.7339341847175911
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NT5C1A,Cytosolic 5'-nucleotidase 1A,2160,104,2.01 [1.40-2.89],0.000160886190821
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NT5C3A,Cytosolic 5'-nucleotidase 3A,2496,123,0.93 [0.77-1.12],0.463279194020101
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NT5E,5'-nucleotidase,2497,124,1.19 [0.90-1.58],0.2298341092850976
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NTF3,Neurotrophin-3,2500,123,1.65 [1.15-2.36],0.0067993036550354
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NTF4,Neurotrophin-4,2421,119,1.28 [0.86-1.89],0.2218037406591352
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NTRK2,BDNF/NT-3 growth factors receptor,2498,123,1.70 [0.94-3.09],0.0806401115727335
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NTRK3,NT-3 growth factor receptor,2516,124,1.97 [0.98-3.96],0.0555045885033198
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NTproBNP,N-terminal prohormone of brain natriuretic peptide,2498,123,1.31 [1.18-1.46],3.464826236808626e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NUB1,NEDD8 ultimate buster 1,2500,123,1.02 [0.84-1.23],0.8718769748336846
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,2161,104,0.98 [0.81-1.20],0.8594486673018087
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NUCB2,Nucleobindin-2,2512,125,2.24 [1.53-3.30],3.916741763507461e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NUDC,Nuclear migration protein nudC,2530,124,1.07 [0.83-1.39],0.5933632024148183
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,2110,105,0.94 [0.40-2.24],0.89449890273598
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NUDT15,Nucleotide triphosphate diphosphatase NUDT15,2105,101,0.83 [0.54-1.27],0.3805621678376426
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NUDT16,U8 snoRNA-decapping enzyme,2161,100,1.10 [0.88-1.38],0.3931548593462309
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],2479,123,0.85 [0.63-1.15],0.2946838732577287
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NUDT5,ADP-sugar pyrophosphatase,2505,122,1.21 [0.87-1.69],0.2495064144788151
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NUMB,Protein numb homolog,2106,103,0.95 [0.76-1.20],0.6943068955118141
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NUP50,Nuclear pore complex protein Nup50,2105,101,1.64 [0.96-2.80],0.0720351576108632
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NXPE4,NXPE family member 4,2105,101,1.21 [0.71-2.06],0.4840563744843519
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NXPH1,Neurexophilin-1,2431,119,1.02 [0.67-1.56],0.9252128948567592
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NXPH3,Neurexophilin-3,2106,103,1.54 [0.82-2.89],0.1747143848688468
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,OBP2B,Odorant-binding protein 2b,2470,122,1.23 [0.93-1.63],0.1431336524044837
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,OCLN,Occludin,2162,104,2.07 [1.45-2.94],5.691306047030936e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ODAM,Odontogenic ameloblast-associated protein,2426,119,1.05 [0.79-1.40],0.718859312240772
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,OFD1,Oral-facial-digital syndrome 1 protein,2135,102,1.17 [0.91-1.51],0.2125296917675486
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,OGA,Protein O-GlcNAcase,2165,101,1.22 [0.93-1.60],0.1494008774551116
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,OGFR,Opioid growth factor receptor,2479,123,1.60 [0.99-2.57],0.0538169055124883
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,OGN,Mimecan,2505,122,2.55 [1.91-3.40],2.2576330251052903e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,2135,102,0.76 [0.52-1.11],0.1514223432022321
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,OLFM4,Olfactomedin-4,2052,99,1.11 [0.95-1.29],0.1959367079657705
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,OLR1,Oxidized low-density lipoprotein receptor 1,2474,122,1.16 [0.91-1.48],0.2375442830520385
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,OMD,Osteomodulin,2510,121,0.89 [0.63-1.24],0.4838413063002688
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,OMG,Oligodendrocyte-myelin glycoprotein,2479,123,0.82 [0.66-1.02],0.0763458466005697
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,OMP,Olfactory marker protein,2108,103,1.01 [0.67-1.52],0.9556659352440116
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,OPHN1,Oligophrenin-1,2160,104,1.01 [0.85-1.20],0.8925640127318029
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,OPLAH,5-oxoprolinase,2110,105,1.20 [0.91-1.57],0.1916972842686046
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,OPTC,Opticin,2479,123,1.31 [0.98-1.76],0.0708122795506421
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ORM1,Alpha-1-acid glycoprotein 1,2164,103,3.37 [1.47-7.73],0.0041195544318552
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,OSBPL2,Oxysterol-binding protein-related protein 2,2160,104,0.86 [0.49-1.49],0.5816616660271374
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,OSCAR,Osteoclast-associated immunoglobulin-like receptor,2505,121,3.50 [2.24-5.49],4.2934115082572695e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,OSM,Oncostatin-M,2489,123,1.05 [0.84-1.31],0.6727275785284172
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,OSMR,Oncostatin-M-specific receptor subunit beta,2505,122,2.39 [1.14-5.00],0.0208645966813857
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,OSTN,Osteocrin,2119,101,1.02 [0.64-1.61],0.9425301546271828
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,OTOA,Otoancorin,2108,103,1.01 [0.72-1.42],0.9558411387145525
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,OTUD6B,Deubiquitinase OTUD6B,2165,101,0.96 [0.68-1.35],0.8168562163677675
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,OTUD7B,OTU domain-containing protein 7B,2162,104,1.16 [0.86-1.57],0.3359047176025735
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",2110,105,0.89 [0.69-1.16],0.3796642488235502
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,OXT,Oxytocin-neurophysin 1,2516,124,1.01 [0.90-1.13],0.85092430158875
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,P4HB,Protein disulfide-isomerase,2480,123,1.48 [0.98-2.23],0.0623215581859813
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PACS2,Phosphofurin acidic cluster sorting protein 2,2105,101,1.04 [0.76-1.42],0.8149536114780163
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PADI2,Protein-arginine deiminase type-2,2444,122,1.26 [1.02-1.55],0.0329588271580532
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PADI4,Protein-arginine deiminase type-4,2426,119,0.88 [0.70-1.10],0.2589463856180936
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PAEP,Glycodelin,2476,122,1.01 [0.87-1.18],0.8553562229396611
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,2162,104,0.98 [0.83-1.16],0.8088022029592291
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",2135,102,0.83 [0.54-1.27],0.3876866320597246
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,2451,119,1.39 [1.06-1.81],0.0170350332607419
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PAGR1,PAXIP1-associated glutamate-rich protein 1,2110,105,1.21 [0.77-1.90],0.4018792267880499
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PAIP2B,Polyadenylate-binding protein-interacting protein 2B,2084,102,0.95 [0.67-1.36],0.7952300546855564
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PAK4,Serine/threonine-protein kinase PAK 4,2431,119,0.94 [0.72-1.22],0.6315346364138469
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PALLD,Palladin,2106,103,1.01 [0.62-1.65],0.9564551567612344
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PALM,Paralemmin-1,2155,101,2.94 [1.83-4.71],7.496707888564953e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PALM2,Paralemmin-2,2160,104,2.68 [1.90-3.79],2.2223556621814723e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PALM3,Paralemmin-3,2105,101,0.98 [0.74-1.30],0.8936194279488867
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PAM,Peptidyl-glycine alpha-amidating monooxygenase,2518,123,1.40 [0.80-2.46],0.2405112582015799
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PAMR1,Inactive serine protease PAMR1,2505,122,1.15 [0.64-2.07],0.6292793502655125
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PAPPA,Pappalysin-1,2444,122,0.78 [0.55-1.11],0.168573131855715
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PARD3,Partitioning defective 3 homolog,2135,102,1.01 [0.78-1.31],0.928611256428891
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PARK7,Parkinson disease protein 7,2505,122,1.00 [0.72-1.39],0.9924696456614291
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PARP1,Poly [ADP-ribose] polymerase 1,2500,123,1.00 [0.76-1.32],0.998892220727042
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PAXX,Protein PAXX,2132,103,1.12 [0.75-1.69],0.578439001342848
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PBK,Lymphokine-activated killer T-cell-originated protein kinase,2087,102,0.72 [0.39-1.32],0.288302667925934
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PBLD,Phenazine biosynthesis-like domain-containing protein,2431,119,0.69 [0.51-0.94],0.0182474963863705
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,2165,101,1.43 [0.80-2.56],0.2332750469859685
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PCARE,Photoreceptor cilium actin regulator,2108,103,0.91 [0.71-1.18],0.4831111699116687
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PCBD1,Pterin-4-alpha-carbinolamine dehydratase,2127,103,0.88 [0.63-1.24],0.4608320427688642
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PCBP2,Poly(rC)-binding protein 2,2162,104,1.01 [0.77-1.31],0.9584599876604948
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PCDH1,Protocadherin-1,2516,124,3.03 [1.63-5.61],0.0004309044934292
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PCDH12,Protocadherin-12,2162,104,1.85 [0.96-3.55],0.0642792066853923
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PCDH17,Protocadherin-17,2498,123,2.05 [1.46-2.87],3.576671892744718e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PCDH7,Protocadherin-7,2165,101,2.04 [1.35-3.08],0.0007163516663682
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PCDH9,Protocadherin-9,2165,101,1.36 [0.80-2.31],0.2517267038507206
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PCDHB15,Protocadherin beta-15,2161,104,2.19 [1.45-3.32],0.0002139210636664
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PCNA,Proliferating cell nuclear antigen,2087,102,0.96 [0.71-1.30],0.7835172013966182
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PCSK7,Proprotein convertase subtilisin/kexin type 7,2161,104,1.04 [0.73-1.48],0.8128895757177729
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PCSK9,Proprotein convertase subtilisin/kexin type 9,2530,124,1.76 [1.19-2.61],0.0046165768510427
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PCYT2,Ethanolamine-phosphate cytidylyltransferase,2165,101,0.95 [0.72-1.25],0.722711185101683
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PDAP1,28 kDa heat- and acid-stable phosphoprotein,2168,106,0.98 [0.80-1.19],0.8296985325622475
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PDCD1,Programmed cell death protein 1,2513,125,1.88 [1.37-2.56],7.632894038535892e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PDCD1LG2,Programmed cell death 1 ligand 2,2479,123,4.04 [2.86-5.69],1.9090049295554906e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PDCD5,Programmed cell death protein 5,2516,124,1.23 [0.93-1.63],0.1414612423157252
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PDCD6,Programmed cell death protein 6,2498,123,1.07 [0.85-1.36],0.561203467734791
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PDCL2,Phosducin-like protein 2,2087,102,0.67 [0.43-1.06],0.0851021198255967
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",2087,102,1.02 [0.71-1.45],0.9231312201481936
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",2105,101,1.01 [0.72-1.41],0.972416494438176
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",2132,103,0.97 [0.81-1.16],0.7612617738435286
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PDGFA,Platelet-derived growth factor subunit A,2530,124,1.10 [0.89-1.36],0.38318264933929
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PDGFB,Platelet-derived growth factor subunit B,2510,121,1.07 [0.89-1.28],0.4701904825185956
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PDGFC,Platelet-derived growth factor C,2421,119,1.37 [0.81-2.32],0.2349800012768231
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PDGFRA,Platelet-derived growth factor receptor alpha,2498,123,3.48 [2.22-5.45],5.287053581345577e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PDGFRB,Platelet-derived growth factor receptor beta,2530,124,1.31 [0.83-2.07],0.2490059106447394
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PDIA2,Protein disulfide-isomerase A2,2087,102,0.65 [0.37-1.14],0.1335701907330932
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PDIA3,Protein disulfide-isomerase A3,2132,103,1.77 [0.90-3.46],0.0967153441554812
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PDIA4,Protein disulfide-isomerase A4,2175,103,1.09 [0.80-1.48],0.5952644359551468
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PDIA5,Protein disulfide-isomerase A5,2087,102,0.93 [0.67-1.28],0.6423731801558281
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PDLIM5,PDZ and LIM domain protein 5,2162,104,0.98 [0.83-1.15],0.765413147661498
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PDLIM7,PDZ and LIM domain protein 7,2510,121,1.07 [0.95-1.22],0.2695388923588311
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",2421,119,1.09 [0.81-1.47],0.5581969089663747
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PDRG1,p53 and DNA damage-regulated protein 1,2119,101,0.76 [0.49-1.18],0.2210173265096076
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,2087,102,0.59 [0.33-1.08],0.0855975691604072
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PDZD2,PDZ domain-containing protein 2,2105,101,1.15 [0.85-1.54],0.3622409742752588
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,2106,103,1.48 [1.07-2.04],0.0178322174185902
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PEAR1,Platelet endothelial aggregation receptor 1,2530,124,5.55 [2.81-10.96],8.0952162708967e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PEBP1,Phosphatidylethanolamine-binding protein 1,2505,122,1.03 [0.77-1.37],0.8383544662372431
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PECAM1,Platelet endothelial cell adhesion molecule,2505,122,1.50 [0.91-2.46],0.110739110983898
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PECR,Peroxisomal trans-2-enoyl-CoA reductase,2110,105,0.86 [0.42-1.77],0.6846805223931265
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PENK,Proenkephalin-A,2132,103,2.14 [1.34-3.41],0.0014364213106988
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PEPD,Xaa-Pro dipeptidase,2174,105,0.65 [0.33-1.25],0.1947325817611009
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PER3,Period circadian protein homolog 3,2106,103,0.90 [0.77-1.06],0.2111028081073618
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PF4,Platelet factor 4,2158,104,1.06 [0.87-1.29],0.5835811482440013
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PFDN2,Prefoldin subunit 2,2431,119,1.27 [0.94-1.72],0.1227577428264248
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PFDN4,Prefoldin subunit 4,2087,102,1.00 [0.68-1.48],0.9878195006594496
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PFDN6,Prefoldin subunit 6,2119,101,0.87 [0.60-1.25],0.4517332149376446
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",2477,123,0.97 [0.79-1.20],0.788530633750478
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PGA4,Pepsin A-4,2174,105,1.35 [1.10-1.66],0.0046056330184622
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PGD,"6-phosphogluconate dehydrogenase, decarboxylating",2168,106,1.11 [0.79-1.56],0.5569203574002077
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PGF,Placenta growth factor,2530,124,5.29 [3.57-7.83],1.0219063080096951e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PGLYRP1,Peptidoglycan recognition protein 1,2520,124,1.90 [1.41-2.55],2.391575897780241e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PGLYRP2,N-acetylmuramoyl-L-alanine amidase,2144,103,1.40 [0.72-2.72],0.321103145457188
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PGLYRP4,Peptidoglycan recognition protein 4,2105,101,1.21 [0.87-1.67],0.2651085144702182
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PGM2,Phosphoglucomutase-2,2119,101,0.89 [0.62-1.28],0.5397447446133081
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PGR,Progesterone receptor,2106,103,1.17 [1.00-1.37],0.0452487215501826
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PHACTR2,Phosphatase and actin regulator 2,2162,104,0.97 [0.82-1.15],0.7159231401546093
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PHLDB1,Pleckstrin homology-like domain family B member 1,2165,101,2.26 [1.63-3.12],8.911001151073577e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PHLDB2,Pleckstrin homology-like domain family B member 2,2087,102,0.94 [0.76-1.18],0.6079524353378436
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,2476,122,2.75 [1.67-4.53],7.314922451610422e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,2132,103,1.00 [0.66-1.53],0.9979044579726084
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PI16,Peptidase inhibitor 16,2174,105,2.22 [1.04-4.75],0.0386919155009307
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PI3,Elafin,2465,121,1.61 [1.32-1.97],3.182416831638632e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",2162,104,0.92 [0.72-1.18],0.5034876715627663
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PIGR,Polymeric immunoglobulin receptor,2470,120,2.53 [1.86-3.43],2.467569107397332e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,2500,123,0.78 [0.60-1.02],0.0746772575067671
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,2505,122,5.25 [3.70-7.45],1.569803621794102e-20
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,2106,103,1.07 [0.76-1.50],0.6958950305560953
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PILRA,Paired immunoglobulin-like type 2 receptor alpha,2505,122,3.06 [2.12-4.42],2.489218508508397e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PILRB,Paired immunoglobulin-like type 2 receptor beta,2498,123,2.12 [1.57-2.88],1.330643195249901e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,2132,103,0.99 [0.76-1.30],0.9702268343575244
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PITHD1,PITH domain-containing protein 1,2084,102,1.07 [0.87-1.32],0.5129046120417586
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PKD1,Polycystin-1,2168,106,4.55 [2.48-8.35],1.00011508206784e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PKD2,Polycystin-2,2105,101,1.31 [0.97-1.77],0.0814198658981521
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PKLR,Pyruvate kinase PKLR,2502,121,0.81 [0.63-1.05],0.1109105182372862
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PKN3,Serine/threonine-protein kinase N3,2135,102,0.99 [0.76-1.28],0.9117971832136076
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PLA2G10,Group 10 secretory phospholipase A2,2476,122,1.57 [1.18-2.07],0.0017449900726955
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PLA2G15,Phospholipase A2 group XV,2497,124,2.20 [1.32-3.68],0.0025717033801359
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PLA2G1B,Phospholipase A2,2528,124,1.11 [0.82-1.51],0.5016646192935634
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PLA2G2A,"Phospholipase A2, membrane associated",2496,121,1.34 [1.07-1.68],0.0105968139889274
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PLA2G4A,Cytosolic phospholipase A2,2510,121,1.03 [0.86-1.23],0.7647980832994452
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PLA2G7,Platelet-activating factor acetylhydrolase,2505,122,0.55 [0.37-0.82],0.0037677483625011
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PLAT,Tissue-type plasminogen activator,2525,124,0.88 [0.66-1.18],0.3877010142059941
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PLAU,Urokinase-type plasminogen activator,2505,122,1.17 [0.71-1.92],0.5476285432547193
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PLAUR,Urokinase plasminogen activator surface receptor,2488,121,5.36 [3.50-8.21],1.136772149952277e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PLB1,"Phospholipase B1, membrane-associated",2160,104,0.59 [0.43-0.81],0.0010890823865328
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",2106,103,0.85 [0.51-1.41],0.5284905545146391
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",2160,104,0.98 [0.81-1.19],0.8536682493312648
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PLEKHO1,Pleckstrin homology domain-containing family O member 1,2160,104,1.12 [0.86-1.45],0.394262361259474
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PLG,Plasminogen,2120,103,2.10 [0.93-4.73],0.074158931997768
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PLIN1,Perilipin-1,2431,119,1.33 [0.90-1.98],0.1536847877034657
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PLIN3,Perilipin-3,2498,123,1.26 [0.88-1.80],0.2120298054662728
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PLPBP,Pyridoxal phosphate homeostasis protein,2498,123,0.87 [0.69-1.11],0.2715627883190374
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PLSCR3,Phospholipid scramblase 3,2155,103,1.31 [0.93-1.84],0.1269342712339313
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PLTP,Phospholipid transfer protein,2520,123,1.02 [0.68-1.52],0.923607954760081
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PLXDC1,Plexin domain-containing protein 1,2421,119,1.27 [0.81-1.99],0.292469172169892
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PLXDC2,Plexin domain-containing protein 2,2160,104,1.93 [1.12-3.31],0.0172042221311141
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PLXNA4,Plexin-A4,2500,123,1.06 [0.87-1.29],0.5734962730848087
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PLXNB2,Plexin-B2,2521,122,5.44 [3.59-8.23],1.2488114390724325e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PLXNB3,Plexin-B3,2490,123,1.06 [0.76-1.49],0.7380258116082261
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,2489,123,0.97 [0.90-1.05],0.4593254290257699
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PMCH,Pro-MCH,2105,101,1.13 [0.92-1.40],0.2474943455403875
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PMM2,Phosphomannomutase 2,2105,101,1.00 [0.72-1.39],0.9946653688859244
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PMS1,PMS1 protein homolog 1,2119,101,1.20 [0.85-1.70],0.294044800624496
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PMVK,Phosphomevalonate kinase,2430,119,0.98 [0.85-1.14],0.7964405733986694
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PNLIP,Pancreatic triacylglycerol lipase,2174,105,0.94 [0.74-1.19],0.5816184354544653
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PNLIPRP1,Inactive pancreatic lipase-related protein 1,2160,104,1.04 [0.86-1.27],0.6724836034211138
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PNLIPRP2,Pancreatic lipase-related protein 2,2500,121,1.01 [0.96-1.07],0.6222589974386821
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PNMA1,Paraneoplastic antigen Ma1,2110,105,0.96 [0.69-1.33],0.7970179197191309
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PNMA2,Paraneoplastic antigen Ma2,2108,103,0.97 [0.62-1.51],0.8980134414222133
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",2444,122,1.00 [0.86-1.16],0.947998850826122
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PODXL,Podocalyxin,2479,123,1.86 [0.67-5.17],0.2349416289567669
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PODXL2,Podocalyxin-like protein 2,2497,124,2.60 [1.57-4.32],0.0002149272019443
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,POF1B,Protein POF1B,2106,103,1.81 [1.33-2.46],0.0001705909785578
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,POLR2A,DNA-directed RNA polymerase II subunit RPB1,2106,103,0.96 [0.49-1.86],0.892949776381739
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",2479,123,1.59 [1.17-2.16],0.002892024969236
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,POMC,Pro-opiomelanocortin,2110,105,0.97 [0.75-1.24],0.785465104859535
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PON1,Serum paraoxonase/arylesterase 1,2174,105,0.50 [0.26-0.95],0.0332303506508389
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PON2,Serum paraoxonase/arylesterase 2,2451,119,1.07 [0.69-1.65],0.7571756417755284
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PON3,Serum paraoxonase/lactonase 3,2510,121,0.64 [0.41-1.00],0.0525380259676756
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,POSTN,Periostin,2175,103,1.32 [0.82-2.15],0.2546100979722235
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PPBP,Platelet basic protein,2156,104,1.15 [0.92-1.45],0.2154297591973216
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PPCDC,Phosphopantothenoylcysteine decarboxylase,2516,124,0.88 [0.63-1.24],0.4662602790236451
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PPIB,Peptidyl-prolyl cis-trans isomerase B,2502,122,1.04 [0.88-1.23],0.6301418208163733
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PPIE,Peptidyl-prolyl cis-trans isomerase E,2135,102,1.37 [1.10-1.71],0.0055939087659817
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",2175,103,0.85 [0.61-1.18],0.3269466226435047
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PPL,Periplakin,2106,103,1.41 [0.82-2.42],0.2167621137703108
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PPM1A,Protein phosphatase 1A,2421,119,0.78 [0.45-1.35],0.3688573845354662
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PPM1B,Protein phosphatase 1B,2106,103,0.90 [0.62-1.31],0.5725296762984617
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PPM1F,Protein phosphatase 1F,2168,106,0.97 [0.68-1.39],0.8733935690264283
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PPME1,Protein phosphatase methylesterase 1,2479,123,0.87 [0.67-1.13],0.2936611070120123
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,2161,104,0.88 [0.70-1.12],0.3036762620160236
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,2497,124,0.97 [0.83-1.15],0.7424429238853183
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,2135,102,1.05 [0.82-1.35],0.6887493220867107
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,2162,104,0.94 [0.73-1.20],0.6110644321545089
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,2162,104,1.92 [1.40-2.63],5.0189356566319456e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PPP1R2,Protein phosphatase inhibitor 2,2498,123,1.01 [0.82-1.23],0.9390007721231922
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PPP1R9B,Neurabin-2,2530,124,1.09 [0.93-1.29],0.2895273969888062
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,2165,101,0.99 [0.85-1.16],0.9266665984602054
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PPP3R1,Calcineurin subunit B type 1,2476,122,1.36 [0.94-1.99],0.1056756815107907
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PPT1,Palmitoyl-protein thioesterase 1,2119,101,1.14 [0.90-1.44],0.2705371826153759
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PPY,Pancreatic prohormone,2487,123,1.26 [1.10-1.45],0.0012840592915698
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PQBP1,Polyglutamine-binding protein 1,2421,119,1.11 [0.85-1.45],0.4482826943227305
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PRAME,Melanoma antigen preferentially expressed in tumors,2087,102,0.86 [0.39-1.90],0.7089580555609079
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PRAP1,Proline-rich acidic protein 1,2175,103,4.84 [2.87-8.17],3.597145537345494e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PRC1,Protein regulator of cytokinesis 1,2161,104,0.74 [0.43-1.28],0.2862659326027559
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PRCP,Lysosomal Pro-X carboxypeptidase,2516,124,2.29 [1.54-3.39],3.7617814207910745e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PRDX1,Peroxiredoxin-1,2421,119,0.91 [0.76-1.10],0.3445765534589849
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PRDX2,Peroxiredoxin-2,2142,104,0.80 [0.59-1.10],0.1729114559575578
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",2444,122,1.23 [1.00-1.52],0.0536810111479953
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PRDX5,"Peroxiredoxin-5, mitochondrial",2530,124,0.94 [0.73-1.20],0.604974679243627
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PRDX6,Peroxiredoxin-6,2516,125,0.92 [0.71-1.19],0.52527048433848
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PREB,Prolactin regulatory element-binding protein,2444,122,2.38 [1.65-3.43],3.4809530255523027e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PRELP,Prolargin,2500,121,5.84 [3.50-9.73],1.2755810605705735e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PRG2,Bone marrow proteoglycan,2175,103,2.21 [1.60-3.07],1.8702627678418888e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PRG3,Proteoglycan 3,2175,103,1.66 [1.15-2.40],0.0073449295830382
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PRKAB1,5'-AMP-activated protein kinase subunit beta-1,2444,122,1.22 [0.93-1.61],0.1589269326783601
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,2119,101,0.83 [0.46-1.53],0.5576349971622004
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,2498,123,0.95 [0.79-1.15],0.6158306395563615
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,2158,104,1.10 [0.85-1.42],0.4537561251502418
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PRKCQ,Protein kinase C theta type,2444,122,1.31 [0.97-1.77],0.0732528482397255
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PRKD2,Serine/threonine-protein kinase D2,2105,101,1.32 [0.90-1.93],0.1594270791896703
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PRKG1,cGMP-dependent protein kinase 1,2132,103,0.94 [0.80-1.09],0.3818172336687468
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,2421,119,1.19 [0.94-1.50],0.1442759075054112
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PRL,Prolactin,2516,124,1.11 [0.91-1.35],0.3043537141779298
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PRND,Prion-like protein doppel,2160,104,1.38 [0.98-1.94],0.0689941350226168
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PROC,Vitamin K-dependent protein C,2503,122,0.72 [0.39-1.31],0.2784611311286977
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PROCR,Endothelial protein C receptor,2105,101,1.27 [0.72-2.26],0.4103592777012281
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PROK1,Prokineticin-1,2500,123,1.18 [0.88-1.58],0.2661919388097139
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PROS1,Vitamin K-dependent protein S,2171,104,0.54 [0.28-1.06],0.0727159551477762
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PRR4,Proline-rich protein 4,2115,103,1.11 [0.86-1.44],0.4035398329440981
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PRR5,Proline-rich protein 5,2106,103,0.99 [0.68-1.44],0.954363961797912
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PRRT3,Proline-rich transmembrane protein 3,2110,105,2.08 [1.44-3.01],9.248172782831804e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PRSS2,Trypsin-2,2503,122,1.31 [1.07-1.62],0.0108870605482525
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PRSS22,Brain-specific serine protease 4,2106,103,1.80 [1.24-2.62],0.0021749144351699
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PRSS27,Serine protease 27,2493,123,2.04 [1.40-2.98],0.0002283953048118
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PRSS53,Serine protease 53,2160,104,0.73 [0.46-1.16],0.1859822296719331
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PRSS8,Prostasin,2488,120,3.81 [2.71-5.36],1.6449749637287505e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,2431,119,0.96 [0.84-1.11],0.6168506877573978
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PRTG,Protogenin,2516,125,3.53 [1.96-6.33],2.43346108886298e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PRTN3,Myeloblastin,2441,120,1.20 [0.90-1.61],0.21124003112599
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PRUNE2,Protein prune homolog 2,2135,102,0.79 [0.41-1.53],0.48512999088393
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PSAP,Prosaposin,2159,103,4.81 [2.66-8.71],2.0514121913654721e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PSAPL1,Proactivator polypeptide-like 1,2165,101,1.27 [0.90-1.80],0.1798804450505359
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PSCA,Prostate stem cell antigen,2165,101,1.05 [0.98-1.13],0.1917917416622898
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PSG1,Pregnancy-specific beta-1-glycoprotein 1,2476,122,1.46 [1.24-1.72],6.638723806739006e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PSIP1,PC4 and SFRS1-interacting protein,2500,123,0.99 [0.77-1.26],0.9261464474303898
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PSMA1,Proteasome subunit alpha type-1,2421,119,1.12 [0.79-1.61],0.5201024152716868
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PSMC3,26S proteasome regulatory subunit 6A,2087,102,0.57 [0.30-1.09],0.0872654611911446
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PSMD1,26S proteasome non-ATPase regulatory subunit 1,2162,104,1.28 [0.91-1.80],0.1520638334042473
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PSMD5,26S proteasome non-ATPase regulatory subunit 5,2119,101,1.22 [0.88-1.68],0.2286551270967082
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PSMD9,26S proteasome non-ATPase regulatory subunit 9,2479,123,0.71 [0.53-0.97],0.0286254554527405
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PSME1,Proteasome activator complex subunit 1,2474,122,1.03 [0.66-1.61],0.8982416778863949
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PSME2,Proteasome activator complex subunit 2,2462,118,1.11 [0.70-1.75],0.6568785313229188
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PSMG3,Proteasome assembly chaperone 3,2500,123,0.83 [0.60-1.15],0.2621639687330777
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PSMG4,Proteasome assembly chaperone 4,2106,103,1.02 [0.73-1.42],0.9073565555011056
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PSPN,Persephin,2500,123,1.10 [0.92-1.31],0.2783476867315345
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PSRC1,Proline/serine-rich coiled-coil protein 1,2421,119,1.12 [0.87-1.45],0.3714298158527713
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,2065,99,0.95 [0.80-1.14],0.5814026409144994
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",2431,119,1.11 [0.66-1.87],0.6818913644330207
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PTGDS,Prostaglandin-H2 D-isomerase,2479,122,2.84 [2.11-3.82],6.414344259084166e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PTGES2,Prostaglandin E synthase 2,2092,102,0.88 [0.61-1.26],0.4830617660529998
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PTGR1,Prostaglandin reductase 1,2168,106,0.93 [0.76-1.13],0.4601339304153234
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PTH,Parathyroid hormone,2119,101,1.10 [0.89-1.36],0.3927537403440658
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,2500,123,1.49 [1.14-1.94],0.0030287811118796
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PTK7,Inactive tyrosine-protein kinase 7,2431,119,2.07 [1.39-3.10],0.0003623283147683
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PTN,Pleiotrophin,2451,119,1.18 [0.86-1.62],0.3105193093880678
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PTP4A3,Protein tyrosine phosphatase type IVA 3,2106,103,1.17 [0.82-1.66],0.3966909868654266
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,2476,122,1.13 [0.93-1.39],0.22555891655354
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PTPN6,Tyrosine-protein phosphatase non-receptor type 6,2509,121,1.00 [0.83-1.19],0.974834375008479
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PTPN9,Tyrosine-protein phosphatase non-receptor type 9,2103,103,1.43 [0.99-2.09],0.0594219791050538
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PTPRB,Receptor-type tyrosine-protein phosphatase beta,2168,106,1.14 [0.63-2.05],0.6664868139425966
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PTPRC,Receptor-type tyrosine-protein phosphatase C,2175,103,3.29 [1.51-7.18],0.002725255278506
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PTPRF,Receptor-type tyrosine-protein phosphatase F,2530,124,2.62 [1.56-4.38],0.0002647327164123
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PTPRH,Receptor-type tyrosine-protein phosphatase H,2165,101,1.94 [1.48-2.54],1.4760995643246153e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PTPRK,Receptor-type tyrosine-protein phosphatase kappa,2165,101,1.70 [0.78-3.69],0.1820461041919976
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PTPRM,Receptor-type tyrosine-protein phosphatase mu,2494,122,1.95 [1.05-3.62],0.0339061698634921
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,2467,121,2.76 [1.85-4.13],6.357508492193632e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PTPRR,Receptor-type tyrosine-protein phosphatase R,2160,104,1.30 [0.84-2.03],0.240869541914528
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PTPRS,Receptor-type tyrosine-protein phosphatase S,2530,124,1.88 [1.07-3.32],0.0294014873813805
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,2168,106,1.17 [0.65-2.08],0.60171992037551
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,2132,103,0.82 [0.59-1.14],0.2293820190657592
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PTS,6-pyruvoyl tetrahydrobiopterin synthase,2422,117,0.97 [0.75-1.24],0.7821853727747703
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PTTG1,Securin,2135,102,0.68 [0.40-1.15],0.147552394534067
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PTX3,Pentraxin-related protein PTX3,2500,123,1.95 [1.30-2.91],0.0011262765737267
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PVALB,Parvalbumin alpha,2506,125,1.11 [0.96-1.29],0.150909335733068
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PVR,Poliovirus receptor,2516,124,2.07 [1.50-2.86],1.0709139741386298e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PXDNL,Peroxidasin-like protein,2161,104,1.02 [0.72-1.44],0.9237095482650942
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PXN,Paxillin,2431,119,1.18 [0.88-1.58],0.2701590199028835
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PYDC1,Pyrin domain-containing protein 1,2110,105,1.15 [0.72-1.82],0.5661114978415754
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PYY,Peptide YY,2105,101,1.35 [1.16-1.58],0.0001043027663191
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PZP,Pregnancy zone protein,2171,104,1.02 [0.62-1.67],0.9425572214903044
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,QDPR,Dihydropteridine reductase,2487,123,0.78 [0.52-1.15],0.2024812291274624
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,QPCT,Glutaminyl-peptide cyclotransferase,2504,124,6.13 [3.55-10.58],7.173849784209059e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,QSOX1,Sulfhydryl oxidase 1,2123,102,1.63 [1.17-2.27],0.003857526673785
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RAB10,Ras-related protein Rab-10,2168,106,0.82 [0.57-1.18],0.2837200442456438
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RAB11FIP3,Rab11 family-interacting protein 3,2168,106,1.01 [0.85-1.20],0.8924347844364686
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RAB27B,Ras-related protein Rab-27B,2168,106,0.95 [0.76-1.19],0.6369317069370124
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RAB2B,Ras-related protein Rab-2B,2161,104,0.89 [0.65-1.23],0.4792717565722164
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RAB33A,Ras-related protein Rab-33A,2105,101,0.83 [0.62-1.12],0.2320621469543609
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RAB37,Ras-related protein Rab-37,2444,122,1.00 [0.81-1.23],0.9864038703173956
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RAB39B,Ras-related protein Rab-39B,2105,101,1.00 [0.82-1.21],0.9714818238861818
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,2108,103,1.10 [0.80-1.53],0.5570109742141383
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RAB44,Ras-related protein Rab-44,2161,104,0.97 [0.65-1.44],0.8623256917584117
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RAB6A,Ras-related protein Rab-6A,2500,123,0.64 [0.46-0.89],0.00763871490617
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RAB6B,Ras-related protein Rab-6B,2431,119,1.16 [0.84-1.61],0.3683306581400262
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RABEP1,Rab GTPase-binding effector protein 1,2132,103,0.96 [0.74-1.23],0.7307078859116458
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RABEPK,Rab9 effector protein with kelch motifs,2421,119,1.01 [0.76-1.34],0.9427783979742982
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RABGAP1L,Rab GTPase-activating protein 1-like,2444,122,0.94 [0.71-1.23],0.6377696522131089
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RAC3,Ras-related C3 botulinum toxin substrate 3,2119,101,1.22 [0.96-1.56],0.1067548349168944
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RAD23B,UV excision repair protein RAD23 homolog B,2421,119,1.27 [0.92-1.73],0.1421978785095475
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RAD51,DNA repair protein RAD51 homolog 1,2135,102,0.94 [0.62-1.45],0.7920323438337715
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RALB,Ras-related protein Ral-B,2106,103,0.88 [0.46-1.68],0.7037335151402028
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RALY,RNA-binding protein Raly,2161,104,1.06 [0.72-1.56],0.776738171300604
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RANBP1,Ran-specific GTPase-activating protein,2110,105,0.84 [0.58-1.21],0.3498553922461699
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RANBP2,E3 SUMO-protein ligase RanBP2,2108,103,0.87 [0.48-1.61],0.666465132581743
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RANGAP1,Ran GTPase-activating protein 1,2421,119,1.09 [0.79-1.49],0.6006356597854284
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RAP1A,Ras-related protein Rap-1A,2106,103,0.83 [0.59-1.15],0.2628877637106712
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RAPGEF2,Rap guanine nucleotide exchange factor 2,2135,102,1.04 [0.73-1.50],0.8131917972179927
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RARRES1,Retinoic acid receptor responder protein 1,2421,119,1.74 [1.10-2.74],0.0175109909241533
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RARRES2,Retinoic acid receptor responder protein 2,2505,122,1.83 [1.41-2.37],6.152652220974958e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RASA1,Ras GTPase-activating protein 1,2431,119,1.17 [0.74-1.85],0.5044224518579927
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,2087,102,0.69 [0.44-1.08],0.1041056027830753
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RASSF2,Ras association domain-containing protein 2,2421,119,1.19 [0.95-1.50],0.1204753643531449
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RBFOX3,RNA binding protein fox-1 homolog 3,2162,104,3.63 [2.55-5.18],1.0154147520228249e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RBKS,Ribokinase,2438,120,0.65 [0.48-0.88],0.0062389183933518
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RBM17,Splicing factor 45,2162,104,1.00 [0.78-1.29],0.991289311292194
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RBM19,Probable RNA-binding protein 19,2105,101,1.28 [0.85-1.92],0.2316132954075503
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RBM25,RNA-binding protein 25,2087,102,1.02 [0.67-1.56],0.9164920848981456
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RBP1,Retinol-binding protein 1,2119,101,1.06 [0.82-1.38],0.6399655713218542
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RBP2,Retinol-binding protein 2,2479,123,1.55 [1.31-1.84],3.548401493893777e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RBP5,Retinol-binding protein 5,2479,123,1.35 [1.06-1.71],0.0157614954127207
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RBP7,Retinoid-binding protein 7,2165,101,1.41 [1.10-1.80],0.006297088555858
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RBPMS,RNA-binding protein with multiple splicing,2106,103,0.83 [0.57-1.20],0.324521393327058
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RBPMS2,RNA-binding protein with multiple splicing 2,2110,105,1.06 [0.88-1.27],0.5418173777683322
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RCC1,Regulator of chromosome condensation,2161,104,1.02 [0.69-1.50],0.9300692573794562
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RCOR1,REST corepressor 1,2451,119,0.90 [0.60-1.35],0.6084114446205422
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,2110,105,2.82 [1.23-6.48],0.0144540895707376
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,REEP4,Receptor expression-enhancing protein 4,2162,104,1.10 [0.83-1.46],0.5024343953476218
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,REG1A,Lithostathine-1-alpha,2480,122,2.59 [2.08-3.23],2.923975053413341e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,REG1B,Lithostathine-1-beta,2530,124,1.94 [1.56-2.42],3.466090455359307e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,REG3A,Regenerating islet-derived protein 3-alpha,2530,124,1.90 [1.55-2.33],7.276459007165235e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,REG3G,Regenerating islet-derived protein 3-gamma,2161,104,0.63 [0.38-1.05],0.0789077530025946
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,REG4,Regenerating islet-derived protein 4,2505,121,2.91 [2.29-3.70],2.5238312731319992e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RELB,Transcription factor RelB,2106,103,0.88 [0.57-1.37],0.5788921524973623
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RELT,Tumor necrosis factor receptor superfamily member 19L,2505,122,3.72 [2.45-5.63],6.116403300930237e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,REN,Renin,2498,123,1.88 [1.64-2.15],1.1268161191977877e-19
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,REPS1,RalBP1-associated Eps domain-containing protein 1,2106,103,0.86 [0.50-1.48],0.5872368133527365
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,REST,RE1-silencing transcription factor,2087,102,0.86 [0.49-1.51],0.6084095788860779
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RET,Proto-oncogene tyrosine-protein kinase receptor Ret,2479,123,1.34 [0.89-2.02],0.1663104158403086
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RETN,Resistin,2499,123,1.92 [1.42-2.59],1.8007303597714384e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,REXO2,"Oligoribonuclease, mitochondrial",2105,101,0.96 [0.61-1.53],0.8699400075669642
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RFC4,Replication factor C subunit 4,2161,104,1.02 [0.44-2.38],0.95414086533526
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RGCC,Regulator of cell cycle RGCC,2162,104,0.92 [0.71-1.17],0.4834987848511544
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RGL2,Ral guanine nucleotide dissociation stimulator-like 2,2135,102,1.07 [0.79-1.45],0.6657946614477875
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RGMA,Repulsive guidance molecule A,2516,124,1.62 [1.02-2.59],0.0412982745997209
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RGMB,RGM domain family member B,2516,124,3.03 [1.90-4.84],3.383307141928859e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RGS10,Regulator of G-protein signaling 10,2162,104,0.94 [0.68-1.30],0.7270400521042412
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RGS8,Regulator of G-protein signaling 8,2444,122,1.15 [0.93-1.43],0.195978830540547
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RHOC,Rho-related GTP-binding protein RhoC,2465,122,1.05 [0.91-1.20],0.5179306903601297
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RICTOR,Rapamycin-insensitive companion of mTOR,2106,103,0.69 [0.40-1.18],0.1711424719719899
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RIDA,2-iminobutanoate/2-iminopropanoate deaminase,2132,103,1.29 [0.94-1.77],0.1185971891761884
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RILP,Rab-interacting lysosomal protein,2511,125,0.85 [0.65-1.11],0.2294528044114341
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RILPL2,RILP-like protein 2,2168,106,0.98 [0.81-1.19],0.850047568939807
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RIPK4,Receptor-interacting serine/threonine-protein kinase 4,2105,101,1.04 [0.79-1.36],0.7995011178781559
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RLN1,Prorelaxin H1,2162,104,0.94 [0.55-1.60],0.8181499826899529
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RLN2,Prorelaxin H2,2127,103,1.08 [0.77-1.51],0.6511319250872898
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RNASE1,Ribonuclease pancreatic,2174,105,4.75 [2.98-7.56],5.4635001869690556e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RNASE10,Inactive ribonuclease-like protein 10,2110,105,1.92 [1.46-2.52],2.2936849665035395e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RNASE3,Eosinophil cationic protein,2489,123,1.02 [0.89-1.17],0.8052206858175344
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RNASE4,Ribonuclease 4,2095,98,4.39 [2.75-6.98],4.6563512834040647e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RNASE6,Ribonuclease K6,2157,104,2.15 [1.65-2.80],1.341000731495248e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RNASEH2A,Ribonuclease H2 subunit A,2162,104,0.88 [0.57-1.35],0.5563971511554291
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RNASET2,Ribonuclease T2,2522,124,7.43 [4.69-11.76],1.141460746452154e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RNF149,E3 ubiquitin-protein ligase RNF149,2110,105,4.49 [2.86-7.04],6.366610615231447e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RNF168,E3 ubiquitin-protein ligase RNF168,2106,103,0.85 [0.50-1.44],0.5417847651450068
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RNF31,E3 ubiquitin-protein ligase RNF31,2106,103,1.10 [0.71-1.71],0.656215754965452
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RNF4,E3 ubiquitin-protein ligase RNF4,2135,102,0.81 [0.57-1.16],0.2522767717979012
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RNF41,E3 ubiquitin-protein ligase NRDP1,2421,119,1.06 [0.83-1.36],0.6253223129611285
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RNF43,E3 ubiquitin-protein ligase RNF43,2135,102,1.13 [0.83-1.53],0.4394540024595137
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RNF5,E3 ubiquitin-protein ligase RNF5,2110,105,0.82 [0.63-1.06],0.1248303005182085
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ROBO1,Roundabout homolog 1,2505,121,2.24 [1.29-3.87],0.0039302640142751
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ROBO2,Roundabout homolog 2,2516,124,1.62 [0.87-3.00],0.128731242380999
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ROBO4,Roundabout homolog 4,2110,105,4.42 [1.59-12.31],0.0044892245492425
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,2498,123,2.18 [1.41-3.36],0.0004396929563887
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RP2,Protein XRP2,2479,123,1.20 [0.87-1.67],0.2659207580512907
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RPA2,Replication protein A 32 kDa subunit,2106,103,0.72 [0.38-1.38],0.3259037557628987
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RPE,Ribulose-phosphate 3-epimerase,2135,102,0.82 [0.61-1.09],0.1721923936425222
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RPGR,X-linked retinitis pigmentosa GTPase regulator,2119,101,0.65 [0.38-1.10],0.1070831229940121
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RPL14,60S ribosomal protein L14,2110,105,0.71 [0.41-1.24],0.2264252227704844
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RPS10,40S ribosomal protein S10,2105,101,1.15 [0.71-1.87],0.5763410877517672
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RRAS,Ras-related protein R-Ras,2119,101,1.02 [0.88-1.19],0.7606343468743897
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RRM2,Ribonucleoside-diphosphate reductase subunit M2,2421,119,1.19 [0.89-1.58],0.2428705563203965
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,2421,119,1.24 [0.98-1.56],0.0758510284757884
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RRP15,RRP15-like protein,2108,103,0.99 [0.80-1.24],0.9523626714098584
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RSPO1,R-spondin-1,2476,122,2.93 [1.84-4.67],5.5812050092501296e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RSPO3,R-spondin-3,2516,125,3.25 [2.16-4.90],1.860729125279312e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RTBDN,Retbindin,2479,123,2.55 [1.56-4.17],0.0002008056387986
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RTKN2,Rhotekin-2,2105,101,1.22 [0.90-1.66],0.20216268423992
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",2162,104,0.96 [0.78-1.18],0.7085457379346761
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RTN4R,Reticulon-4 receptor,2516,125,4.32 [2.98-6.26],1.2364273545959686e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RUVBL1,RuvB-like 1,2421,119,1.14 [0.99-1.32],0.0736094605532242
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RWDD1,RWD domain-containing protein 1,2516,124,0.99 [0.77-1.29],0.9549746575169924
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RYR1,Ryanodine receptor 1,2105,101,1.11 [0.70-1.75],0.660456712422893
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,S100A11,Protein S100-A11,2471,121,0.86 [0.60-1.23],0.4118141756245166
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,S100A12,Protein S100-A12,2452,123,0.98 [0.79-1.22],0.8689661466723552
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,S100A13,Protein S100-A13,2106,103,1.26 [0.78-2.04],0.3435769043693202
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,S100A14,Protein S100-A14,2162,104,0.61 [0.41-0.93],0.0201431508183155
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,S100A16,Protein S100-A16,2426,119,0.78 [0.59-1.04],0.0883908130941103
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,S100A3,Protein S100-A3,2161,104,1.28 [0.99-1.66],0.0579541579130245
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,S100A4,Protein S100-A4,2497,124,0.78 [0.59-1.02],0.0722215825134094
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,S100G,Protein S100-G,2162,104,1.07 [0.75-1.52],0.7065395939372056
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,S100P,Protein S100-P,2451,119,1.35 [1.10-1.66],0.004624262024691
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SAA4,Serum amyloid A-4 protein,2171,104,0.50 [0.19-1.36],0.1764413272805084
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SAFB2,Scaffold attachment factor B2,2162,104,0.87 [0.41-1.84],0.7091373387434186
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SAG,S-arrestin,2108,103,1.24 [0.83-1.86],0.2847572286865856
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SAMD9L,Sterile alpha motif domain-containing protein 9-like,2500,123,1.12 [0.90-1.40],0.2983710559527023
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SAP18,Histone deacetylase complex subunit SAP18,2135,102,1.13 [0.89-1.44],0.2995046411981417
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SARG,Specifically androgen-regulated gene protein,2162,106,1.06 [0.90-1.25],0.4933829166873058
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SART1,U4/U6.U5 tri-snRNP-associated protein 1,2105,101,1.35 [0.89-2.03],0.1530552364947123
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SAT1,Diamine acetyltransferase 1,2105,101,0.79 [0.48-1.28],0.3304769438676695
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SAT2,Thialysine N-epsilon-acetyltransferase,2135,102,1.07 [0.83-1.36],0.6094814317609084
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SATB1,DNA-binding protein SATB1,2162,104,0.78 [0.37-1.65],0.524193737008502
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SBSN,Suprabasin,2172,103,1.54 [0.95-2.50],0.077755470596065
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SCAMP3,Secretory carrier-associated membrane protein 3,2479,123,1.14 [0.94-1.37],0.1784767034790578
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SCARA5,Scavenger receptor class A member 5,2516,124,4.81 [3.18-7.28],1.0749664816464425e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SCARB1,Scavenger receptor class B member 1,2431,119,1.53 [1.27-1.85],9.65071754264016e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SCARB2,Lysosome membrane protein 2,2427,121,4.22 [3.17-5.63],8.127937006605724e-23
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SCARF1,Scavenger receptor class F member 1,2530,124,2.11 [1.51-2.96],1.4335289124356674e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SCARF2,Scavenger receptor class F member 2,2516,124,4.62 [3.35-6.37],8.067987225126161e-21
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SCG2,Secretogranin-2,2507,125,5.16 [3.54-7.53],1.722569096479107e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SCG3,Secretogranin-3,2505,121,1.69 [1.07-2.68],0.0252820143233642
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SCGB1A1,Uteroglobin,2500,121,1.95 [1.44-2.63],1.4368433557802476e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SCGB2A2,Mammaglobin-A,2105,101,0.92 [0.45-1.88],0.8200264513595636
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SCGB3A1,Secretoglobin family 3A member 1,2132,103,2.02 [1.00-4.07],0.0491335203719936
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SCGB3A2,Secretoglobin family 3A member 2,2509,121,1.24 [1.07-1.45],0.0048666013961284
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SCGN,Secretagogin,2444,122,2.26 [1.72-2.98],6.414187309793272e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SCIN,Adseverin,2108,103,0.81 [0.61-1.09],0.1605319994099695
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SCLY,Selenocysteine lyase,2511,125,0.89 [0.65-1.20],0.43308646990636
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SCN2A,Sodium channel protein type 2 subunit alpha,2108,103,1.20 [0.84-1.71],0.3130979619607014
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SCN2B,Sodium channel subunit beta-2,2119,101,0.81 [0.39-1.69],0.573928848011508
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SCN3A,Sodium channel protein type 3 subunit alpha,2119,101,0.68 [0.37-1.27],0.2238417817628336
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SCN3B,Sodium channel subunit beta-3,2108,103,1.02 [0.65-1.59],0.9373622492819568
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SCN4B,Sodium channel subunit beta-4,2110,105,1.89 [1.37-2.61],0.0001008725463467
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SCP2,Non-specific lipid-transfer protein,2421,119,0.99 [0.78-1.26],0.9420526690457124
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SCPEP1,Retinoid-inducible serine carboxypeptidase,2105,105,1.09 [0.74-1.59],0.6661803559599132
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SCRG1,Scrapie-responsive protein 1,2168,106,2.27 [1.30-3.98],0.0040589291128304
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SCRIB,Protein scribble homolog,2110,105,1.09 [0.89-1.32],0.4204375616625156
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SCRN1,Secernin-1,2500,123,1.11 [0.83-1.49],0.4619542498855684
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SCT,Secretin,2119,101,1.42 [1.00-2.03],0.0511664073671991
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SDC1,Syndecan-1,2498,123,1.50 [1.08-2.09],0.0161306028739139
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SDC4,Syndecan-4,2498,123,0.67 [0.50-0.92],0.0120601773332142
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SDCCAG8,Serologically defined colon cancer antigen 8,2161,104,1.07 [0.90-1.26],0.447914719072396
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SDHB,Succinate dehydrogenase,2165,101,1.07 [0.78-1.46],0.6885024491591714
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SDK2,Protein sidekick-2,2132,103,1.66 [1.16-2.40],0.0061737656873994
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SEC31A,Protein transport protein Sec31A,2110,105,0.88 [0.69-1.12],0.3107421194676191
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SEL1L,Protein sel-1 homolog 1,2110,105,2.36 [1.62-3.44],7.731899128117587e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SELE,E-selectin,2530,124,1.77 [1.34-2.34],6.599513303971813e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SELENOP,Selenoprotein P,2171,104,0.87 [0.39-1.90],0.7189297118767273
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SELL,L-selectin,2171,104,1.12 [0.49-2.56],0.7910164164590403
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SELP,P-selectin,2503,122,1.23 [0.93-1.62],0.142628729180419
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SELPLG,P-selectin glycoprotein ligand 1,2500,123,1.02 [0.60-1.73],0.940699709099358
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SEMA3F,Semaphorin-3F,2498,123,3.12 [1.84-5.29],2.2700439025774457e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SEMA3G,Semaphorin-3G,2132,103,1.40 [0.99-1.99],0.0589909313812836
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SEMA4C,Semaphorin-4C,2479,123,1.50 [1.15-1.96],0.0028003804960546
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SEMA4D,Semaphorin-4D,2516,124,1.27 [0.74-2.18],0.3878273617838356
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SEMA6C,Semaphorin-6C,2106,103,0.96 [0.47-1.93],0.9006491359032998
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SEMA7A,Semaphorin-7A,2525,124,2.84 [1.89-4.25],4.40846010848029e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SEPTIN3,Neuronal-specific septin-3,2162,104,1.02 [0.82-1.29],0.838019753445061
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SEPTIN7,Septin-7,2135,102,1.31 [1.04-1.64],0.0204700461052293
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SEPTIN8,Septin-8,2153,104,3.42 [2.25-5.20],9.070565889201617e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SEPTIN9,Septin-9,2479,123,1.10 [0.65-1.87],0.7252879743667374
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SERPINA1,Alpha-1-antitrypsin,2135,104,15.08 [1.72-132.31],0.0143467664854617
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SERPINA11,Serpin A11,2530,124,1.45 [0.99-2.10],0.054361480164536
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SERPINA12,Serpin A12,2442,121,0.87 [0.75-1.02],0.0893098267750765
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SERPINA3,Alpha-1-antichymotrypsin,2163,104,5.12 [1.65-15.93],0.004776743328917
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SERPINA4,Kallistatin,2128,104,2.21 [1.01-4.84],0.0483222831396626
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SERPINA5,Plasma serine protease inhibitor,2136,104,1.31 [0.71-2.45],0.3887516976863
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SERPINA6,Corticosteroid-binding globulin,2171,104,7.71 [2.65-22.41],0.0001759829101313
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SERPINA7,Thyroxine-binding globulin,2171,104,1.32 [0.48-3.66],0.5885540613709754
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SERPINA9,Serpin A9,2471,122,0.98 [0.79-1.22],0.8719164510543651
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SERPINB1,Leukocyte elastase inhibitor,2498,122,1.00 [0.84-1.20],0.970481813498738
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SERPINB5,Serpin B5,2451,119,0.85 [0.62-1.17],0.3188025403728519
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SERPINB6,Serpin B6,2508,124,1.19 [0.91-1.57],0.2035217595410141
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SERPINB8,Serpin B8,2530,124,1.13 [0.90-1.43],0.2888838094779279
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SERPINB9,Serpin B9,2476,122,1.11 [0.67-1.83],0.6779493093178449
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SERPINC1,Antithrombin-III,2166,104,5.48 [1.66-18.09],0.0052715999368924
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SERPIND1,Heparin cofactor 2,2166,104,1.68 [0.88-3.18],0.1132072513125293
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SERPINE1,Plasminogen activator inhibitor 1,2530,124,1.12 [0.89-1.43],0.3374107686195527
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SERPINE2,Glia-derived nexin,2168,106,0.92 [0.69-1.23],0.5794526125613987
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SERPINF1,Pigment epithelium-derived factor,2139,103,4.13 [2.11-8.07],3.396364106640024e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SERPINF2,Alpha-2-antiplasmin,2126,104,1.59 [0.41-6.10],0.4984468272430802
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SERPING1,Plasma protease C1 inhibitor,2166,104,3.96 [1.54-10.20],0.0042811446079061
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SERPINH1,Serpin H1,2135,102,1.05 [0.91-1.22],0.5108604104371943
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SERPINI1,Neuroserpin,2131,102,0.66 [0.33-1.32],0.2399649190236251
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SERPINI2,Serpin I2,2165,101,0.96 [0.70-1.33],0.826504811721221
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SESTD1,SEC14 domain and spectrin repeat-containing protein 1,2431,119,1.10 [0.86-1.40],0.4510468336756984
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SETMAR,Histone-lysine N-methyltransferase SETMAR,2469,122,0.68 [0.39-1.17],0.1623698179535174
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SEZ6,Seizure protein 6 homolog,2119,101,1.26 [0.71-2.22],0.4264315412478455
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SEZ6L,Seizure 6-like protein,2497,124,3.18 [1.98-5.12],1.7456035758020451e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SEZ6L2,Seizure 6-like protein 2,2479,123,2.55 [1.54-4.21],0.0002754281274237
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SF3B4,Splicing factor 3B subunit 4,2479,123,0.99 [0.80-1.24],0.9550265103572676
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SFRP1,Secreted frizzled-related protein 1,2468,122,2.09 [1.57-2.78],4.102546831912172e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SFRP4,Secreted frizzled-related protein 4,2132,103,0.92 [0.58-1.44],0.7018394533738697
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SFTPA1,Pulmonary surfactant-associated protein A1,2421,119,1.33 [1.03-1.72],0.0270386407318533
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SFTPA2,Pulmonary surfactant-associated protein A2,2421,119,1.32 [0.99-1.77],0.0568832634176261
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SFTPD,Pulmonary surfactant-associated protein D,2498,123,1.24 [0.99-1.56],0.0635412119743474
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SGSH,N-sulphoglucosamine sulphohydrolase,2137,105,1.34 [0.98-1.82],0.0652266756510945
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SH2B3,SH2B adapter protein 3,2421,119,1.08 [0.91-1.27],0.3862372917735912
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SH2D1A,SH2 domain-containing protein 1A,2500,123,1.05 [0.80-1.38],0.703863078148223
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,2108,103,1.00 [0.73-1.37],0.9939203114449024
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SH3BP1,SH3 domain-binding protein 1,2165,101,0.88 [0.59-1.31],0.5341587051605112
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SH3GL3,Endophilin-A3,2124,102,1.15 [0.91-1.45],0.2342734091950203
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SH3GLB2,Endophilin-B2,2160,104,1.02 [0.77-1.36],0.8661477563653223
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SHBG,Sex hormone-binding globulin,2174,105,0.89 [0.62-1.27],0.5082476297296574
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SHC1,SHC-transforming protein 1,2087,102,1.02 [0.85-1.21],0.8620526105379209
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SHD,SH2 domain-containing adapter protein D,2099,101,1.13 [0.94-1.36],0.186859475628817
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SHH,Sonic hedgehog protein,2106,103,1.02 [0.67-1.56],0.921288676229948
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SHISA5,Protein shisa-5,2175,103,3.53 [2.41-5.17],9.325656595651379e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SHMT1,"Serine hydroxymethyltransferase, cytosolic",2509,121,0.93 [0.77-1.12],0.4480686497166116
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SHPK,Sedoheptulokinase,2135,102,0.80 [0.47-1.36],0.4032713973635188
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SIAE,Sialate O-acetylesterase,2494,124,1.40 [1.01-1.96],0.0457952240547939
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SIGLEC1,Sialoadhesin,2510,121,3.12 [2.24-4.36],2.238999568960829e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SIGLEC10,Sialic acid-binding Ig-like lectin 10,2500,123,2.86 [2.08-3.93],8.19744534483448e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SIGLEC15,Sialic acid-binding Ig-like lectin 15,2431,119,1.15 [0.96-1.37],0.1362450792328059
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SIGLEC5,Sialic acid-binding Ig-like lectin 5,2505,122,1.21 [1.03-1.42],0.0184710089400357
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SIGLEC6,Sialic acid-binding Ig-like lectin 6,2516,125,4.15 [2.83-6.08],2.9030475018884765e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SIGLEC7,Sialic acid-binding Ig-like lectin 7,2498,123,2.70 [1.57-4.62],0.0003135278514108
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SIGLEC8,Sialic acid-binding Ig-like lectin 8,2110,105,1.74 [1.23-2.46],0.0018473114076082
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SIGLEC9,Sialic acid-binding Ig-like lectin 9,2514,125,1.74 [1.04-2.91],0.0357199806410347
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SIL1,Nucleotide exchange factor SIL1,2110,105,1.40 [0.88-2.23],0.1542328776142069
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,2504,121,1.52 [1.11-2.08],0.0087141241869685
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SIRPB1,Signal-regulatory protein beta-1,2493,121,2.75 [2.05-3.69],1.7287263251029418e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SIRT1,NAD-dependent protein deacetylase sirtuin-1,2106,103,1.16 [0.96-1.41],0.1293106101365491
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SIRT2,NAD-dependent protein deacetylase sirtuin-2,2479,123,1.00 [0.83-1.21],0.991399617998787
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",2431,119,1.04 [0.78-1.39],0.7836718378936198
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SIT1,Signaling threshold-regulating transmembrane adapter 1,2444,122,1.39 [1.04-1.84],0.0235357172741083
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SKAP1,Src kinase-associated phosphoprotein 1,2471,121,1.04 [0.83-1.31],0.7285654302525963
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SKAP2,Src kinase-associated phosphoprotein 2,2510,121,1.01 [0.86-1.17],0.9491949349527506
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SKIV2L,Helicase SKI2W,2105,101,0.79 [0.45-1.38],0.4072358386208988
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SLA2,Src-like-adapter 2,2162,104,0.96 [0.80-1.15],0.6660068672093171
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SLAMF1,Signaling lymphocytic activation molecule,2444,122,1.94 [1.48-2.54],1.477308945648476e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SLAMF6,SLAM family member 6,2421,119,1.82 [1.28-2.61],0.0009754969376517
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SLAMF7,SLAM family member 7,2500,123,1.55 [1.20-2.00],0.0008558753322102
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SLAMF8,SLAM family member 8,2421,119,1.86 [1.40-2.46],1.698803513792434e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SLC12A2,Solute carrier family 12 member 2,2105,101,2.07 [1.01-4.25],0.0466270375194987
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SLC13A1,Solute carrier family 13 member 1,2161,104,1.05 [0.78-1.43],0.7370260154177461
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SLC16A1,Monocarboxylate transporter 1,2431,119,1.14 [0.84-1.53],0.4023445202139115
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SLC1A4,Neutral amino acid transporter A,2119,101,0.90 [0.57-1.43],0.6666706480779956
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SLC27A4,Long-chain fatty acid transport protein 4,2431,119,1.10 [0.87-1.38],0.4140450622049438
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SLC28A1,Sodium/nucleoside cotransporter 1,2087,102,1.05 [0.75-1.46],0.7883291897998933
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SLC34A3,Sodium-dependent phosphate transport protein 2C,2087,102,0.83 [0.52-1.33],0.4417715264006738
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SLC39A14,Zinc transporter ZIP14,2431,119,1.74 [1.25-2.42],0.0009971291306586
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SLC39A5,Zinc transporter ZIP5,2500,123,1.46 [1.21-1.76],9.660539612139148e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SLC44A4,Choline transporter-like protein 4,2119,101,1.03 [0.77-1.37],0.8545447244305935
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SLC4A1,Band 3 anion transport protein,2175,103,0.65 [0.42-0.99],0.045372645739839
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SLC51B,Organic solute transporter subunit beta,2105,101,0.92 [0.69-1.23],0.5673176900241432
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,2132,103,0.90 [0.71-1.13],0.3573240477990494
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,2165,101,1.01 [0.69-1.47],0.978485897973311
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",2087,102,1.01 [0.71-1.43],0.9613082969261146
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SLIT2,Slit homolog 2 protein,2431,119,1.35 [1.03-1.78],0.0290245732427028
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SLITRK1,SLIT and NTRK-like protein 1,2106,103,0.84 [0.48-1.46],0.5327375622791666
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SLITRK2,SLIT and NTRK-like protein 2,2516,125,2.65 [1.83-3.84],2.4298251529273224e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SLITRK6,SLIT and NTRK-like protein 6,2451,119,2.09 [1.40-3.10],0.0002706698668934
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SLK,STE20-like serine/threonine-protein kinase,2135,102,1.09 [0.86-1.37],0.4916214887907759
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SLMAP,Sarcolemmal membrane-associated protein,2165,101,1.24 [1.00-1.53],0.0534358567720197
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SLURP1,Secreted Ly-6/uPAR-related protein 1,2161,103,2.17 [1.35-3.48],0.0013736129824164
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SMAD1,Mothers against decapentaplegic homolog 1,2421,119,1.03 [0.85-1.24],0.7982279146640177
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SMAD2,Mothers against decapentaplegic homolog 2,2161,104,0.99 [0.75-1.29],0.9159542016845034
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SMAD3,Mothers against decapentaplegic homolog 3,2161,104,1.11 [0.78-1.59],0.570669797025569
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SMAD5,Mothers against decapentaplegic homolog 5,2479,123,0.64 [0.29-1.40],0.2605361240186036
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SMARCA2,Probable global transcription activator SNF2L2,2431,119,0.86 [0.67-1.11],0.244729967885777
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SMC3,Structural maintenance of chromosomes protein 3,2087,102,0.94 [0.63-1.40],0.7662246330515115
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SMNDC1,Survival of motor neuron-related-splicing factor 30,2165,101,0.93 [0.67-1.29],0.6661458491870711
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SMOC1,SPARC-related modular calcium-binding protein 1,2516,125,3.03 [2.01-4.59],1.4536996488434018e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SMOC2,SPARC-related modular calcium-binding protein 2,2510,121,2.98 [2.11-4.21],5.84113112965623e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SMPD1,Sphingomyelin phosphodiesterase,2507,123,1.33 [0.99-1.78],0.0592385157575414
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SMPD3,Sphingomyelin phosphodiesterase 3,2106,103,1.19 [0.89-1.61],0.2429264495949562
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,2503,121,0.99 [0.78-1.26],0.9278439615857452
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,2161,104,0.76 [0.55-1.05],0.099126926932393
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SMS,Spermine synthase,2108,103,0.86 [0.62-1.20],0.369135854161964
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SMTN,Smoothelin,2156,104,1.28 [1.07-1.54],0.0062895096578989
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SNAP23,Synaptosomal-associated protein 23,2498,123,0.98 [0.82-1.17],0.8111138337083761
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SNAP25,Synaptosomal-associated protein 25,2108,103,0.80 [0.54-1.18],0.2635982226668926
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SNAP29,Synaptosomal-associated protein 29,2497,124,1.01 [0.85-1.20],0.9151495272424748
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SNAPIN,SNARE-associated protein Snapin,2162,104,0.85 [0.61-1.17],0.3140556091761401
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SNCA,Alpha-synuclein,2132,103,0.92 [0.78-1.08],0.2964830527224729
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SNCG,Gamma-synuclein,2476,122,1.95 [1.54-2.49],4.7990409598492447e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",2110,105,1.90 [1.12-3.24],0.0180633387975919
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SNRPB2,U2 small nuclear ribonucleoprotein B'',2160,104,1.20 [0.87-1.65],0.2682078080515149
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SNU13,NHP2-like protein 1,2105,101,0.96 [0.68-1.35],0.7990239482335828
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SNX15,Sorting nexin-15,2132,103,0.88 [0.62-1.24],0.4647211487274353
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SNX18,Sorting nexin-18,2165,101,0.77 [0.46-1.29],0.3210977530129926
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SNX2,Sorting nexin-2,2161,104,1.01 [0.82-1.24],0.936137356052967
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SNX5,Sorting nexin-5,2110,105,0.93 [0.48-1.80],0.8263444416809795
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SNX9,Sorting nexin-9,2498,123,1.06 [0.84-1.33],0.6379824419215541
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SOD1,Superoxide dismutase [Cu-Zn],2447,119,0.88 [0.63-1.24],0.4643387731727726
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SOD2,"Superoxide dismutase [Mn], mitochondrial",2505,122,0.71 [0.48-1.04],0.0784882665064893
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SOD3,Extracellular superoxide dismutase,2174,105,0.85 [0.60-1.19],0.3364477463830155
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SORBS1,Sorbin and SH3 domain-containing protein 1,2162,104,1.42 [1.04-1.93],0.0266462655587999
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SORCS2,VPS10 domain-containing receptor SorCS2,2421,119,2.60 [1.87-3.59],9.011119118322986e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SORD,Sorbitol dehydrogenase,2505,124,0.82 [0.66-1.01],0.0585830817911849
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SORT1,Sortilin,2498,123,1.50 [1.02-2.21],0.0376878153390366
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SOST,Sclerostin,2498,123,1.74 [1.18-2.56],0.0047478014892335
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,2119,101,0.49 [0.28-0.87],0.0146516343683822
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SOX2,Transcription factor SOX-2,2159,104,1.08 [0.51-2.27],0.8457748895865294
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SOX9,Transcription factor SOX-9,2119,101,1.83 [0.90-3.73],0.0957166795233629
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SPACA5_SPACA5B,Sperm acrosome-associated protein 5,2162,104,1.78 [1.12-2.85],0.0155847552992824
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SPAG1,Sperm-associated antigen 1,2162,104,1.01 [0.71-1.44],0.9662143147051484
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SPARC,SPARC,2497,124,1.05 [0.84-1.32],0.6593728067147676
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SPARCL1,SPARC-like protein 1,2489,120,2.32 [1.33-4.04],0.0029057883849242
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SPART,Spartin,2132,103,1.01 [0.79-1.30],0.926912373563312
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SPESP1,Sperm equatorial segment protein 1,2168,106,1.86 [1.15-2.99],0.0108624029327703
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SPINK1,Serine protease inhibitor Kazal-type 1,2505,122,3.00 [2.33-3.85],9.62306989565304e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SPINK2,Serine protease inhibitor Kazal-type 2,2132,103,1.71 [1.08-2.71],0.0209591306537175
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SPINK4,Serine protease inhibitor Kazal-type 4,2500,123,2.33 [1.95-2.79],2.0092812421904623e-20
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SPINK5,Serine protease inhibitor Kazal-type 5,2505,122,1.98 [1.29-3.03],0.0018034092017139
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SPINK6,Serine protease inhibitor Kazal-type 6,2516,125,1.21 [0.89-1.64],0.2245564025806455
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SPINK8,Serine protease inhibitor Kazal-type 8,2105,101,1.02 [0.57-1.80],0.954942235768512
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SPINT1,Kunitz-type protease inhibitor 1,2498,122,2.84 [1.82-4.45],4.528401205934937e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SPINT2,Kunitz-type protease inhibitor 2,2510,121,2.70 [1.97-3.72],8.91901223287162e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SPINT3,Kunitz-type protease inhibitor 3,2165,101,0.99 [0.88-1.11],0.8342306196566636
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SPOCK1,Testican-1,2476,122,0.56 [0.32-0.99],0.0473672361552685
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SPON1,Spondin-1,2505,121,3.92 [2.83-5.42],1.5335661067506524e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SPON2,Spondin-2,2489,123,3.32 [2.23-4.92],2.653495865735824e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SPP1,Osteopontin,2525,124,1.60 [1.17-2.18],0.0033027235206622
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",2106,103,1.06 [0.67-1.66],0.8057825596953929
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SPRING1,SREBP regulating gene protein,2087,102,1.10 [0.82-1.48],0.5110082775764803
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SPRR1B,Cornifin-B,2135,102,0.92 [0.71-1.18],0.5176222353278795
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SPRR3,Small proline-rich protein 3,2160,104,1.44 [1.12-1.83],0.0037892607833622
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SPRY2,Protein sprouty homolog 2,2444,122,0.98 [0.83-1.17],0.8339707534965188
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SPTBN2,"Spectrin beta chain, non-erythrocytic 2",2108,103,1.12 [0.62-2.00],0.7134420574124928
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SPTLC1,Serine palmitoyltransferase 1,2160,104,0.92 [0.55-1.56],0.7696812755244281
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SRC,Proto-oncogene tyrosine-protein kinase Src,2492,123,1.01 [0.88-1.16],0.8602016506702367
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SRP14,Signal recognition particle 14 kDa protein,2479,123,1.07 [0.82-1.40],0.6279316325872921
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SRPK2,SRSF protein kinase 2,2500,123,1.06 [0.88-1.27],0.5544157578146632
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SRPX,Sushi repeat-containing protein SRPX,2168,106,3.19 [2.00-5.11],1.3061997561059575e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SSB,Lupus La protein,2431,119,0.99 [0.75-1.31],0.941138633311878
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SSBP1,"Single-stranded DNA-binding protein, mitochondrial",2106,103,0.77 [0.43-1.38],0.3851054645702358
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,2498,123,0.89 [0.79-1.00],0.0484960617870007
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,2503,122,1.19 [0.83-1.70],0.357067945249222
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SSH3,Protein phosphatase Slingshot homolog 3,2087,102,0.55 [0.27-1.15],0.1146417443429072
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SSNA1,Sjoegren syndrome nuclear autoantigen 1,2165,101,1.11 [0.77-1.61],0.5755162993844252
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ST13,Hsc70-interacting protein,2132,103,0.75 [0.53-1.06],0.1069319633493183
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",2479,123,1.79 [1.40-2.30],4.801776399188401e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",2530,124,2.62 [1.62-4.23],9.010267009591249e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",2106,103,0.95 [0.63-1.42],0.7856141951062229
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,STAB2,Stabilin-2,2175,103,1.75 [0.88-3.48],0.1109289116563323
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,STAM,Signal transducing adapter molecule 1,2161,104,1.37 [0.86-2.18],0.1862917549099063
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,STAMBP,STAM-binding protein,2471,121,1.05 [0.81-1.36],0.7096450612310126
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,STAT2,Signal transducer and activator of transcription 2,2106,103,1.03 [0.81-1.31],0.8187263144368079
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,STAT5B,Signal transducer and activator of transcription 5B,2479,123,0.98 [0.88-1.11],0.7847473009784536
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,STAU1,Double-stranded RNA-binding protein Staufen homolog 1,2087,102,1.08 [0.82-1.43],0.5818289971745899
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,STC1,Stanniocalcin-1,2516,124,2.08 [1.55-2.79],1.0007633291924631e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,STC2,Stanniocalcin-2,2500,121,4.39 [2.31-8.37],6.796726334283603e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,STEAP4,Metalloreductase STEAP4,2108,103,0.93 [0.69-1.25],0.6227171689734522
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,STIP1,Stress-induced-phosphoprotein 1,2501,122,0.92 [0.72-1.19],0.5451387550743347
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,STK11,Serine/threonine-protein kinase STK11,2451,119,1.03 [0.83-1.29],0.7795195956359983
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,STK24,Serine/threonine-protein kinase 24,2431,119,1.01 [0.77-1.32],0.9453932671494772
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,STK4,Serine/threonine-protein kinase 4,2498,123,0.87 [0.73-1.05],0.1420190524641742
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,STOML2,"Stomatin-like protein 2, mitochondrial",2087,102,0.92 [0.74-1.14],0.4350278528667785
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,STX16,Syntaxin-16,2421,119,1.32 [1.00-1.73],0.0505865101895842
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,STX1B,Syntaxin-1B,2119,101,1.24 [0.83-1.85],0.2855348906326187
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,STX3,Syntaxin-3,2160,104,0.63 [0.33-1.18],0.1449338922907923
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,STX4,Syntaxin-4,2479,123,1.19 [0.94-1.50],0.1447448145967731
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,STX5,Syntaxin-5,2106,103,1.15 [0.80-1.66],0.440864685860265
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,STX6,Syntaxin-6,2421,119,1.20 [0.96-1.50],0.1068850415024248
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,STX7,Syntaxin-7,2106,103,1.13 [0.76-1.68],0.5362118587092755
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,STX8,Syntaxin-8,2500,123,1.31 [0.96-1.80],0.0939868002725263
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,STXBP1,Syntaxin-binding protein 1,2162,104,0.91 [0.72-1.16],0.4523627291447997
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,STXBP3,Syntaxin-binding protein 3,2421,119,1.06 [0.73-1.55],0.7497963259423942
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SUGP1,SURP and G-patch domain-containing protein 1,2165,101,0.90 [0.55-1.47],0.6741722383602211
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SUGT1,Protein SGT1 homolog,2421,119,1.10 [0.89-1.36],0.3786949816008941
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SULT1A1,Sulfotransferase 1A1,2516,124,0.97 [0.85-1.09],0.5755084405136015
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SULT2A1,Bile salt sulfotransferase,2500,123,1.17 [0.95-1.44],0.138083739297029
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SUMF1,Formylglycine-generating enzyme,2106,103,0.88 [0.63-1.23],0.4597386087243672
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,2516,124,1.29 [0.93-1.78],0.1235300673169966
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SUOX,"Sulfite oxidase, mitochondrial",2162,104,1.05 [0.81-1.38],0.696714886947525
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SUSD1,Sushi domain-containing protein 1,2451,119,1.02 [0.73-1.42],0.9141121895193224
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SUSD2,Sushi domain-containing protein 2,2505,122,2.94 [1.79-4.85],2.2495470905492223e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SUSD4,Sushi domain-containing protein 4,2161,104,1.29 [0.89-1.86],0.1745794833031762
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SUSD5,Sushi domain-containing protein 5,2124,102,2.39 [1.45-3.94],0.0006534647563949
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SV2A,Synaptic vesicle glycoprotein 2A,2119,101,1.24 [0.95-1.62],0.1078773297822942
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SWAP70,Switch-associated protein 70,2165,101,1.13 [0.69-1.86],0.6174497596538941
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SYAP1,Synapse-associated protein 1,2132,103,0.90 [0.65-1.26],0.54687687789606
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,2108,103,0.84 [0.59-1.21],0.3592116871696952
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SYT1,Synaptotagmin-1,2160,104,1.09 [0.67-1.78],0.7146035905941679
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SYTL4,Synaptotagmin-like protein 4,2168,106,0.97 [0.75-1.25],0.8172650380754328
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,2135,102,1.01 [0.84-1.22],0.8816610485943581
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TACC3,Transforming acidic coiled-coil-containing protein 3,2479,123,1.01 [0.88-1.16],0.8572837938803947
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TACSTD2,Tumor-associated calcium signal transducer 2,2196,108,4.31 [2.82-6.60],1.5273748767210097e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TADA3,Transcriptional adapter 3,2161,104,1.07 [0.67-1.73],0.771582514453625
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TAFA5,Chemokine-like protein TAFA-5,2479,123,3.05 [2.27-4.08],9.605948652854793e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TAGLN3,Transgelin-3,2087,102,1.24 [0.92-1.66],0.1509031436227539
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TALDO1,Transaldolase,2170,103,1.22 [0.80-1.86],0.3606130032777099
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TANK,TRAF family member-associated NF-kappa-B activator,2444,122,1.17 [0.93-1.47],0.1727121355948208
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TAP1,Antigen peptide transporter 1,2135,102,0.93 [0.66-1.30],0.6697588763086708
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TARBP2,RISC-loading complex subunit TARBP2,2431,119,1.21 [0.99-1.49],0.069039774753729
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",2119,101,1.29 [1.05-1.57],0.013670233809859
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TARS1,"Threonine--tRNA ligase 1, cytoplasmic",2161,104,0.77 [0.45-1.31],0.3395903623419276
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TAX1BP1,Tax1-binding protein 1,2160,104,1.26 [0.95-1.67],0.1053603130782095
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TBC1D17,TBC1 domain family member 17,2431,119,0.89 [0.61-1.29],0.5447741317328373
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TBC1D23,TBC1 domain family member 23,2479,123,1.05 [0.88-1.25],0.5927671376041314
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TBC1D5,TBC1 domain family member 5,2500,123,1.11 [0.91-1.34],0.2932754248385723
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TBCA,Tubulin-specific chaperone A,2132,103,0.95 [0.75-1.20],0.6407971000278097
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TBCB,Tubulin-folding cofactor B,2476,122,1.01 [0.86-1.19],0.929377562098572
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TBCC,Tubulin-specific chaperone C,2476,122,1.02 [0.83-1.25],0.835091611152453
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TBL1X,F-box-like/WD repeat-containing protein TBL1X,2421,119,1.03 [0.85-1.25],0.7528443224440289
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TBR1,T-box brain protein 1,2119,101,0.74 [0.46-1.17],0.1954360208135855
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TCL1A,T-cell leukemia/lymphoma protein 1A,2475,121,0.81 [0.69-0.94],0.0054144893510636
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TCL1B,T-cell leukemia/lymphoma protein 1B,2451,119,0.93 [0.74-1.16],0.5103579852831135
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TCN1,Transcobalamin-1,2120,102,1.12 [0.66-1.93],0.6722643205374412
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TCN2,Transcobalamin-2,2525,124,2.81 [1.81-4.35],3.670640990483215e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TCOF1,Treacle protein,2168,106,1.79 [1.14-2.82],0.012226301834383
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TCP11,T-complex protein 11 homolog,2135,102,0.79 [0.51-1.21],0.2817328172129855
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TCTN3,Tectonic-3,2168,106,1.37 [0.77-2.44],0.2834734861852977
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TDGF1,Teratocarcinoma-derived growth factor 1,2431,119,1.09 [0.98-1.21],0.1025306043497817
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TDO2,"Tryptophan 2,3-dioxygenase",2119,101,0.87 [0.52-1.45],0.5873009884678975
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TDP1,Tyrosyl-DNA phosphodiesterase 1,2161,104,1.02 [0.79-1.32],0.8786187770250302
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TDRKH,Tudor and KH domain-containing protein,2431,119,1.10 [0.91-1.33],0.3228232039995954
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TEF,Thyrotroph embryonic factor,2105,101,0.95 [0.60-1.51],0.8405048323975052
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TEK,Angiopoietin-1 receptor,2497,124,3.22 [1.70-6.10],0.0003460600918428
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TERF1,Telomeric repeat-binding factor 1,2106,103,0.87 [0.43-1.73],0.683334981111996
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TET2,Methylcytosine dioxygenase TET2,2130,102,0.94 [0.76-1.16],0.5779458043231321
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TEX101,Testis-expressed protein 101,2119,101,1.28 [0.96-1.72],0.0961986862449232
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TEX33,Testis-expressed protein 33,2135,102,1.06 [0.70-1.60],0.799743807143574
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TF,Serotransferrin,2171,104,4.00 [1.73-9.24],0.0011792652963393
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TFAP2A,Transcription factor AP-2-alpha,2108,103,0.80 [0.55-1.16],0.2353512534704833
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TFF1,Trefoil factor 1,2493,122,1.66 [1.44-1.91],5.288088259999401e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TFF2,Trefoil factor 2,2509,121,2.23 [1.84-2.71],2.875093539564284e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TFF3,Trefoil factor 3,2482,120,2.23 [1.85-2.69],5.318071653739201e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TFPI,Tissue factor pathway inhibitor,2494,122,1.14 [0.72-1.79],0.5778741023368829
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TFPI2,Tissue factor pathway inhibitor 2,2494,124,1.46 [1.12-1.91],0.0050714417693963
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TFRC,Transferrin receptor protein 1,2502,122,1.63 [1.12-2.37],0.0104912818052647
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TG,Thyroglobulin,2161,104,1.18 [1.01-1.39],0.0425450287409515
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TGFA,Protransforming growth factor alpha,2500,123,2.02 [1.52-2.68],1.2388847004213187e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TGFB1,Transforming growth factor beta-1 proprotein,2524,124,1.94 [1.42-2.65],2.8068062042182853e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TGFB2,Transforming growth factor beta-2 proprotein,2161,104,1.03 [0.71-1.50],0.8607615704295729
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TGFBI,Transforming growth factor-beta-induced protein ig-h3,2484,122,0.79 [0.45-1.37],0.3952420759227798
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TGFBR1,TGF-beta receptor type-1,2106,103,1.64 [0.75-3.61],0.2185086377437819
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TGFBR2,TGF-beta receptor type-2,2497,124,3.09 [2.40-3.98],2.3509422033908642e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TGFBR3,Transforming growth factor beta receptor type 3,2530,124,2.78 [1.79-4.31],5.113045537048116e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TGM2,Protein-glutamine gamma-glutamyltransferase 2,2492,123,0.85 [0.69-1.05],0.1276444495662183
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TGOLN2,Trans-Golgi network integral membrane protein 2,2174,105,4.53 [2.67-7.71],2.331599492715644e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,THAP12,52 kDa repressor of the inhibitor of the protein kinase,2084,102,1.01 [0.81-1.25],0.9358414954136918
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,THBD,Thrombomodulin,2498,123,2.51 [1.72-3.65],1.5964161741332776e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,THBS2,Thrombospondin-2,2505,122,1.79 [1.36-2.37],3.861328240443335e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,THBS4,Thrombospondin-4,2499,122,1.33 [0.97-1.82],0.0798817707038041
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,THOP1,Thimet oligopeptidase,2491,123,0.53 [0.35-0.82],0.0038036875688245
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,THPO,Thrombopoietin,2451,119,1.16 [0.78-1.71],0.4653770594591021
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,THRAP3,Thyroid hormone receptor-associated protein 3,2105,101,1.04 [0.87-1.24],0.6516737382262181
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,THSD1,Thrombospondin type-1 domain-containing protein 1,2093,102,0.67 [0.37-1.22],0.1899785916425674
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,THTPA,Thiamine-triphosphatase,2157,104,0.98 [0.78-1.23],0.8597925655694214
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,THY1,Thy-1 membrane glycoprotein,2516,124,3.88 [2.50-6.03],1.6840712014832752e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TIA1,Nucleolysin TIA-1 isoform p40,2426,118,1.04 [0.91-1.19],0.5685644612266573
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TIE1,Tyrosine-protein kinase receptor Tie-1,2530,124,1.45 [0.93-2.24],0.0993734686967723
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TIGAR,"Fructose-2,6-bisphosphatase TIGAR",2426,118,1.18 [0.83-1.67],0.3513667572145327
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TIGIT,T-cell immunoreceptor with Ig and ITIM domains,2135,102,1.33 [1.01-1.76],0.0418998753963989
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,2503,122,1.22 [0.86-1.72],0.2630361132746212
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,2168,106,1.13 [0.71-1.78],0.6104028269480819
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,2160,104,0.96 [0.77-1.20],0.7309566909409504
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TIMP1,Metalloproteinase inhibitor 1,2463,120,4.21 [2.82-6.30],2.34798939875679e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TIMP2,Metalloproteinase inhibitor 2,2168,106,1.72 [1.19-2.47],0.0036636262789038
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TIMP3,Metalloproteinase inhibitor 3,2510,121,1.10 [0.98-1.23],0.1144075515679352
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TIMP4,Metalloproteinase inhibitor 4,2505,122,1.84 [1.27-2.67],0.0011787276584179
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TINAGL1,Tubulointerstitial nephritis antigen-like,2494,123,3.75 [1.94-7.26],8.399361591028586e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TJAP1,Tight junction-associated protein 1,2497,124,1.06 [0.88-1.29],0.5168915754494756
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TJP3,Tight junction protein ZO-3,2108,103,1.04 [0.67-1.61],0.8649762034205539
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TK1,"Thymidine kinase, cytosolic",2135,102,1.18 [0.81-1.73],0.3934071917518724
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TLR1,Toll-like receptor 1,2106,103,2.40 [1.29-4.46],0.0054561721835971
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TLR2,Toll-like receptor 2,2135,102,1.88 [0.82-4.32],0.1374551206234689
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TLR3,Toll-like receptor 3,2530,124,1.07 [0.83-1.37],0.6023239057189876
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TLR4,Toll-like receptor 4,2106,103,1.40 [0.73-2.69],0.3098621698444035
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,2119,101,0.89 [0.61-1.30],0.5543937432712714
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TMED1,Transmembrane emp24 domain-containing protein 1,2135,102,1.22 [0.87-1.72],0.2439363794339251
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TMED10,Transmembrane emp24 domain-containing protein 10,2105,101,0.95 [0.58-1.55],0.8282586386998186
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TMED4,Transmembrane emp24 domain-containing protein 4,2105,101,0.82 [0.53-1.25],0.3496048776395944
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TMED8,Protein TMED8,2165,101,0.99 [0.83-1.20],0.941121884128186
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TMEM106A,Transmembrane protein 106A,2161,104,0.91 [0.69-1.19],0.4798609226084513
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TMEM132A,Transmembrane protein 132A,2110,105,0.64 [0.47-0.86],0.0038228192871747
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TMEM25,Transmembrane protein 25,2162,104,1.46 [1.02-2.10],0.0403087275416386
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TMOD4,Tropomodulin-4,2087,102,0.88 [0.54-1.44],0.6135001529829063
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TMPRSS11B,Transmembrane protease serine 11B,2108,103,1.03 [0.80-1.32],0.8380633866249841
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TMPRSS11D,Transmembrane protease serine 11D,2153,104,1.52 [1.00-2.31],0.0522804002757061
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TMPRSS15,Enteropeptidase,2479,123,1.32 [1.11-1.57],0.0021146603242408
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TMPRSS5,Transmembrane protease serine 5,2466,121,1.87 [1.23-2.86],0.0036437572128861
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TMSB10,Thymosin beta-10,2505,122,1.21 [0.98-1.51],0.0749051726611533
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TNC,Tenascin,2503,122,1.45 [1.07-1.97],0.0171643952471491
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TNF,Tumor necrosis factor,2448,118,1.71 [1.30-2.24],0.0001076008772907
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TNFAIP2,Tumor necrosis factor alpha-induced protein 2,2165,101,1.13 [0.80-1.60],0.4806475267519819
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TNFAIP8,Tumor necrosis factor alpha-induced protein 8,2444,122,1.06 [0.69-1.62],0.7878700343554477
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,2132,103,0.77 [0.56-1.05],0.1015611060632494
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,2476,122,2.69 [2.14-3.38],2.6520833520285265e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,2476,122,1.66 [1.47-1.87],3.0896626812751592e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,2509,123,1.76 [1.24-2.49],0.0016570199304318
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,2530,124,3.08 [2.38-3.98],1.1710447659028773e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,2500,121,3.35 [2.14-5.25],1.149824533999481e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,2497,124,4.45 [3.24-6.11],2.346161747486832e-20
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,2505,121,2.32 [1.73-3.12],2.1324191983010413e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,2444,122,1.23 [0.86-1.76],0.2491879748168557
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,2505,121,3.80 [2.82-5.12],1.6483221217780549e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TNFRSF17,Tumor necrosis factor receptor superfamily member 17,2132,103,1.87 [1.20-2.90],0.0055014246407592
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,2516,125,2.79 [2.14-3.64],3.4628118367186205e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,2505,122,5.41 [3.83-7.64],9.50351682527757e-22
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,2505,122,1.80 [1.51-2.14],3.3401981515598377e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,2516,124,3.93 [2.48-6.24],6.001327659222992e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,2524,124,3.68 [2.73-4.95],7.451597067488942e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,2476,122,1.48 [1.16-1.89],0.0016362107371862
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,2516,124,1.71 [1.26-2.34],0.0006610409865676
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,2476,122,2.21 [1.77-2.77],2.617833009720369e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TNFSF10,Tumor necrosis factor ligand superfamily member 10,2530,124,0.89 [0.49-1.63],0.7123556392661142
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TNFSF11,Tumor necrosis factor ligand superfamily member 11,2500,123,0.83 [0.64-1.09],0.1840544833948688
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TNFSF12,Tumor necrosis factor ligand superfamily member 12,2530,124,1.14 [0.66-1.96],0.641760506437647
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TNFSF13,Tumor necrosis factor ligand superfamily member 13,2510,121,5.11 [3.14-8.31],4.5751997579343646e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,2529,124,2.08 [1.29-3.35],0.0026733258153229
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TNFSF14,Tumor necrosis factor ligand superfamily member 14,2476,122,1.04 [0.79-1.38],0.7694375650596466
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TNFSF8,Tumor necrosis factor ligand superfamily member 8,2175,103,1.66 [1.06-2.61],0.0268877379277182
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TNIP1,TNFAIP3-interacting protein 1,2160,104,1.08 [0.87-1.34],0.4735960404378709
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TNN,Tenascin-N,2175,103,2.02 [1.31-3.10],0.0013465622210496
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TNNI3,"Troponin I, cardiac muscle",2451,119,1.09 [0.89-1.33],0.4231402419635753
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TNPO1,Transportin-1,2135,102,0.81 [0.47-1.40],0.4458077188691631
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TNR,Tenascin-R,2476,122,1.60 [1.11-2.31],0.0125514413788267
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TNXB,Tenascin-X,2505,122,0.55 [0.31-0.96],0.0356769361932998
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TOMM20,Mitochondrial import receptor subunit TOM20 homolog,2168,106,1.02 [0.80-1.31],0.8672511460472377
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TOP1,DNA topoisomerase 1,2165,101,0.96 [0.82-1.11],0.5619024024023416
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TOP1MT,"DNA topoisomerase I, mitochondrial",2087,102,0.77 [0.49-1.21],0.25705644819801
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TOP2B,DNA topoisomerase 2-beta,2106,103,1.04 [0.82-1.31],0.7461282578105264
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TOR1AIP1,Torsin-1A-interacting protein 1,2110,105,1.05 [0.74-1.48],0.7923417733790082
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TP53,Cellular tumor antigen p53,2421,119,1.16 [0.81-1.66],0.4176217343679134
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TP53BP1,TP53-binding protein 1,2106,103,1.08 [0.86-1.35],0.5135854034244862
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TP53I3,Quinone oxidoreductase PIG3,2082,100,0.92 [0.63-1.33],0.6571515377037774
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TP53INP1,Tumor protein p53-inducible nuclear protein 1,2451,119,0.66 [0.34-1.30],0.2318083368098549
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TP73,Tumor protein p73,2119,101,0.71 [0.39-1.27],0.2444489446481161
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TPBGL,Trophoblast glycoprotein-like,2119,101,0.54 [0.30-0.98],0.0409721464090037
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TPD52L2,Tumor protein D54,2132,103,0.92 [0.77-1.10],0.3403835666136402
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TPK1,Thiamin pyrophosphokinase 1,2168,106,0.47 [0.24-0.90],0.022402630669435
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TPM3,Tropomyosin alpha-3 chain,2105,101,1.49 [1.03-2.18],0.0365671305953729
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TPMT,Thiopurine S-methyltransferase,2421,119,0.79 [0.62-1.01],0.0598308538230857
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TPP1,Tripeptidyl-peptidase 1,2482,121,1.42 [1.04-1.95],0.0282021059781263
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TPPP2,Tubulin polymerization-promoting protein family member 2,2135,102,1.14 [0.88-1.47],0.3252238125629932
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TPPP3,Tubulin polymerization-promoting protein family member 3,2431,119,1.19 [0.76-1.87],0.4418265257133381
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TPR,Nucleoprotein TPR,2105,101,1.05 [0.73-1.50],0.8099248546245378
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TPRKB,EKC/KEOPS complex subunit TPRKB,2087,102,1.14 [0.88-1.47],0.3317095690861104
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TPSAB1,Tryptase alpha/beta-1,2526,124,1.34 [0.97-1.85],0.0762728388681838
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TPSD1,Tryptase delta,2162,104,1.71 [1.10-2.65],0.0163749367231163
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TPSG1,Tryptase gamma,2106,103,0.56 [0.26-1.23],0.1467433353924134
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TPT1,Translationally-controlled tumor protein,2444,122,1.01 [0.78-1.32],0.9141798720799124
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TRAF2,TNF receptor-associated factor 2,2500,123,1.21 [0.97-1.52],0.0955840562303944
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TRAF3,"TNF receptor-associated factor 3, Isoform 2",2106,103,0.80 [0.46-1.37],0.4102499311676757
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,2105,101,1.02 [0.70-1.48],0.9233628764891378
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,2135,102,1.03 [0.84-1.28],0.7562903932565753
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TREH,Trehalase,2175,103,1.19 [0.92-1.54],0.1816616894439636
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TREM2,Triggering receptor expressed on myeloid cells 2,2500,121,1.32 [1.01-1.71],0.0425599458670023
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TREML1,Trem-like transcript 1 protein,2174,105,0.97 [0.67-1.39],0.8557003796556399
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TREML2,Trem-like transcript 2 protein,2505,122,2.03 [1.33-3.09],0.000968551805196
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TRIAP1,TP53-regulated inhibitor of apoptosis 1,2516,125,1.30 [1.01-1.68],0.0441691034800331
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TRIM21,E3 ubiquitin-protein ligase TRIM21,2500,123,0.86 [0.69-1.06],0.1541936536600829
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TRIM24,Transcription intermediary factor 1-alpha,2132,102,0.97 [0.72-1.31],0.8477812622370089
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,2165,101,1.08 [0.90-1.29],0.4100183817465206
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TRIM26,Tripartite motif-containing protein 26,2087,102,0.91 [0.63-1.31],0.6209376694685815
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TRIM40,E3 ubiquitin ligase TRIM40,2119,101,0.82 [0.64-1.06],0.1317826559844322
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TRIM5,Tripartite motif-containing protein 5,2500,123,1.02 [0.85-1.22],0.8443408782486265
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TRIM58,E3 ubiquitin-protein ligase TRIM58,2161,104,1.00 [0.81-1.23],0.9968999091871628
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TRPV3,Transient receptor potential cation channel subfamily V member 3,2105,101,0.86 [0.57-1.29],0.45921188108245
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TSC1,Hamartin,2106,103,1.06 [0.82-1.36],0.680835668829001
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TSC22D1,TSC22 domain family protein 1,2162,104,1.09 [0.82-1.45],0.5624862857046042
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TSHB,Thyrotropin subunit beta,2498,123,0.75 [0.60-0.93],0.01038854077501
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TSLP,Thymic stromal lymphopoietin,2451,119,1.17 [0.94-1.47],0.1650700677998951
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TSNAX,Translin-associated protein X,2105,101,0.80 [0.47-1.34],0.3962624734460803
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TSPAN1,Tetraspanin-1,2451,119,0.77 [0.61-0.98],0.0302027005606283
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TSPAN15,Tetraspanin-15,2105,101,1.17 [0.85-1.62],0.3364145694361438
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TSPAN7,Tetraspanin-7,2108,103,0.70 [0.53-0.93],0.0147506851717017
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TSPAN8,Tetraspanin-8,2165,101,1.05 [0.87-1.27],0.6054007016827326
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TSPYL1,Testis-specific Y-encoded-like protein 1,2106,103,1.03 [0.63-1.66],0.9167419303019548
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TST,Thiosulfate sulfurtransferase,2428,118,0.96 [0.76-1.20],0.7219017907316583
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TTF2,Transcription termination factor 2,2119,101,1.02 [0.69-1.50],0.914203345111174
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TTN,Titin,2105,101,1.08 [0.82-1.42],0.5998241110049187
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TTR,Transthyretin,2147,103,1.07 [0.53-2.16],0.8498721684955564
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TUBB3,Tubulin beta-3 chain,2108,103,1.33 [0.65-2.74],0.4394004676882436
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TWF2,Twinfilin-2,2175,103,0.99 [0.79-1.24],0.931969381482227
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TXK,Tyrosine-protein kinase TXK,2135,102,0.94 [0.72-1.21],0.6188586018465116
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TXLNA,Alpha-taxilin,2476,122,1.08 [0.90-1.30],0.4225054150980807
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TXN,Thioredoxin,2136,102,1.00 [0.62-1.59],0.9854476620842708
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TXNDC15,Thioredoxin domain-containing protein 15,2497,124,2.13 [1.22-3.71],0.007788196335062
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TXNDC5,Thioredoxin domain-containing protein 5,2516,124,1.34 [1.07-1.68],0.0114072648973171
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TXNDC9,Thioredoxin domain-containing protein 9,2160,104,0.98 [0.69-1.40],0.9076472969720972
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TXNL1,Thioredoxin-like protein 1,2106,103,0.93 [0.76-1.14],0.4909632516185183
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TXNRD1,"Thioredoxin reductase 1, cytoplasmic",2505,122,0.93 [0.66-1.31],0.6668387764468717
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TYMP,Thymidine phosphorylase,2480,120,1.00 [0.78-1.29],0.9693945342490944
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TYRO3,Tyrosine-protein kinase receptor TYRO3,2498,123,2.20 [1.27-3.80],0.0049744142876714
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",2106,103,1.49 [1.09-2.03],0.0116227436561546
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,UBAC1,Ubiquitin-associated domain-containing protein 1,2479,123,0.96 [0.60-1.53],0.8543697554446525
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,UBE2B,Ubiquitin-conjugating enzyme E2 B,2161,104,0.63 [0.31-1.31],0.2179486494146769
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,2168,106,1.23 [0.90-1.69],0.1838532572148722
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,UBE2Z,Ubiquitin-conjugating enzyme E2 Z,2106,103,0.93 [0.65-1.35],0.7133320426351698
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,UBQLN3,Ubiquilin-3,2105,101,1.34 [1.10-1.64],0.0041655301173218
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,UBXN1,UBX domain-containing protein 1,2132,103,1.00 [0.76-1.32],0.9865448905497328
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,2165,101,1.01 [0.87-1.16],0.9302129940635284
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,UGDH,UDP-glucose 6-dehydrogenase,2105,101,1.08 [0.91-1.30],0.3804477626317679
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,UHRF2,E3 ubiquitin-protein ligase UHRF2,2105,101,0.73 [0.36-1.47],0.3781538397916905
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ULBP2,UL16-binding protein 2,2476,122,3.98 [2.85-5.57],6.324088668929072e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,UMOD,Uromodulin,2524,124,0.55 [0.43-0.70],1.893398699071662e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,UNC5D,Netrin receptor UNC5D,2106,103,1.48 [0.81-2.71],0.1989648552446814
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,UNC79,Protein unc-79 homolog,2087,102,1.08 [0.78-1.51],0.6338553287680566
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,UNG,Uracil-DNA glycosylase,2161,104,1.03 [0.58-1.83],0.9098174728562862
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,UPB1,Beta-ureidopropionase,2168,106,0.94 [0.78-1.13],0.4893461127589749
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,UPK3A,Uroplakin-3a,2108,103,0.87 [0.60-1.25],0.4447210250936296
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,UPK3BL1,Uroplakin-3b-like protein 1,2132,102,1.20 [0.94-1.54],0.1494270373678265
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,UROD,Uroporphyrinogen decarboxylase,2132,103,0.99 [0.74-1.32],0.9335864027573416
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,UROS,Uroporphyrinogen-III synthase,2119,101,0.87 [0.64-1.19],0.3751282496677882
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,USO1,General vesicular transport factor p115,2479,123,1.03 [0.86-1.24],0.713087772630273
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,USP25,Ubiquitin carboxyl-terminal hydrolase 25,2161,104,1.13 [0.87-1.48],0.3673613646058085
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,USP28,Ubiquitin carboxyl-terminal hydrolase 28,2160,104,1.83 [1.24-2.72],0.0024812582901539
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,USP47,Ubiquitin carboxyl-terminal hydrolase 47,2105,101,0.93 [0.74-1.17],0.5510360930965645
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,USP8,Ubiquitin carboxyl-terminal hydrolase 8,2451,119,1.06 [0.89-1.26],0.5177006727471211
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,UXS1,UDP-glucuronic acid decarboxylase 1,2421,119,1.27 [0.97-1.67],0.0853179867227216
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,VAMP5,Vesicle-associated membrane protein 5,2451,119,1.34 [1.07-1.68],0.0103655849092804
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,VAMP8,Vesicle-associated membrane protein 8,2106,103,0.95 [0.76-1.18],0.629108442415135
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,VASH1,Tubulinyl-Tyr carboxypeptidase 1,2500,123,1.03 [0.85-1.24],0.7970943509389558
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,VASN,Vasorin,2460,121,3.20 [1.94-5.28],5.210247616676658e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,VASP,Vasodilator-stimulated phosphoprotein,2174,105,0.91 [0.70-1.18],0.4903034005724719
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,VAT1,Synaptic vesicle membrane protein VAT-1 homolog,2479,123,0.63 [0.29-1.40],0.2596829789972323
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,VAV3,Guanine nucleotide exchange factor VAV3,2108,103,1.02 [0.84-1.24],0.8060317523585042
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,VCAM1,Vascular cell adhesion protein 1,2503,122,4.47 [2.88-6.92],2.1830364247959467e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,VCAN,Versican core protein,2516,124,2.24 [1.33-3.76],0.0023369449193699
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,VCPKMT,Protein-lysine methyltransferase METTL21D,2087,102,0.89 [0.69-1.16],0.390524104051126
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,VEGFA,Vascular endothelial growth factor A,2520,123,1.53 [1.18-1.98],0.0012951813235066
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,VEGFB,Vascular endothelial growth factor B,2106,103,2.62 [1.44-4.77],0.0016846274511507
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,VEGFC,Vascular endothelial growth factor C,2497,124,1.18 [0.90-1.56],0.2297434762417473
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,VEGFD,Vascular endothelial growth factor D,2524,123,2.73 [1.92-3.88],2.2592140909628496e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,VGF,Neurosecretory protein VGF,2162,104,1.55 [0.88-2.71],0.1280415339181584
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,VIM,Vimentin,2451,119,0.86 [0.75-0.97],0.0144886210325759
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,VIPR1,Vasoactive intestinal polypeptide receptor 1,2110,105,0.73 [0.29-1.84],0.5077957503047754
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,VIT,Vitrin,2168,106,1.60 [1.00-2.57],0.0489736109864998
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,VMO1,Vitelline membrane outer layer protein 1 homolog,2479,123,1.71 [1.32-2.22],5.876460627604638e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,VNN1,Pantetheinase,2174,105,1.19 [0.92-1.54],0.1824092495202753
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,VNN2,Vascular non-inflammatory molecule 2,2479,123,1.47 [1.03-2.10],0.0352321454774133
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,VPS28,Vacuolar protein sorting-associated protein 28 homolog,2135,102,1.12 [0.84-1.50],0.4202164343621187
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,VPS37A,Vacuolar protein sorting-associated protein 37A,2479,123,1.17 [0.96-1.43],0.1175818520647644
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,VPS4B,Vacuolar protein sorting-associated protein 4B,2161,104,0.93 [0.76-1.15],0.501618840823931
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,VPS53,Vacuolar protein sorting-associated protein 53 homolog,2479,123,1.04 [0.85-1.26],0.7341598344626217
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,VSIG10,V-set and immunoglobulin domain-containing protein 10,2161,104,1.17 [0.73-1.88],0.5212845735607217
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,2105,101,1.68 [1.02-2.76],0.0418016292652915
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,VSIG2,V-set and immunoglobulin domain-containing protein 2,2161,104,1.98 [1.62-2.42],3.7252470701561796e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,VSIG4,V-set and immunoglobulin domain-containing protein 4,2500,121,3.70 [2.75-4.98],5.381763335721876e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,2494,123,0.99 [0.77-1.28],0.956601200884708
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,VSNL1,Visinin-like protein 1,2160,104,0.53 [0.32-0.86],0.0095929454085615
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,VSTM1,V-set and transmembrane domain-containing protein 1,2431,119,1.54 [1.14-2.08],0.0052739006566388
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,VSTM2B,V-set and transmembrane domain-containing protein 2B,2135,102,0.83 [0.49-1.39],0.4698054374725059
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,2451,119,1.30 [1.01-1.67],0.0429483113784085
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,2516,124,0.95 [0.75-1.20],0.663032623959831
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,VTCN1,V-set domain-containing T-cell activation inhibitor 1,2421,119,1.90 [1.29-2.78],0.0010896723934877
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,2132,103,1.04 [0.75-1.44],0.8006015487136274
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,VWA1,von Willebrand factor A domain-containing protein 1,2513,125,1.68 [1.16-2.44],0.0057867195864881
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,VWA5A,von Willebrand factor A domain-containing protein 5A,2087,102,1.06 [0.85-1.32],0.6296596124809599
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,VWC2,Brorin,2467,121,2.84 [2.02-4.01],2.618578343440764e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,VWC2L,von Willebrand factor C domain-containing protein 2-like,2162,104,1.26 [0.89-1.78],0.1862214350984854
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,VWF,von Willebrand factor,2530,124,1.29 [1.04-1.60],0.0180136715279094
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,WARS,"Tryptophan--tRNA ligase, cytoplasmic",2505,122,1.16 [0.76-1.77],0.4872981885271353
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,WAS,Wiskott-Aldrich syndrome protein,2444,122,1.13 [0.90-1.43],0.2950890094555591
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,WASF1,Wiskott-Aldrich syndrome protein family member 1,2451,119,1.08 [0.91-1.28],0.3574011182080193
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,WASF3,Wiskott-Aldrich syndrome protein family member 3,2431,119,0.96 [0.80-1.15],0.6543722942122394
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,WASHC3,WASH complex subunit 3,2160,104,1.11 [0.87-1.42],0.4006890126958027
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,WASL,Neural Wiskott-Aldrich syndrome protein,2106,103,0.92 [0.65-1.30],0.6335189021517909
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,WDR46,WD repeat-containing protein 46,2161,104,0.94 [0.54-1.62],0.8132565185093009
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,WFDC1,WAP four-disulfide core domain protein 1,2122,101,1.26 [0.95-1.67],0.1155708507088553
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,WFDC12,WAP four-disulfide core domain protein 12,2511,124,1.18 [0.93-1.50],0.174502120221391
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,WFDC2,WAP four-disulfide core domain protein 2,2371,113,3.23 [2.48-4.19],2.181316429797004e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",2469,122,0.95 [0.65-1.39],0.7903756762562739
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",2505,121,2.62 [1.65-4.17],4.81075097023794e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,WIF1,Wnt inhibitory factor 1,2516,125,0.85 [0.54-1.34],0.4890915000136038
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,WNT9A,Protein Wnt-9a,2444,122,3.59 [2.55-5.05],2.2198032852421922e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,2476,122,0.87 [0.64-1.19],0.3948060890450416
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,XCL1,Lymphotactin,2516,125,1.37 [1.08-1.73],0.0083222168624477
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,XG,Glycoprotein Xg,2515,123,3.40 [2.47-4.66],3.5656696020035336e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,XIAP,E3 ubiquitin-protein ligase XIAP,2106,103,1.20 [0.88-1.65],0.2545765154161336
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,XPNPEP2,Xaa-Pro aminopeptidase 2,2497,124,0.89 [0.78-1.03],0.1202850233988956
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,XRCC4,DNA repair protein XRCC4,2431,119,0.92 [0.59-1.44],0.7179857084103647
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,YAP1,Transcriptional coactivator YAP1,2160,104,5.40 [3.47-8.40],8.019738155895263e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,YARS1,"Tyrosine--tRNA ligase, cytoplasmic",2165,101,0.99 [0.86-1.13],0.8745799776753448
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,YES1,Tyrosine-protein kinase Yes,2479,123,1.12 [0.97-1.28],0.1144925255035948
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,YJU2,Splicing factor YJU2,2161,104,0.85 [0.46-1.58],0.6140252259171239
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,YOD1,Ubiquitin thioesterase OTU1,2105,101,0.82 [0.60-1.11],0.2039437908830138
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,YTHDF3,YTH domain-containing family protein 3,2444,122,1.01 [0.84-1.22],0.900378745171848
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,YWHAQ,14-3-3 protein theta,2132,103,0.98 [0.76-1.27],0.8898186051287791
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,YY1,Transcriptional repressor protein YY1,2106,103,1.00 [0.50-1.98],0.991981421084654
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ZBP1,Z-DNA-binding protein 1,2106,103,1.14 [0.72-1.81],0.578445927403167
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ZBTB16,Zinc finger and BTB domain-containing protein 16,2421,119,1.20 [0.97-1.48],0.0940652224578587
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ZBTB17,Zinc finger and BTB domain-containing protein 17,2451,119,1.21 [0.86-1.70],0.2643595899542901
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ZCCHC8,Zinc finger CCHC domain-containing protein 8,2105,101,0.94 [0.69-1.29],0.7159934993326711
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ZFYVE19,Abscission/NoCut checkpoint regulator,2165,101,0.93 [0.74-1.15],0.4895197623426129
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ZHX2,Zinc fingers and homeoboxes protein 2,2160,104,1.16 [0.71-1.91],0.5549025001325345
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ZNF174,Zinc finger protein 174,2106,103,0.89 [0.49-1.59],0.6869163627704001
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ZNF75D,Zinc finger protein 75D,2135,102,1.30 [1.02-1.66],0.0323318756400975
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ZNF830,Zinc finger protein 830,2161,104,0.86 [0.64-1.16],0.3328589400282582
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ZNRD2,Protein ZNRD2,2165,101,1.26 [0.98-1.61],0.0702337568061801
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ZNRF4,E3 ubiquitin-protein ligase ZNRF4,2161,104,0.89 [0.61-1.31],0.565984170428308
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ZP3,Zona pellucida sperm-binding protein 3,2110,105,1.04 [0.96-1.12],0.3397976249396319
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ZP4,Zona pellucida sperm-binding protein 4,2087,102,0.52 [0.23-1.15],0.1047164135391983
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ZPR1,Zinc finger protein ZPR1,2108,103,0.95 [0.76-1.19],0.6679412770530968
